
<html lang="en"     class="pb-page"  data-request-id="a28624f6-74fd-47a6-a437-e4213d55e707"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b01279;issue:issue:10.1021/jmcmar.2018.61.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate" /></meta><meta name="dc.Creator" content="Christa C.  Chrovian" /></meta><meta name="dc.Creator" content="Akinola  Soyode-Johnson" /></meta><meta name="dc.Creator" content="Alexander A.  Peterson" /></meta><meta name="dc.Creator" content="Christine F.  Gelin" /></meta><meta name="dc.Creator" content="Xiaohu  Deng" /></meta><meta name="dc.Creator" content="Curt A.  Dvorak" /></meta><meta name="dc.Creator" content="Nicholas I.  Carruthers" /></meta><meta name="dc.Creator" content="Brian  Lord" /></meta><meta name="dc.Creator" content="Ian  Fraser" /></meta><meta name="dc.Creator" content="Leah  Aluisio" /></meta><meta name="dc.Creator" content="Kevin J.  Coe" /></meta><meta name="dc.Creator" content="Brian  Scott" /></meta><meta name="dc.Creator" content="Tatiana  Koudriakova" /></meta><meta name="dc.Creator" content="Freddy  Schoetens" /></meta><meta name="dc.Creator" content="Kia  Sepassi" /></meta><meta name="dc.Creator" content="David J.  Gallacher" /></meta><meta name="dc.Creator" content="Anindya  Bhattacharya" /></meta><meta name="dc.Creator" content="Michael A.  Letavic" /></meta><meta name="dc.Description" content="A single pot dipolar cycloaddition reaction/Cope elimination sequence was developed to access novel 1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridine P2X7 antagonists that contain a syntheticall..." /></meta><meta name="Description" content="A single pot dipolar cycloaddition reaction/Cope elimination sequence was developed to access novel 1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridine P2X7 antagonists that contain a syntheticall..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 20, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01279" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01279" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01279" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01279" /></link>
        
    
    

<title>A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01279" /></meta><meta property="og:title" content="A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0019.jpeg" /></meta><meta property="og:description" content="A single pot dipolar cycloaddition reaction/Cope elimination sequence was developed to access novel 1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridine P2X7 antagonists that contain a synthetically challenging chiral center. The structure–activity relationships of the new compounds are described. Two of these compounds, (S)-(2-fluoro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridin-5-yl)methanone (compound 29) and (S)-(3-fluoro-2-(trifluoromethyl)pyridin-4-yl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridin-5-yl)methanone (compound 35), were found to have robust P2X7 receptor occupancy at low doses in rat with ED50 values of 0.06 and 0.07 mg/kg, respectively. Compound 35 had notable solubility compared to 29 and showed good tolerability in preclinical species. Compound 35 was chosen as a clinical candidate for advancement into phase I clinical trials to assess safety and tolerability in healthy human subjects prior to the initiation of proof of concept studies for the treatment of mood disorders." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01279"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01279">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01279&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01279&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01279&amp;href=/doi/10.1021/acs.jmedchem.7b01279" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 207-223</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01245" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01300" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christa+C.++Chrovian">Christa C. Chrovian</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4971-1538" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Akinola++Soyode-Johnson">Akinola Soyode-Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+A.++Peterson">Alexander A. Peterson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+F.++Gelin">Christine F. Gelin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaohu++Deng">Xiaohu Deng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Curt+A.++Dvorak">Curt A. Dvorak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+I.++Carruthers">Nicholas I. Carruthers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Lord">Brian Lord</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian++Fraser">Ian Fraser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leah++Aluisio">Leah Aluisio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+J.++Coe">Kevin J. Coe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Scott">Brian Scott</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tatiana++Koudriakova">Tatiana Koudriakova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Freddy++Schoetens">Freddy Schoetens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kia++Sepassi">Kia Sepassi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Gallacher">David J. Gallacher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anindya++Bhattacharya">Anindya Bhattacharya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Letavic">Michael A. Letavic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7503-0189" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Janssen Research & Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#10737378627f667971507964633e7a7e7a3e737f7d"><span class="__cf_email__" data-cfemail="bbd8d8d3c9d4cdd2dafbd2cfc895d1d5d195d8d4d6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01279&amp;href=/doi/10.1021%2Facs.jmedchem.7b01279" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 207–223</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 6, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 August 2017</li><li><span class="item_label"><b>Published</b> online</span>20 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 January 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01279" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01279</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D207%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChrista%2BC.%2BChrovian%252C%2BAkinola%2BSoyode-Johnson%252C%2BAlexander%2BA.%2BPeterson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D1%26contentID%3Dacs.jmedchem.7b01279%26title%3DA%2BDipolar%2BCycloaddition%2BReaction%2BTo%2BAccess%2B6-Methyl-4%252C5%252C6%252C7-tetrahydro-1H-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-c%255Dpyridines%2BEnables%2Bthe%2BDiscovery%2BSynthesis%2Band%2BPreclinical%2BProfiling%2Bof%2Ba%2BP2X7%2BAntagonist%2BClinical%2BCandidate%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D223%26publicationDate%3DJanuary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01279"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2691</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01279" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christa&quot;,&quot;last_name&quot;:&quot;C. Chrovian&quot;},{&quot;first_name&quot;:&quot;Akinola&quot;,&quot;last_name&quot;:&quot;Soyode-Johnson&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;A. Peterson&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;F. Gelin&quot;},{&quot;first_name&quot;:&quot;Xiaohu&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Curt&quot;,&quot;last_name&quot;:&quot;A. Dvorak&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;I. Carruthers&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Lord&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Fraser&quot;},{&quot;first_name&quot;:&quot;Leah&quot;,&quot;last_name&quot;:&quot;Aluisio&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;J. Coe&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Scott&quot;},{&quot;first_name&quot;:&quot;Tatiana&quot;,&quot;last_name&quot;:&quot;Koudriakova&quot;},{&quot;first_name&quot;:&quot;Freddy&quot;,&quot;last_name&quot;:&quot;Schoetens&quot;},{&quot;first_name&quot;:&quot;Kia&quot;,&quot;last_name&quot;:&quot;Sepassi&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Gallacher&quot;},{&quot;first_name&quot;:&quot;Anindya&quot;,&quot;last_name&quot;:&quot;Bhattacharya&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Letavic&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;207-223&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01279&quot;},&quot;abstract&quot;:&quot;A single pot dipolar cycloaddition reaction/Cope elimination sequence was developed to access novel 1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridine P2X7 antagonists that contain a synthetically challenging chiral center. The structure–activity relationships of the new compounds are described. Two of these compounds, (S)-(2-fluoro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridin-5-yl)methanone (compound 29) and (S)-(3-fluoro-2-(trifluoromethyl)pyridin-4-yl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridin-5-yl)methanone (compound 35), were found to have robust P2X7 receptor occupancy at low doses in rat with ED50 values of 0.06 and 0.07 mg/kg, respectively. Compound 35 had notable solubility compared to 29 and showed good tolerability in preclinical species. Compound 35 was chosen as a clinical candidate for advancement into phase I clinical trials to assess safety and tolerability in healthy human sub&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01279&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01279" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01279&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01279" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01279&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01279" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01279&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01279&amp;href=/doi/10.1021/acs.jmedchem.7b01279" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01279" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01279" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01279%26sid%3Dliteratum%253Aachs%26pmid%3D29211470%26genre%3Darticle%26aulast%3DChrovian%26date%3D2018%26atitle%3DA%2BDipolar%2BCycloaddition%2BReaction%2BTo%2BAccess%2B6-Methyl-4%252C5%252C6%252C7-tetrahydro-1H-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-c%255Dpyridines%2BEnables%2Bthe%2BDiscovery%2BSynthesis%2Band%2BPreclinical%2BProfiling%2Bof%2Ba%2BP2X7%2BAntagonist%2BClinical%2BCandidate%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D1%26spage%3D207%26epage%3D223%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292038" title="Azides">Azides</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/jmcmar.2018.61.issue-1/20180111/jmcmar.2018.61.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A single pot dipolar cycloaddition reaction/Cope elimination sequence was developed to access novel 1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine P2X7 antagonists that contain a synthetically challenging chiral center. The structure–activity relationships of the new compounds are described. Two of these compounds, (<i>S</i>)-(2-fluoro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (compound <b>29</b>) and (<i>S</i>)-(3-fluoro-2-(trifluoromethyl)pyridin-4-yl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (compound <b>35</b>), were found to have robust P2X7 receptor occupancy at low doses in rat with ED<sub>50</sub> values of 0.06 and 0.07 mg/kg, respectively. Compound <b>35</b> had notable solubility compared to <b>29</b> and showed good tolerability in preclinical species. Compound <b>35</b> was chosen as a clinical candidate for advancement into phase I clinical trials to assess safety and tolerability in healthy human subjects prior to the initiation of proof of concept studies for the treatment of mood disorders.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proinflammatory cytokines may be a significant contributor to the pathology of psychiatric malfunctioning. Indeed, elevated levels of inflammatory biomarkers have been identified in individuals diagnosed with bipolar and major depressive disorders.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The P2X7 receptor is an ATP-gated ion channel involved in a prominent inflammatory cascade in central nervous system (CNS) immune cells (microglia) that results in the release of the “master” inflammatory cytokine IL-1β, so-called because of its role in triggering an acute phase response.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> P2X7 enables the release of IL-1β by converting pro-IL-1β into its mature form. In the CNS this occurs primarily in microglia and triggers a neuroinflammatory cascade. As part of our ongoing interest in the chronic effects of prolonged neuroinflammation, and in particular the role of neuroinflammation in psychiatric conditions, we have been working to advance brain-penetrant selective P2X7 antagonists into clinical proof of concept (PoC) studies in order to study the effect of inhibiting overall IL-1β release (CNS + peripheral) on individuals suffering from mood disorders. Toward this goal, we have found that P2X7 antagonists are efficacious in preclinical chronic models of depression.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Data have also been presented suggesting that P2X7 antagonists that can cross the blood–brain barrier may be the most effective at treating psychiatric conditions.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a></div><div class="NLM_p">At least two selective P2X7 antagonists have advanced into PoC studies for the treatment of Crohn’s disease (CD)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and/or rheumatoid arthritis (RA).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> These two compounds (one from Pfizer<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and one from AstraZeneca<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a>) were both effective at blocking peripheral IL-1β release in ex vivo ATP-activated patient plasma samples. Neither compound ultimately met its desired clinical end point in the studies, and their development for either RA<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> and/or CD<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> was discontinued.</div><div class="NLM_p">We recently disclosed the structure of JNJ-54175446 (<b>1</b>, <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), which has successfully completed initial phase I clinical studies.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Compound <b>1</b> is a potent P2X7 antagonist with significant brain penetration and exhibits dose-dependent P2X7 receptor occupancy in the hippocampus of rats and dogs. It is considered to be a Biopharmaceutical Classification System (BCS) class II compound based on its high permeability and low solubility; in aqueous buffer its solubility was 39 μM at pH 2 and 21 μM at pH 7 but was found to be readily absorbed in preclinical species, with a bioavailability of ∼100% in dog. The predicted human half-life of <b>1</b> was 29 h.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Fused Triazole and Pyrimidine Core P2X7 Antagonists Containing a C-Methyl or -Phenyl Substituent in the Piperidine or Piperazine Ring</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While compound <b>1</b> progressed into preclinical development, the project team remained interested in a backup compound with high solubility as well as differentiated absorption, distribution, metabolism, and elimination (ADME) properties, specifically, one with more rapid elimination.</div><div class="NLM_p last">Throughout our work on P2X7 antagonists containing 5,6-fused cores,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> we have found that a 4<i>R</i>-methyl (as in <b>1</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and <b>2</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>) or -phenyl (as in <b>3</b>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> substituent provides improved potency compared to an unsubstituted 4-position,<a onclick="showRef(event, 'ref10 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref13">(10, 13)</a> particularly in rodent species. The added 4<i>R</i>-substituent also provided improved microsomal stability<a onclick="showRef(event, 'ref9 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref11">(9, 11)</a> and decreased CYP2C19 inhibition.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The recent report describing compound <b>1</b> establishes that a methyl 4<i>R</i>-orientation is the preferred epimer for P2X7 potency of 4-methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridines.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Separately, we have shown that 6-methyl groups also provide benefit in fused ring cores (<b>4</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and <b>5</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>), and the stereochemistry was determined to be <i>S</i> in the examples for which an assignment was conclusively made, including <b>4</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and 1-(5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8<i>H</i>)-yl)methanones.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> It should be noted that while the absolute configuration of <b>5</b> was not determined, the specific rotation value was positive.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The 6<i>S</i>-methyl group had been underexplored with 4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine cores. We thus became interested in investigating (<i>S</i>)-6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridines.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthetic Methodology Development</h3><div class="NLM_p">One challenge in executing this proposal was devising synthetic methods for the rapid assembly of final compounds. Compelling 1,2,3-triazole syntheses includes click chemistry of an alkyne and an azide.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In our case of a fused triazole, this would be followed by elaborating the 5-position of the ring with functionality that could, after a ring closing reaction with a 4-methylamino group, form the fused triazole system (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, this strategy is rarely used with Het- or aryl-azides and becomes more challenging given the 6-methyl group we needed to install.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> In an alternative method, the fused triazole can be formed from a diaminopyridine, which is followed by a reduction of the pyridine ring (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B).<a onclick="showRef(event, 'ref13 ref20'); return false;" href="javascript:void(0);" class="ref ref13 ref20">(13, 20)</a> Both of these routes require several challenging steps. With the required absolute configuration, the synthesis becomes additionally arduous. We were interested in developing a concise route to enable rapid access to the 1-Het-6<i>S</i>-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridines and thought that a 1,3-dipolar cycloaddition of an azide and a ketone was worth investigating.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Methods for the Preparation of 1-Het-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridines</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As early as 1967, Huisgen et al. reported 1,3-dipolar cycloadditions with azides and an enamide that could form triazoles in a fused ring system.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This reaction has been more recently elaborated using ketones and azides in the presence of an amine organocatalyst. In one example, Ramachary and co-workers reported the use of activated ketones in an enamine amination/elimination followed by [3 + 2]-cycloaddition/hydrolysis in an organocatalytic cascade as a synthetic approach to substituted 1,2,3-triazoles (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>A).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Perhaps more relevant to our work is the cascade reaction using unactivated ketones reported in 2011 by Belkheira et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In this work, carbocyclic ketones were reacted with aryl azides, presumably via enamine formation, in a dipolar cycloaddition reaction (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>B). We hoped we could extend this methodology to the formation of 6-methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridines from unsymmetrical ketone heterocycles containing a chiral center (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>C). We kept in mind, however, that the altered electronics and added steric bulk of our starting ketone (versus the literature), as well as the need for a specific regiochemical outcome, could make the optimization challenging.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Fused 1,2,3-Triazoles by an Enamine Amination/Elimination Followed by [3 + 2]-Cycloaddition/Hydrolysis Organocatalytic Cascade</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initial investigations were conducted using phenyl azide and ketone <i>rac</i>-<b>6</b> following the protocol reported by Belkheira et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We found that the reaction did not proceed with <b>6</b> using their optimized conditions of catalytic proline and CH<sub>2</sub>Cl<sub>2</sub> solvent (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, entry 1). We found that when pyrrolidine was used instead of proline, the reaction proceeded, albeit in low yields (entry 2). However, the products that were isolated contained a pyrrolidine adduct (<b>7a</b> and <b>8a</b>), which we supposed was an intermediate that could be readily converted to the desired product. It was not surprising that the yield improved when a full equivalent of pyrrolidine was used (entry 3). Comparable yields were achieved with ethanol solvent (entry 4) and were higher using toluene (entry 5).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial Results of a Dipolar Cycloaddition with 2-Methylpiperidone and Phenyl Azide</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0012.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">amine</th><th class="colsep0 rowsep0" align="center">solvent</th><th class="colsep0 rowsep0" align="center">conditions</th><th class="colsep0 rowsep0" align="center">isolated yield<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">proline, catalytic</td><td class="colsep0 rowsep0" align="left">DCM</td><td class="colsep0 rowsep0" align="left">rt or 80 °C, microwave</td><td class="colsep0 rowsep0" align="left">no reaction</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">pyrrolidine, catalytic</td><td class="colsep0 rowsep0" align="left">DCM</td><td class="colsep0 rowsep0" align="left">80 °C, microwave</td><td class="colsep0 rowsep0" align="left"><5% <b>7a</b> + <b>8a</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">pyrrolidine, 1 equiv</td><td class="colsep0 rowsep0" align="left">DCM</td><td class="colsep0 rowsep0" align="left">80 °C, microwave</td><td class="colsep0 rowsep0" align="left">34% <b>7a</b> + <b>8a</b> (1:1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">pyrrolidine, 1 equiv</td><td class="colsep0 rowsep0" align="left">EtOH</td><td class="colsep0 rowsep0" align="left">120 °C, microwave</td><td class="colsep0 rowsep0" align="left">29% <b>7a</b> + <b>8a</b> (1:1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">pyrrolidine, 1 equiv</td><td class="colsep0 rowsep0" align="left">toluene</td><td class="colsep0 rowsep0" align="left">100 °C</td><td class="colsep0 rowsep0" align="left">63% <b>7a</b> + <b>8a</b> (1:1)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">In these examples, the yields and relative ratios of <b>7a</b> and <b>8a</b> were not rigorously determined.</p></div></div></div><div class="NLM_p">Unfortunately, attempts to facilitate an acid catalyzed elimination of <b>7a</b> + <b>8a</b> to form <b>9a</b> + <b>10a</b> were unsuccessful using either catalytic or stoichiometric amounts of <i>p</i>-TSA. One thought we had was to use oxidative conditions in order to set up a Cope elimination. Gratifyingly, after treating an isolated mixture of <b>7a</b> + <b>8a</b> (1:1) with <i>m</i>-CPBA, a rapid transformation occurred to form <b>9a</b> + <b>10a</b> in a 1:1 ratio and 83% isolated yield (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). In fact, this elimination could even be conducted in a single pot format, following the [3 + 2] cycloaddition step. The best overall yields for the sequence were obtained when we combined the ketone, azide, and pyrrolidine at once with heating. Then, after formation of the intermediates <b>7</b> and <b>8</b> in roughly 2 h, <i>m-</i>CPBA was added. Due to this development, our experimental procedure for forming fused triazoles was now quite simple in that three steps, (i) enamine formation, (ii) dipolar cycloaddition, and (iii) Cope elimination, are conducted in a single pot.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Pyrrolidine Adduct Elimination via Oxidation and Cope Elimination</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, an unresolved problem remained for the formation of phenyl-substituted 6-methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridines. There was no regioselectivity for the formation of <b>7a</b> versus <b>8a</b>. Since the reaction appeared to have many variables that could potentially be optimized, we undertook a more detailed investigation of nitrogen protecting groups, amine bases, solvents, and temperatures.</div><div class="NLM_p">The next reaction optimizations were conducted using 2-azido-5-fluoropyrimidine (the same pyrimidine featured in <b>1</b>) and N-protected 2-methylpiperidones (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). A solvent and temperature screen revealed that the best yields and regioselectivities were obtained at higher temperatures with toluene or 1,4-dioxane (entries 1–6). Dean–Stark conditions had minimal impact on the regioselectivity and yield (entry 7). It is interesting to note that using phenyl azide under the best reaction conditions resulted in a significantly lower regioselectivity than when the fluoropyrimidine azide was used (compare entry 1, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> (88:12) with entry 5, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> (1:1)). This is a curious and unexpected finding. One possible reason for this could be that the electron deficiency of the fluoropyrimidine azide favors a thermodynamic product by enabling reversibility, although this hypothesis has not been tested. The nitrogen protecting groups were also screened, and carbamate protecting groups worked well but <i>N</i>-methyl and -benzyl groups resulted in no reaction (entries 8–11). A screen of secondary amines appeared to favor the use of unsubstituted pyrrolidine (a subset of amines is shown in entries 12–16). Proline once again did not promote the reaction (entry 14).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. One Pot Dipolar Cycloaddition/Cope Elimination Reaction Optimization Using 2-Azido-5-fluoropyrimidine</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0013.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0014.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Reported as isolated yield of the mixture of regioisomers.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">The result is the average yield of <i>n</i> = 5 reactions.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Byproducts were observed but not characterized.</p></div></div><div></div></div><div class="NLM_p">The scope of the reaction was investigated using a variety of carbocyclic and heterocyclic ketones, as well as aryl and alkyl azides. The reaction’s utility is enhanced by the fact that both aromatic and alkyl azides were reactive. All of the reactions in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> were conducted using commercially available azides. The highest yields were with phenyl azide and carbocyclic or N-heterocyclic ketones (<b>11</b>–<b>13</b>), an exception being five-membered ring ketones that did not react to form product (<b>14</b> and <b>17</b>). <i>tert</i>-Butyl 4-oxoazepane-1-carboxylate reacted to form the two possible regioisomeric products with roughly equal preference (1:1 for <b>13a</b>/<b>13b</b> and 1:2 for <b>23a</b>/<b>23b</b>). The oxygen- and sulfur-containing ketones reacted in low to moderate yields (<b>15</b>–<b>16</b> and <b>24</b>–<b>25</b>). Products <b>18</b>–<b>20</b> are examples from reactions using different aromatic azides, and low to moderate yields were obtained in these cases as well. It should be noted, however, that despite low to moderate yields obtained, the ability to form a fused triazole ring system using a variety of functionalized azides is an excellent option for medicinal chemists at the hit-to-lead or lead optimization stage of a program, where facile access to relevant substrates is of high value in order to quickly evaluate structure–activity relationships (SARs).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Screen of Cyclic Ketones in the Dipolar Cycloaddition/Cope Elimination Using Aryl or Alkyl Azides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Reported as isolated yield.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">The yield is the average range of several reactions.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">The product mass was observed not isolated.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> SAR of (1)-(6<i>S</i>-Methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanones</h3><div class="NLM_p">We were eager to apply the [3 + 2] cycloaddition/Cope elimination method to the synthesis of the desired 6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine core in order to evaluate P2X7 SAR. After formation of the core, a Boc deprotection followed by amide bond formation gave the desired final compounds. Compounds <b>26</b>–<b>29</b> and <b>32</b>–<b>40</b> in <a class="ref internalNav" href="#tbl4" aria-label="Tables 4">Tables 4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> were synthesized using this method.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Data for 1-(6<i>S</i>-Methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone P2X7 Antagonists with 2-R<sup>2</sup>,3-(rifluoromethyl)phenyl Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0016.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0017.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were determined by a calcium mobilization assay in 1321N1 cells expressing the recombinant human or rat P2X7 channel, and values reported are the mean of three experiments unless otherwise stated. H is human, r is rat. All data are reported as the mean value of 3–4 assays run in triplicate; IC<sub>50</sub> ± SD values are reported.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">CYP IC<sub>50</sub> values were obtained in human liver microsomes using a “cocktail” of CYP-selective probes for the six isoforms: 1A2, 2C19, 2C8, 2C9, 2D6, 3A4.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Stability in human and rat liver microsomes. Data are reported as extraction ratios where predicted hepatic clearance is divided by the species specific hepatic blood flow.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Data for 1-(6<i>S</i>-Methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone P2X7 Antagonists with Nitrogen-Containing Aromatic Amides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0018.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were determined by a calcium mobilization assay in 1321N1 cells expressing the recombinant human or rat P2X7 channel, and values reported are the mean of three experiments unless otherwise stated. H is human, r is rat. All data are reported as the mean value of 3–4 assays run in triplicate; IC<sub>50</sub> ± SD values are reported.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">CYP IC<sub>50</sub> values were obtained in human liver microsomes using a “cocktail” of CYP-selective probes for the six isoforms: 1A2, 2C19, 2C8, 2C9, 2D6, 3A4.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Stability in human and rat liver microsomes. Data are reported as extraction ratios where predicted hepatic clearance is divided by the species specific hepatic blood flow.</p></div></div><div></div></div><div class="NLM_p">We began with 2,3-substituted benzamide analogs in order to evaluate SAR of different <i>N</i>-aryl triazole substituents. This choice was made due to previous work that established 2,3-halo, -alkyl, and -haloalkyl groups to be preferred substituents on the benzamide moiety of 5,6-fused core P2X7 antagonists.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref24'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref24">(9-15, 24)</a> We focused almost exclusively on the 6<i>S</i>-methyl configuration based on earlier findings as well with related cores; all of the 6<i>R</i>-methyl epimers prepared and tested on 6,6- and 5,6-fused cores had poor P2X7 potency.<a onclick="showRef(event, 'ref10 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref10 ref14 ref15">(10, 14, 15)</a></div><div class="NLM_p">Shown in <a class="ref internalNav" href="#tbl4" aria-label="Tables 4">Tables 4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> are IC<sub>50</sub> values of the final compounds as measured in a calcium mobilization assay, as well as their in vitro CYP inhibition, solubility, and liver microsomal turnover extraction ratios (ER). Compounds <b>26</b>–<b>34</b> contain a 2-chloro, -fluoro, or -methyl substituted 3-trifluoromethylphenylamide and the fused triazole is N-linked to a pyridine, pyrazine, pyrimidine, or pyrazole (substituted or unsubstituted) group. They all demonstrated good human P2X7 potency with IC<sub>50</sub> values of 1.7–19 nM. In rat, IC<sub>50</sub> values were also <20 nM, with the exception of <b>33</b> (rP2X7 IC<sub>50</sub> = 404 nM). In this set of compounds, CYP2C19 and 2C9 inhibition was prevalent, although <b>29</b> showed no significant inhibition of any of the six CYP isoforms tested.</div><div class="NLM_p">Many of the compounds in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> have low solubilities. In addition, compounds <b>26</b> and <b>30</b>–<b>34</b> had poor stability in vitro human and rat liver microsomes. The compounds that demonstrated higher stability in liver microsomes have a 5-fluoropyrimidine-substituted triazole (<b>27</b>–<b>29</b>). The electron deficiency of this moiety might explain its lower propensity for oxidative metabolism as compared to the other heteroaromatic groups.</div><div class="NLM_p">Compound <b>29</b> demonstrated good potency and ADME properties worthy of progressing. Still, we continued our SAR exploration by introducing isonicotinamides in place of the benzamide with the thought that we could affect physicochemical properties of the substrates, solubility in particular, and alter their ADME properties (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Compounds with chloro or fluoro substituents in the 3-position of the isonicotinamide were found to be potent both in human and in rat (<b>35</b>, <b>36</b>, <b>39</b>, <b>40</b>), whereas the 3-methyl analog was potent in human but not in rat (<b>37</b>). A trifluoromethyl-substituted pyrazole (<b>38</b>) had poor P2X7 potency (human IC<sub>50</sub> = 4034 nM; rat IC<sub>50</sub> = 2889 nM).</div><div class="NLM_p">The compounds containing isonicotinamides showed excellent aqueous solubility as compared to the benzamide analogs (<b>35</b> vs <b>29</b>, <b>37</b> vs <b>28</b>, <b>36</b> vs <b>27</b>). This improved solubility is likely aided by a decrease in measured partition coefficient at pH 7.4 (log <i>D</i><sub>7.4</sub>) for <b>35</b> (1.65) versus <b>29</b> (2.23). The isonicotinic nitrogen is not basic, however, due to the strongly deficient amide. In an ionization constant (<i>K</i><sub>a</sub>) assay with <b>35</b>, no dissociation was measured in the pH range of 2–12. It also may be that a disruption to crystal packing contributes to the superior solubility of <b>35</b>. Nevertheless, compound <b>35</b> also has superior solubility as compared to lead clinical candidate <b>1</b>, which is an advantage for both formulation work and intestinal absorption in preclinical and clinical studies.</div><div class="NLM_p">The isonicotinamides also helped to improve metabolic stability as well as reduce CYP2C19 inhibition. Introducing a pyrazole, pyridine, or pyrazine to the 1-Het position improved compound solubility (<b>30</b>–<b>33</b>), but these compounds are unstable in liver microsomes and inhibit CYP2C9 and CYP2C19.</div><div class="NLM_p last">Overall compounds <b>29</b> and <b>35</b> had the most promising in vitro profile, and the appeal of <b>35</b> was augmented by its excellent solubility. The two compounds were advanced to in vivo evaluation.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Ex Vivo Receptor Occupancy Studies in Rat</h3><div class="NLM_p">Compounds <b>29</b> and <b>35</b> were next assessed in a receptor occupancy duration of action study measured by ex vivo autoradiography to determine P2X7 target engagement in the rat brain. Animals were dosed 10 mg/kg po, <b>29</b> as a suspension and <b>35</b> as a solution, and receptor occupancy was measured at three time points. The brain versus plasma ratios of <b>29</b> and <b>35</b> were found to be approximately 1:1 or greater at the three time points, indicating high brain distribution for both compounds (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). The 10 mg/kg dose resulted in ≥90% occupancy for both compounds at the 6 h time point. The two compounds were next evaluated in a dose–response receptor occupancy study where they performed especially well, with ED<sub>50</sub> P2X7 occupancy values of 0.06 mg/kg and 0.07 mg/kg for <b>29</b> and <b>35</b>, respectively, in the rat brain (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). These ED<sub>50</sub> values corresponded to brain/plasma EC<sub>50</sub> values of 19/16 and 12/15 ng/mL for <b>29</b> and <b>35</b>, respectively. (The concentrations are the sum of plasma protein bound and unbound fractions.)</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Plasma and Brain Levels and ex Vivo P2X7 Occupancies of <b>29</b> and <b>35</b> in Rat Hippocampus at Three Time Points after a 10 mg/kg Oral Dose<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">plasma levels (ng/mL)</th><th class="rowsep1 colsep0" colspan="3" align="center">brain levels (ng/mL)</th><th class="rowsep1 colsep0" align="center">P2X7 % occup</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">0.5 h</th><th class="colsep0 rowsep0" align="center">2.0 h</th><th class="colsep0 rowsep0" align="center">6.0 h</th><th class="colsep0 rowsep0" align="center">0.5 h</th><th class="colsep0 rowsep0" align="center">2.0 h</th><th class="colsep0 rowsep0" align="center">6.0 h</th><th class="colsep0 rowsep0" align="center">6.0 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">854.9 ± 46</td><td class="colsep0 rowsep0" align="left">1882 ± 103</td><td class="colsep0 rowsep0" align="left">1046 ± 104</td><td class="colsep0 rowsep0" align="left">1056 ± 131</td><td class="colsep0 rowsep0" align="left">2388 ± 597</td><td class="colsep0 rowsep0" align="left">1620 ± 480</td><td class="colsep0 rowsep0" align="left">95 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">3194 ± 275</td><td class="colsep0 rowsep0" align="left">3430 ± 195</td><td class="colsep0 rowsep0" align="left">2437 ± 361</td><td class="colsep0 rowsep0" align="left">3045 ± 292</td><td class="colsep0 rowsep0" align="left">2911 ± 32</td><td class="colsep0 rowsep0" align="left">1993 ± 212</td><td class="colsep0 rowsep0" align="left">96 ± 1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Mean ± SEM (<i>n</i> = 2).</p></div></div></div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dose dependency of P2X7 occupancy of <b>29</b> (0.5% HPMC suspension) and <b>35</b> (20% HP-β-cyclodextrin solution) as measured 2 h after oral administration, as measured in rat brain sections using ex vivo receptor autoradiography. Shown are the mean ± SEM (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The data for compounds <b>29</b> and <b>35</b> compared favorably with previous P2X7 antagonists, as measured by the efficacious doses in rat (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). The compounds in <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a> represent six different structural classes of compounds, and their ED<sub>50</sub> values were all generated using the same radiotracer in the receptor occupancy dose–response assay.<a onclick="showRef(event, 'ref9 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref9 ref11 ref12 ref13 ref14">(9, 11-14)</a> Of this set, a 6,6-fused core compound (<b>5</b>) has the lowest EC<sub>50</sub> values. However, its preclinical pharmacokinetic (PK) data from three species translated to a relatively high human dose prediction.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Compound <b>4</b> also had promising EC<sub>50</sub> receptor occupancy data; however its rat ED<sub>50</sub> was 10-fold higher than for compound <b>29</b> or <b>35</b>. Ameriks et al. suggests that brain uptake of <b>4</b> is perhaps limited by efflux mechanisms, based on its unbound brain-to-plasma partition ratio (<i>K</i><sub>p u,u</sub>) of 0.51.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Compounds <b>2</b> and <b>3</b> also demonstrated inferior ED<sub>50</sub> and EC<sub>50</sub> values compared to <b>29</b> and <b>35</b>. Compound <b>1</b> has advanced as the lead.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> We continued to profile <b>29</b> and <b>35</b> as potential backup compounds.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Comparison of ED<sub>50</sub> Values at 2 h of Previously Reported P2X7 Antagonists with <b>29</b> and <b>35</b> in ex Vivo Receptor Occupancy Studies in Rat</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">ED<sub>50</sub> (mg)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> brain (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> plasma (ng/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">362</td><td class="colsep0 rowsep0" align="char" char=".">125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">408</td><td class="colsep0 rowsep0" align="char" char=".">748</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">108</td><td class="colsep0 rowsep0" align="char" char=".">105</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Scale Up Syntheses and Characterization</h3><div class="NLM_p">Given the excellent results in the target engagement study, compounds <b>29</b> and <b>35</b> were scaled up for further studies. The synthesis of the (<i>S</i>)-1-(5-fluoropyrimidin-2-yl)-6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine core was conducted using our optimized dipolar cycloaddition reaction. 2-Azido-5-fluoropyrimidine was prepared in two steps from 2-chloro-5-fluoropyrimidine and then condensed with <i>tert</i>-butyl (<i>S</i>)-2-methyl-4-oxopiperidine-1-carboxylate (commercially available in 99.7% enantiopurity) (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The yields of the cycloaddition/Cope elimination sequence on scales from 1 to 100 g ranged from 58% to 71%, and the ratio of regioisomers ranged from 88:12 to 91:9 in favor of the 6-methyl regioisomer. The purification of <b>29</b> was a simple wash with hot methanol to give crystalline <b>29</b> in 100% purity. The absolute configuration of the molecule was established by anomalous dispersion using the Parson’s method (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Route Used for Both Medicinal Chemistry and Scale-Up Syntheses of <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) pyrrolidine, toluene, 110 °C, 4 h; <i>m-</i>CPBA, NaHCO<sub>3</sub>, rt, 10 min (58–71%, <b>9b</b>/<b>10b</b> = 9:1); (b) HCl in dioxane, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (<b>41</b>/<b>42</b> = 9:1); (c) 2-fluoro-3-(trifluoromethyl)benzoyl chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h (85% over 2 steps); (d) stir in MeOH, 60 °C, 24 h (55%, >99% ee).</p></p></figure><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Single crystal structure and stereochemical assignment of <b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystallization protocol utilized to obtain pure <b>29</b> was not successful when attempted with compound <b>35</b> because <b>35</b> is highly soluble in organic solvents and did not crystallize under a variety of conditions. In fact, in subsequent studies, identifying a stable polymorph of <b>35</b> has been unachieveable.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In contrast, intermediates <b>26</b> and <b>27</b> were found to be crystalline and could be separated, but due to impure or low recoveries, a slightly different route was used for the largest discovery synthesis. In this sequence, a 100 g cycloaddition/Cope elimination reaction was conducted using intermediate <b>44</b>, which has the final amide in place prior to the cycloaddition (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). The reaction occurred in 69% yield, producing a 10:1 mixture of regioisomers <b>35</b> and <b>30</b> and was followed by SFC (supercritical fluid chromatography) separation to obtain <b>35</b> in 99.5% purity. The overall yield of <b>35</b> from commercially available starting materials was 40%, and this material was used in a variety of preclinical studies.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Scale-Up Route for the Synthesis of <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) oxalyl chloride, DMF, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (b) (<i>S</i>)-2-methyl-4-oxopiperidine, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h (77% over 2 steps); (c) 2-azido-5-fluoropyrimidine, pyrrolidine, <i>p-</i>TSA, toluene, Dean–Stark, 110 °C, 4 h; <i>m-</i>CPBA, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2,</sub> rt, 2 h (69%, <b>35</b>/<b>30</b> = 10:1); (d) SFC separation, 75%.</p></p></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vitro Studies</h3><div class="NLM_p">The key in vitro data set used to advance compounds <b>29</b> and <b>35</b> is shown in <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>. <i>K</i><sub>i</sub> values were measured in the 1321N1 cell line overexpressing human and rat P2X7. Compounds <b>29</b> and <b>35</b> were both quite stable in human and rat liver microsomes, demonstrated insignificant inhibition of nine CYP isoforms (IC<sub>50</sub> ≥ 19 μM), as determined by measuring the effect of <b>29</b> and <b>35</b> on metabolite formation by probe substrates, and had no hERG channel inhibition up to 3 μM as measured in an automated patch-clamp assay. Compounds <b>29</b> and <b>35</b> were not found to be substrates for efflux transporters such as P-glycoprotein (P-gp) in the Caco-2 human intestinal cell line with measured efflux ratios (BA/AB) of <2. Neither compound exhibited CYP3A4 time-dependent inhibition (TDI) in human liver microsomes, and neither induced CYP1A1/2, although <b>29</b> showed moderate activation of human PXR (66% of rifampicin control at 10 μM) and thus has the potential to induce CYP3A4. No significant activity of <b>29</b> or <b>35</b> was measured in a panel of related P2X receptors (P2X1, P2X2, P2X3, P2X2/3, and P2X4 FLIPR assays, tested up to 10 μM), and no significant binding to 50 ion channels, receptors, and transporters was detected in a commercial in vitro panel (Eurofins-CEREP, <a href="http://www.eurofins.com" class="extLink">http://www.eurofins.com</a>, tested at 10 μM). Compound <b>35</b> demonstrated moderate/low plasma protein binding in rat, dog, and human (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>) as determined by an equilibrium dialysis method and is considered to be a BCS class I compound based on its high permeability and high solubility.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vitro ADME and Selectivity Data for <b>29</b> and <b>35</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>29</b></th><th class="colsep0 rowsep0" align="center"><b>35</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rP2X7 <i>K</i><sub>i</sub> <a class="ref internalNav" href="#t8fn1" aria-label="a">a</a> (nM)</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.34</td><td class="colsep0 rowsep0" align="left">2.9 ± 0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hP2X7 <i>K</i><sub>i</sub> <a class="ref internalNav" href="#t8fn1" aria-label="a">a</a> (nM)</td><td class="colsep0 rowsep0" align="left">6.5 ± 1.6</td><td class="colsep0 rowsep0" align="left">7.1 ± 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h/rat/dog/monkey microsomal stability<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.47/0.37/<0.26/0.66</td><td class="colsep0 rowsep0" align="left"><0.30/<0.20/<0.26/<0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP isoform IC<sub>50</sub> (if IC<sub>50</sub> < 50 μM)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">2C19 (30 μM)</td><td class="colsep0 rowsep0" align="left">2C19 (19 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3A4 time-dependent inhibition</td><td class="colsep0 rowsep0" align="left">no</td><td class="colsep0 rowsep0" align="left">no</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP induction</td><td class="colsep0 rowsep0" align="left">3A4</td><td class="colsep0 rowsep0" align="left">no</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">permeability (Caco-2)<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">73/49</td><td class="colsep0 rowsep0" align="left">45/35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG QPatch IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>3</td><td class="colsep0 rowsep0" align="left">>3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h/r plasma proteins (% bound)<a class="ref internalNav" href="#t8fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">75/76</td><td class="colsep0 rowsep0" align="left">47/56</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values are reported as the mean of 4–7 experiments in triplicate. H is human, r is rat. <i>K</i><sub>i</sub> ± SEM is reported.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Stability in liver microsomes. Data are reported as extraction ratios where predicted hepatic clearance is divided by the species specific hepatic blood flow.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Values were determined for CYPs 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4 by incubation with CYP probe substrates as described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last"><i>P</i><sub>app</sub> is reported as [B–A (×10<sup>–6</sup>) cm/s]/[A–B (×10<sup>–6</sup>) cm/s].</p></div><div class="footnote" id="t8fn5"><sup>e</sup><p class="last">Plasma protein binding of 0.2 μM for <b>35</b> and 0.5 μM for <b>29</b> determined by equilibrium dialysis method as previously described.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Preclinical Pharmacokinetics and Human Dose Predictions</h3><div class="NLM_p">The PK of compounds <b>29</b> and <b>35</b> were investigated in preclinical species. The intravenous PK in rat, dog, and monkey were characterized by low or moderate clearance (CL) and moderate volume of distribution (<i>V</i><sub>ss</sub>). The high oral bioavailability (% <i>F</i>) measured across species was suggestive of complete absorption (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Pharmacokinetic Data of <b>29</b> and <b>35</b> in Three Preclinical Species</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center">compound and dose ((iv mg/kg)/(po mg/kg))</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">rat</th><th class="rowsep1 colsep0" colspan="2" align="center">dog</th><th class="rowsep1 colsep0" colspan="2" align="center">monkey</th><th class="rowsep1 colsep0" colspan="2" align="center">human predicted</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>29</b>,<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a> 0.5/2.5</th><th class="colsep0 rowsep0" align="center"><b>35</b>,<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a> 1/5</th><th class="colsep0 rowsep0" align="center"><b>29</b>,<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a> 0.125/0.625</th><th class="colsep0 rowsep0" align="center"><b>35</b>,<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a> 0.25/1.25</th><th class="colsep0 rowsep0" align="center"><b>29</b>,<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a> 0.125/0.625</th><th class="colsep0 rowsep0" align="center"><b>35</b>,<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a> 0.5/2.5</th><th class="colsep0 rowsep0" align="center"><b>29</b></th><th class="colsep0 rowsep0" align="center"><b>35</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">81</td><td class="colsep0 rowsep0" align="left">123</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h) iv</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">21.2</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">541</td><td class="colsep0 rowsep0" align="left">1747</td><td class="colsep0 rowsep0" align="left">305</td><td class="colsep0 rowsep0" align="left">1123</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">1864</td><td class="colsep0 rowsep0" align="left">368</td><td class="colsep0 rowsep0" align="left">105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>24h</sub> ((ng/mL)·h)</td><td class="colsep0 rowsep0" align="left">3190</td><td class="colsep0 rowsep0" align="left">17549</td><td class="colsep0 rowsep0" align="left">3039</td><td class="colsep0 rowsep0" align="left">23262</td><td class="colsep0 rowsep0" align="left">122</td><td class="colsep0 rowsep0" align="left">16262</td><td class="colsep0 rowsep0" align="left">5616</td><td class="colsep0 rowsep0" align="left">1786</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Vehicle is 50% PEG400/50% water.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Vehicle is 20% HP-β-CD.</p></div></div></div><div class="NLM_p">The human CL for <b>29</b> was predicted using three species allometry of unbound CL corrected for in vitro CL. The human <i>V</i><sub>ss</sub> was predicted to be 1.9 L/kg, after correction for plasma protein binding. On the basis of these CL and <i>V</i><sub>ss</sub> values, a half-life estimate in humans was determined to be 6 h. For a dose of 76 mg twice daily, plasma trough levels at steady state would be expected to be above the EC<sub>50</sub> of 98 ng/mL over 24 h (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The plasma concentration over time profile (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) was simulated using the predicted human PK parameters shown in <a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Simulated human plasma concentration profile of <b>29</b> at a dose of 76 mg twice daily over 5 days of administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The human predictions for <b>35</b> were conducted using three species allometry of unbound CL <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <i>V</i><sub>ss.</sub> The human CL and <i>V</i><sub>ss</sub> were predicted to be 0.8 mL min<sup>–1</sup> kg<sup>–1</sup> and 1.1 L/kg, respectively, resulting in a predicted human <i>t</i><sub>1/2</sub> of 16 h. The plasma concentration over time profile (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) was simulated using the predicted human PK parameters shown in <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Simulated human plasma concentration profile of <b>35</b> at a dose of 6 mg once daily over 6 days of administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For a dose of 6 mg once daily, plasma trough levels at steady state are expected to be above the predicted EC<sub>50</sub> of 45 ng/mL over 24 h, when correcting for the human vs rat <i>K</i><sub>i</sub> value differences. The estimated <i>C</i><sub>max</sub> at steady state and AUC in humans for a 6 mg q.d. dose are 105 ng/mL and 1786 (ng/mL)·h, respectively. Given that greater blockade of IL-1β may be important for efficacy, the human dose required to maintain steady state plasma trough concentrations above the EC<sub>80</sub> (225 ng/mL) was also calculated and estimated to be 30 mg q.d., with a corresponding <i>C</i><sub>max</sub> of 525 ng/mL and AUC of 8930 (ng/mL)·h.</div><div class="NLM_p last">On the basis of the predicted human doses, <b>35</b> at this point appeared be the compound of choice to progress further. However, it was decided to assess both <b>29</b> and <b>35</b> in preclinical toleration in the event that <b>29</b> turned out to have a superior safety profile.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Preclinical Toleration Studies</h3><div class="NLM_p">Compounds <b>29</b> and <b>35</b> were taken into rat and dog toleration studies in order to assess their potential toxicity after oral administration, first in single dose escalation, followed by 4- or 5-day repeated dosing toleration studies. The doses selected for <b>29</b> in the 4-day study were 62.5, 125, and 250 mg/kg in rats and 35, 100, and 300 mg/kg in dogs. The doses for <b>29</b> were chosen for comparison purposes to the lead (<b>1</b>),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> with the top doses chosen because of apparent saturation of absorption observed at higher doses in the single dose study. The doses selected for <b>35</b> in the repeated dose studies were 30, 125, 250, and 500 mg kg<sup>–1</sup> day<sup>–1</sup> in rats and 10, 50, and 250 mg kg<sup>–1</sup> day<sup>–1</sup> in dogs. The doses in dog were chosen based on exposure levels in the single dose escalation; the <i>C</i><sub>max</sub> and AUC were approximately the same for 250 mg/kg and 1000 mg/kg doses; thus the highest dose was not tested in the repeated dosing studies. Mortality, body weight, clinical observations, clinical pathology, gross necropsy and microscopic examination of selected tissues, toxicokinetic parameters, and gene expression analysis of liver samples were evaluated.</div><div class="NLM_p">Both compounds were well tolerated in rats and dogs. The only compound-related findings for <b>29</b> in rats were a mild increase in cholesterol (125 and 250 mg/kg) and a slight increase in total protein and albumin (250 mg/kg). In dog, there were no clinical pathology, macroscopic, or microscopic abnormalities for <b>29</b> at any dose. In rats dosed for 4 days at 250 mg kg<sup>–1</sup> day<sup>–1</sup>, the mean day 4 <i>C</i><sub>max</sub> was 9260 ng/mL and AUC<sub>0–24h</sub> was 108 000 ng·h/mL. In dogs, day 5 <i>C</i><sub>max</sub> at the 300 mg kg<sup>–1</sup> day<sup>–1</sup> dose was 5330 ng/mL and AUC<sub>0–24h</sub> was 78 350 ng·h/mL.</div><div class="NLM_p">Compound <b>35</b> exhibited higher exposures overall than <b>29</b>, increasing with dose up to 500 mg/kg in rats and 250 mg/kg in dogs. In rats, doses up to and including 125 mg kg<sup>–1</sup> day<sup>–1</sup> of <b>35</b> were well tolerated. Higher doses (250 and 500 mg kg<sup>–1</sup> day<sup>–1</sup>) were associated with adverse effects, mainly on body weight, weight gain, body temperature, and neurobehavioral integrity. In dogs dosed for 5 days, there were no adverse changes at 10 mg kg<sup>–1</sup> day<sup>–1</sup>. Doses of 50 and 250 mg kg<sup>–1</sup> day<sup>–1</sup> resulted in body weight loss and lower food consumption and were associated with emesis and salivation among other clinical observations. Serum chemistry parameters (ALT, serum triglycerides, and bilirubin) were also affected. Histopathological examination identified the lymphoid tissue (lymphoid depletion of the spleen and/or Peyer’s patches) as target of toxicity in the high dose animals. Although histological changes were absent at the liver, this organ was nevertheless regarded as a potential target organ of toxicity because of the changes in serum chemistry. In rats dosed for 5 days at 125 mg kg<sup>–1</sup> day<sup>–1</sup>, the mean day 5 <i>C</i><sub>max</sub> was 26 000 ng/mL and AUC<sub>0–24h</sub> was 291 000 ng·h/mL. In dogs, the <i>C</i><sub>max</sub> measured on day 4 at the 10 mg kg<sup>–1</sup> day<sup>–1</sup> dose was 10 680 ng/mL and AUC<sub>0–24h</sub> was 167 000 ng·h/mL.</div><div class="NLM_p">The maximum tolerated doses of <b>29</b> and <b>35</b> were determined in rat and dog and used for the calculation of the predicted therapeutic index (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>).</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Tolerated Exposures in Animal Studies and Predicted Human Therapeutic Levels for <b>29</b> and <b>35</b> Used To Calculate Therapeutic Index</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">rat NOAEL</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">dog NOAEL<a class="ref internalNav" href="#t10fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">human predicted concentrations</th><th class="rowsep1 colsep0" colspan="2" align="center">predicted safety margins<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a><i>C</i><sub>max</sub>/AUC</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">mg dose</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">AUC<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">mg dose</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center" char=".">AUC</th><th class="colsep0 rowsep0" align="center" char=".">daily dose (mg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center" char=".">AUC</th><th class="colsep0 rowsep0" align="center">rat/human</th><th class="colsep0 rowsep0" align="center">dog/human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">9260</td><td class="colsep0 rowsep0" align="char" char=".">108000</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">5330</td><td class="colsep0 rowsep0" align="char" char=".">78350</td><td class="colsep0 rowsep0" align="char" char=".">152</td><td class="colsep0 rowsep0" align="char" char=".">368</td><td class="colsep0 rowsep0" align="char" char=".">5616</td><td class="colsep0 rowsep0" align="left">25<i>C</i><sub>max</sub>/19 AUC</td><td class="colsep0 rowsep0" align="left">14<i>C</i><sub>max</sub>/14 AUC</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">125</td><td class="colsep0 rowsep0" align="char" char=".">26000</td><td class="colsep0 rowsep0" align="char" char=".">291000</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">10680</td><td class="colsep0 rowsep0" align="char" char=".">167000</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">105</td><td class="colsep0 rowsep0" align="char" char=".">1786</td><td class="colsep0 rowsep0" align="left">247<i>C</i><sub>max</sub> /163 AUC</td><td class="colsep0 rowsep0" align="left">100<i>C</i><sub>max</sub>/93 AUC</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last">Units for <i>C</i><sub>max</sub> are ng/mL.</p></div><div class="footnote" id="t10fn2"><sup>b</sup><p class="last">Units for AUC are ng·h/mL.</p></div><div class="footnote" id="t10fn3"><sup>c</sup><p class="last">Values shown are the average <i>C</i><sub>max</sub> and AUC for the male and female dog.</p></div><div class="footnote" id="t10fn4"><sup>d</sup><p class="last">Human dose is predicted to translate in a 50% central P2X7 inhibition in humans.</p></div></div></div><div class="NLM_p">Our initial requirements for advancing a second P2X7 compound into the clinic were (1) a highly soluble compound and (2) a compound with predicted PK human parameters consistent with a predicted <i>t</i><sub>1/2</sub> of <30 h. Compound <b>35</b> meets both of these criteria. In addition, the safety margins for <b>35</b> were calculated to be 5- to 10-fold higher than <b>29</b>, and <b>29</b> was shown to have a lower potential for CYP3A4 induction. For these reasons, <b>35</b> was chosen for further detailed evaluation in cardiovascular and pharmacodynamic models.</div><div class="NLM_p last">Compound <b>35</b> was taken into cardiovascular safety studies in the anesthetized guinea pig and dog. No notable electrophysiological effects were found up to the highest doses tested (associated with plasma levels of 15 500 and 12 150 ng/mL). Plasma concentrations of 2820 and 4095 ng/mL of <b>35</b> and higher in dog and guinea pig, respectively, showed increases in blood pressures. The NOAEL were 1280 and 1850 ng/mL in dog and guinea pig, respectively.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Pharmacodynamic Models</h3><div class="NLM_p">The effect of <b>35</b> on brain IL-1β release was investigated in an in vivo microdialysis assay as previously described in freely moving rats challenged with the P2X7 agonist Bz-ATP.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Rats were dosed orally with either vehicle or 10 mg/kg of <b>35</b> 4 h prior to infusion of Bz-ATP via a microdialysis probe. Compared to vehicle, <b>35</b> significantly inhibited Bz-ATP induced IL-1β release in the rat hippocampus at the 5 and 6 h time points (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo microdialysis assay to measure brain IL-1β levels in freely moving rats after oral administration of 10 mg/kg <b>35</b>. IL-1β release was triggered by 2′(3′)-<i>O</i>-(4-benzoylbenzoyl)adenosine-5′-triphosphate (Bz-ATP) infusion (100 mM) in rat hippocampus. Solid line indicates time of Bz-ATP infusion (between the 4 and 6 h time points). IL-1β concentrations are given as mean values ± SEM (<i>n</i> = 7); <i>P</i> < 0.05. Robust <i>t</i> test at 5 and 6 h time points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>35</b> was also evaluated in models of depression and pain.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In a depression model of chronic mild unpredictable stress in rats, the animals’ sucrose intake was lowered after being subjected to a chronic stress regimen for 2 weeks. Compound <b>35</b> was found to reverse this deficit.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The details of this model as well as the full pharmacology of compound <b>35</b> will be published in due course.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>35</b>, JNJ-55308942, has been chosen as the second P2X7 antagonist from Janssen to enter clinical trials, as a backup to compound <b>1</b>. The compound was designed to have high solubility in aqueous media. This physicochemical property was achieved by incorporating an isonicotinamide moiety on a 1-(6<i>S</i>-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone core. Synthetically, the preparation of the 1-((5-fluoropyrimidin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone core featuring the 6<i>S-</i>methyl group was foreseen to be challenging, as existing methods would have made the synthesis lengthy and cumbersome. As such, a novel single pot dipolar cycloaddition/Cope elimination sequence was developed, which constructed the core with a heteroaryl-substituted triazole in place in a single step. This novel method is expected to have utility in the rapid construction of a broader class of fused triazole systems.</div><div class="NLM_p last">Besides having high aqueous solubility, compound <b>35</b> showed an increased plasma free fraction compared to closely related fused 1,2,3-triazole core compounds. This is also thought to be due to the isonicotinamide moiety. Compound <b>35</b> showed excellent P2X7 receptor occupancy in the hippocampus of rats, demonstrating a low ED<sub>50</sub> of 0.07 mg/kg and unbound plasma EC<sub>50</sub> of 12 ng/mL. In addition, <b>35</b> suppressed brain IL-1β release in vivo in freely moving rats challenged with the P2X7 agonist Bz-ATP. The compound also demonstrated good tolerability margins in preclinical species, as well as an acceptable cardiovascular safety profile in vivo. FIH enabling safety studies are currently underway for compound <b>35</b> in anticipation of phase I clinical trials to determine the safety and tolerability of <b>35</b> in healthy human subjects.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Solvents and reagents were used as supplied by the manufacturer. Concentrated refers to concentrated using a rotary evaporator under reduced pressure.</div><div class="NLM_p">Unless specified otherwise, normal-phase silica gel column chromatography was performed on silica gel (SiO<sub>2</sub>) using prepackaged cartridges and the indicated solvents. Preparative reverse-phase high performance liquid chromatography (HPLC) was performed on an Agilent HPLC with a Waters XBridge C18 column or Xterra Prep RP<sub>18</sub> column (5 μm, 30 mm × 100 mm, or 50 mm × 150 mm) and a gradient of 5–99% acetonitrile/water (20 mM NH<sub>4</sub>OH) over 12–18 min and a flow rate of 30 or 80 mL/min, unless otherwise indicated. Preparative SFC was performed on a JASCO preparative SFC system, an APS 1010 system from Berger instruments, or an SFC-PICLAB-PREP 200 (PIC SOLUTION, Avignon, France). The separations were conducted between 100 and 150 bar with a flow rate ranging from 40 to 60 mL/min. The columns used were heated to 35–40 °C.</div><div class="NLM_p">Mass spectra were obtained on an Agilent series 1100 MSD using electrospray ionization (ESI) in positive mode. The calculated (calcd) mass corresponds to the exact mass. HRMS was obtained on a Bruker microTOF, using ESI in positive mode with a scan range of 200–700 amu. Sodium formate solution (Fluka 97574, 100mL) was used to calibrate the TOF and as an internal standard. High accuracy MS was run on an Agilent 5975 series GCMS, EI source. Cerno Biosciences Mass works software was used to process the data. PFTBA was used as an internal calibrant. Nuclear magnetic resonance (NMR) spectra were obtained on Bruker model DRX spectrometers. If rotamers were present, VT NMR was used to determine which peaks coalesce at 120 °C in DMSO-<i>d</i><sub>6</sub>. The <sup>1</sup>H spectra are reported as a mixture of all rotamers at rt in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub>, and the <sup>13</sup>C spectra are reported as the major rotamer only at rt in DMSO-<i>d</i><sub>6</sub>.</div><div class="NLM_p">Melting points (mp) were determined using differential scanning calorimetry (DSC) on a TA Instruments Q100 series instrument equipped with a standard cell (FC). The DSC was cooled using a TA Instruments refrigerated cooling system 90 (RCS 90). Nitrogen gas purge was set to 50 mL/min. The DSC method equilibrated at 25 °C and used a heating ramp of 10 °C/min up to 300 °C. Samples were analyzed in pinhole hermetic pans. Data analysis was performed using TA Universal Analysis software. Data are reported as the range of <i>T</i><sub>onset</sub>–<i>T</i><sub>peak</sub>.</div><div class="NLM_p">All compounds tested were of a minimum of 95% purity as determined by HPLC. The HPLC method used for purity determinations is as follows: Analytical LCMS was obtained on an Agilent 1100/1200 series LCMS with ESI in positive mode and a scan range of 100–700 amu. Samples were run on a Halo C18 column (2.7 μm, 50 mm × 3 mm) with a mobile phase of 5–99% ACN in 0.05% TFA over 3.5 min and then held at 99% ACN for 0.5 min at a flow rate of 1 mL/min (temperature of 50 °C).</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Two-Step Cycloaddition/Cope Elimination Procedure A</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step 1. <i>tert</i>-Butyl (<i>S</i>)-6-Methyl-1-phenyl-7a-(pyrrolidin-1-yl)-1,3a,4,6,7,7a-hexahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>7a</b>) and <i>tert</i>-Butyl (4<i>S</i>)-4-Methyl-1-phenyl-7a-(pyrrolidin-1-yl)-1,3a,4,6,7,7a-hexahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>8a</b>)</h4><div class="NLM_p last">To a solution of <i>rac</i>-<b>6</b> (210 mg, 0.98 mmol) in toluene (5 mL) at 100 °C in a sealed tube was added phenyl azide (152 mg, 1.28 mmol) followed immediately by pyrrolidine (0.08 mL, 0.98 mmol). The reaction was stirred for 75 min at 100 °C and became dark red in color. It was cooled to rt, and a solution of sat. NaHCO<sub>3</sub> (5 mL) was added. After stirring for 30 min the layers were separated and the water layer was extracted once with EtOAc. The organic layers were combined, dried over MgSO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography (SiO<sub>2</sub>; 0–30% EtOAc/hexanes) to give the title compounds (119 mg, 31% for the first eluting peak, <b>8a</b>; 121 mg, 32% for the second eluting peak, <b>7a</b>). MS (ESI) mass calcd C<sub>21</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>, 385.2 for <b>7a</b>; <i>m</i>/<i>z</i> found, 386.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR of <b>7a</b> (400 MHz, CDCl<sub>3</sub>) δ 7.68–7.46 (m, 2H), 7.42–7.29 (m, 2H), 7.17–7.04 (m, 1H), 4.64–4.33 (m, 2H), 3.68–3.00 (br m, 2H), 2.63–2.35 (m, 5H), 2.02–1.89 (m, 1H), 1.82–1.67 (m, 4H), 1.58–1.35 (m, 9H), 1.03 (d, <i>J</i> = 5.7 Hz, 3H). MS (ESI) mass calcd C<sub>21</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>, 385.2 for <b>8a</b>; <i>m</i>/<i>z</i> found, 386.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR of <b>8a</b> (500 MHz, CDCl<sub>3</sub>) δ 7.71–7.61 (m, 2H), 7.39–7.28 (m, 2H), 7.16–7.07 (m, 1H), 4.73 (br s, 1H), 4.27 (s, 1H), 3.37–3.24 (m, 1H), 2.84–2.71 (m, 1H), 2.65–2.51 (m, 4H), 2.43–2.26 (m, 2H), 1.87–1.74 (m, 4H), 1.59–1.35 (m, 12H).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Step 2. <i>tert</i>-Butyl 4-methyl-1-phenyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>9a</b>)</h4><div class="NLM_p last">To a solution of <b>7a</b> (120 mg, 0.31 mmol) in DCM (3 mL) were added NaHCO<sub>3</sub> (25 mg, 0.31 mmol) and <i>m-</i>CPBA (103 mg, 0.46 mmol). The reaction was stirred for 5 min and then 0.6 N NaHSO<sub>3</sub> (3 mL) was added. After stirring for 30 min the layers were separated and the water layer was extracted two times more with DCM. The organic layers were combined, dried over MgSO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography (SiO<sub>2</sub>; 0–100% EtOAc/hexanes) to give the title compound (81 mg, 83%). MS (ESI) mass calcd C<sub>17</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>, 314.1; <i>m</i>/<i>z</i> found, 315.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72–7.50 (m, 5H), 4.93 (d, <i>J</i> = 16.3 Hz, 1H), 4.82–4.72 (m, 1H), 4.18 (d, <i>J</i> = 15.9 Hz, 1H), 3.30–3.19 (m, 1H), 2.65–2.57 (m, 1H), 1.45 (s, 9H), 1.02 (d, <i>J</i> = 6.9 Hz, 3H).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis of 2-Azido-5-fluoropyrimidine</h3><div class="NLM_p"><i>Safety Note: Extreme caution should be exercised when synthesizing/using organic azides. Organic azides are especially sensitive to violent decomposition from external energy sources such as light, heat, friction, and pressure.</i> The stability of an organic azide is dependent upon its chemical structure. 2-Azido-5-fluoropyrimidine underwent thermal and shock sensitivity analysis before isolating quantitiesof >1g. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_001.pdf" class="ext-link">Supporting Information</a> for more details.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Step 1. 5-Fluoro-2-hydrizinylpyrimidine</h4><div class="NLM_p last">To a solution of 2-chloro-5-fluoropyrimidine (0.983 g, 7.42 mmol) in EtOH (10 mL) was added hydrazine monohydrate (0.233 mL, 7.42 mmol). The flask was stirred at reflux for 16 h. The reaction was cooled and evaporated under reduced pressure, and MeOH was added until the solids dissolved. Silica gel was added (10 g), and the solids were concentrated to dryness. The compound was purified by flash chromatography (0–6% 2 N NH<sub>3</sub> in MeOH/DCM gradient over 20 min) to yield the product as a white solid (0.74 g, 78%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (d, <i>J</i> = 1.0 Hz, 2H), 8.19 (s, 1H), 4.13 (s, 2H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Step 2. 2-Azido-5-fluoropyrimidine</h4><div class="NLM_p last">To a solution of 5-fluoro-2-hydrizinylpyrimidine (3.19 g, 24.9 mmol) in 3:1 acetic acid/water (100 mL) at 5 °C was added dropwise over 30 min by addition funnel a solution of sodium nitrite (3.44 g, 49.8 mmol) in water (25 mL). After completion of addition, the reaction was stirred for 2 h at 5 °C and then diluted with more water (100 mL). The solution was extracted with Et<sub>2</sub>O/pentane (1:1) (3 × 100 mL). The organic layers were combined and made basic to pH 8 using saturated Na<sub>2</sub>CO<sub>3</sub> (∼500 mL) and stirring. The layers were separated and the water layer was extracted three times more with Et<sub>2</sub>O/pentane. The organic layers were combined, washed with brine, dried with MgSO<sub>4</sub>, filtered, and evaporated under reduced pressure over an ice bath to give a white solid at 0 °C (2.92 g, 84%) which melted upon warming to rt. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47 (s, 1H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 158.13, 158.12, 156.01, 154.29, 146.91, 146.76. GCMS (EI) mass calcd for C<sub>4</sub>H<sub>2</sub>N<sub>5</sub>F, 139.0289; <i>m</i>/<i>z</i> found 139.0314 (spectral accuracy = 97.43%).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> One-Pot Cycloaddition/Cope Elimination Procedure B</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>tert</i>-Butyl (<i>S</i>)-1-(5-Fluoropyrimidin-2-yl)-6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>9b</b>) and <i>tert</i>-Butyl (<i>S</i>)-1-(5-Fluoropyrimidin-2-yl)-4-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>10b</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-<b>6</b> (2.76 g, 12.9 mmol) in toluene (100 mL) at 100 °C was added 2-azido-5-fluoropyrimidine (2.34 g, 16.8 mmol) as a solution in toluene (15 mL) followed by pyrrolidine (1.06 mL, 12.9 mmol). After stirring for 3 h, the reaction was cooled to 0 °C and CH<sub>2</sub>Cl<sub>2</sub> (100 mL) was added followed by NaHCO<sub>3</sub> (2.17g, 25.9 mmol) and <i>m-</i>CPBA (4.47g, 25.9 mmol). The reaction was allowed to warm to rt over 30 min followed by the addition of 1 N NaOH (100 mL). The organic layer was separated and the water layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> two times. The combined organic layers were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated. Chromatography on silica gel (0–100% ethyl acetate/hexanes) provided the desired product as a mixture of regioisomers. <sup>1</sup>H NMR integration of the C6-methyl group was used to determine the ratio of products (9:1 = <b>9b</b>/<b>10b</b>, 2.85g, 66%). MS (ESI) mass calcd C<sub>15</sub>H<sub>19</sub>FN<sub>6</sub>O<sub>2</sub>, 334.16; <i>m</i>/<i>z</i> found, 335.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR of major regioisomer (500 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 2H), 5.16 (d, <i>J</i> = 16.1 Hz, 1H), 4.96 (br s, 1H), 4.25 (d, <i>J</i> = 16.4 Hz, 1H), 3.38–3.28 (m, 1H), 3.19–3.10 (m, 1H), 1.50 (s, 9H), 1.16 (d, <i>J</i> = 7.0 Hz, 3H).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Procedure for the Preparation of 1-Aryl Substituted Triazoles (Compounds <b>11</b>–<b>20</b>)</h3><div class="NLM_p">To a solution of the ketone (0.5 mmol) in toluene (2.5 mL) under N<sub>2</sub> at 100 °C was added the aryl azide (1.0 mmol) followed by pyrrolidine (0.5 mmol). After stirring at 100 °C for 2 h the reaction was cooled to room temperature, uncapped, and diluted with DCM (2 mL). <i>m-</i>CPBA (0.75 mmol) and NaHCO<sub>3</sub> (1.0 mmol) were added and allowed to stir for 30 min. Saturated NaHCO<sub>3</sub> (2.5 mL) was added and allowed to stir for an additional 30 min. The organic phase was separated, and the aqueous phase was washed 2× with DCM. The organic layers were combined, dried over MgSO<sub>4</sub>, and concentrated. The crude product was purified by column chromatography (0–50% EtOAc/Hex) to afford the triazole product.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>tert</i>-Butyl 1-Phenyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>11</b>)</h4><div class="NLM_p last">Isolated as a light yellow solid (66%). Mp 133.97–136.12 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.57–7.52 (m, 4H), 7.50–7.45 (m, 1H), 4.73 (s, 2H), 3.76 (s, 2H), 2.87 (t, <i>J</i> = 5.58 Hz, 2H), 1.50 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.01, 141.81, 136.49, 130.90, 129.78, 129.08, 122.93, 80.74, 41.94, 40.45, 28.50, 22.47. HRMS calcd for C<sub>16</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 301.1659, found 301.1669.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-Phenyl-4,5,6,7-tetrahydro-1<i>H</i>-benzo[<i>d</i>][1,2,3]triazole (<b>12</b>)</h4><div class="NLM_p last">Isolated as a light yellow solid (59%). Mp 116.46–117.40 °C. <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 7.56–7.49 (m, 4H) 7.44 (m, 1H) 2.84 (t, <i>J</i> = 5.00 Hz, 2H), 2.74 (t, <i>J</i> = 4.99 Hz, 2H), 1.91–1.84 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 144.11, 137.05, 132.21, 129.61, 128.76, 123.29, 22.91, 22.63, 22.10, 22.00. HRMS calcd for C<sub>12</sub>H<sub>13</sub>N<sub>3</sub> [M + H]<sup>+</sup> 200.1182, found 200.1198.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>tert</i>-Butyl 1-Phenyl-4,5,7,8-tetrahydro[1,2,3]triazolo[4,5-<i>d</i>]azepine-6(1<i>H</i>)-carboxylate (<b>13a</b>)</h4><div class="NLM_p last">Isolated as the first of two peaks after chromatographic separation as a white solid (31%). Mp 153.60–157.26 °C. <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 7.52 (m, 3H), 7.43–7.41 (m, 2H), 3.65–3.57 (m, 4H), 3.18–3.12 (m, 2H), 2.92–2.80 (m, 2H), 1.50 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 154.72, 144.86, 136.62, 133.99, 129.48, 125.33, 125.25, 80.21, 47.93, 46.71, 28.51, 27.88, 25.21. HRMS calcd for C<sub>17</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 315.1816, found 315.1830.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>tert</i>-Butyl 1-Phenyl-4,6,7,8-tetrahydro[1,2,3]triazolo[4,5-<i>c</i>]azepine-5(1<i>H</i>)-carboxylate (<b>13b</b>)</h4><div class="NLM_p last">Isolated as the second of two peaks after chromatographic separation as a white solid (32%). Mp 110.57–113.20 °C. <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 7.56–7.50 (m, 3H), 7.44–7.41 (m, 2H), 4.80–4.74 (m, 2H), 3.72–3.64 (m, 2H), 2.82 (t, <i>J</i> = 6.07 Hz, 2H), 1.93 (s, 1H) 1.45(s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.03, 145.18, 136.23, 134.89, 129.48, 125.17, 80.33, 48.45, 44.46, 28.39, 26.14, 23.22. HRMS calcd for C<sub>17</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 315.1816, found 315.1822.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-Phenyl-1,4,6,7-tetrahydropyrano[3,4-<i>d</i>][1,2,3]triazole (<b>15</b>)</h4><div class="NLM_p last">Isolated as a light yellow solid (25%). Mp 92.94–94.65 °C. <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 7.60–7.53 (m, 4H), 7.47 (m, 1H), 4.91 (t, <i>J</i> = 1.28 Hz, 2H), 3.97 (t, <i>J</i> = 5.47 Hz, 2H), 2.93 (tt, <i>J</i> = 5.43 Hz, 1.27 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 142.39, 136.62, 129.84, 129.64, 129.08, 122.84, 64.23, 64.10, 23.61. HRMS calcd for C<sub>11</sub>H<sub>11</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 202.0975, found 202.0980.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-Phenyl-1,4,6,7-tetrahydrothiopyrano[3,4-<i>d</i>][1,2,3]triazole (<b>16</b>)</h4><div class="NLM_p last">Isolated as a yellow amorphous solid (8%). <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 7.57–7.48 (m, 5H), 3.95 (s, 2H), 3.01 (t, <i>J</i> = 5.52 Hz, 2H), 2.91 (t, <i>J</i> = 5.70 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 139.98, 136.62, 131.88, 129.61, 129.21, 123.88, 25.65, 24.57, 23.50. HRMS calcd for C<sub>11</sub>H<sub>11</sub>N<sub>3</sub>S [M + H]<sup>+</sup> 218.0746, found 208.0755.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>tert</i>-Butyl 1-Benzyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>18</b>)</h4><div class="NLM_p last">Isolated as a white solid (38%). Mp 131.43–133.23 °C. <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 7.37–7.32 (m, 3H), 7.21–7.19 (m, 2H), 5.46 (s, 2H), 4.62 (s, 2H), 3.65 (s, 2H), 2.51 (s, 2H), 1.45 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 154.93, 141.73, 134.51, 130.89, 129.22, 128.70, 127.75, 80.67, 52.32, 41.92, 40.26, 28.49, 20.93. HRMS calcd for C<sub>14</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 281.1972, found 281.1967.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>tert</i>-Butyl 1-(4-Fluorophenyl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>19</b>)</h4><div class="NLM_p last">Isolated as a light yellow solid (32% and 50% for <i>n</i> = 2 reactions). Mp 127.95–129.74 °C. <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 7.55–7.51 (m, 2H), 7.22 (m, 2H), 4.72 (s, 2H), 3.76 (s, 2H), 2.83 (t, <i>J</i> = 5.56, 2H), 1.50 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.54, 161.55, 154.87, 141.76, 132.52, 124.85, 124.78, 116.80, 116.62, 80.68, 41.74, 40.33, 28.37, 22.23. HRMS calcd for C<sub>16</sub>H<sub>19</sub>N<sub>4</sub>O<sub>2</sub>F [M + H]<sup>+</sup> 319.1565, found 319.1570.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>tert</i>-Butyl 1-(4-Methoxyphenyl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>20</b>)</h4><div class="NLM_p last">Isolated as an orange oil (13%). <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 7.46–7.43 (m, 2H), 7.04–7.02 (m, 2H), 4.72 (s, 2H), 3.87 (s, 3H), 3.75 (s, 2H), 2.81 (t, <i>J</i> = 5.56, 2H), 1.50 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.11, 155.08, 141.55, 129.56, 124.58, 114.90, 114.36, 80.75, 55.77, 42.12, 40.45, 28.53, 22.28. HRMS calcd for C<sub>17</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 331.1765, found 331.1619.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> General Procedure for the Preparation of 1-Alkyl Substituted Triazoles (Compounds <b>21</b>–<b>25</b>)</h3><div class="NLM_p">The procedure using alkyl azides is the same as the general procedure for aryl azides except the reaction was heated for 18 h at 100 °C.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>tert</i>-Butyl 1-Isopropyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (<b>21</b>)</h4><div class="NLM_p last">Isolated as a yellow oil (55%). <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 4.63 (m, 3H)*, 3.75 (m, 2H), 2.74 (t, <i>J</i> = 5.60 Hz, 2H), 1.59 (d, <i>J</i> = 6.79, 6H), 1.48 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.00, 141.19, 129.59, 80.62, 51.54, 42.05, 40.37, 28.50, 22.49, 21.24. The asterisk (∗) indicates overlapped alkyl singlet from piperdine ring with the septet of isopropyl proton. HRMS calcd for C<sub>13</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 267.1816, found 267.1819.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>tert</i>-Butyl 1-Isopropyl-4,5,6,7-tetrahydro-1<i>H</i>-benzo[<i>d</i>][1,2,3]triazole (<b>22</b>)</h4><div class="NLM_p last">Isolated as a yellow oil (38%). <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 4.55 (sept, <i>J</i> = 6.78, 1H), 2.75 (t, <i>J</i> = 6.0 Hz, 2H), 2.62 (t, <i>J</i> = 6.0 Hz, 2H), 1.83 (m, 4H), 1.57 (d, <i>J</i> = 6.78, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 143.48, 130.77, 51.01, 22.88, 22.75, 22.47, 22.10, 20.59. HRMS calcd for C<sub>9</sub>H<sub>15</sub>N<sub>3</sub> [M + H]<sup>+</sup> 166.1339, found 166.1339.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>tert</i>-Butyl 1-Isopropyl-4,5,7,8-tetrahydro[1,2,3]triazolo[4,5-<i>d</i>]azepine-6(1<i>H</i>)-carboxylate (<b>23a</b>) and <i>tert</i>-Butyl 1-Isopropyl-4,6,7,8-tetrahydro[1,2,3]triazolo[4,5-<i>c</i>]azepine-5(1<i>H</i>)-carboxylate (<b>23b</b>)</h4><div class="NLM_p last">Two products isolated together as a colorless oil (43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.76–4.60 (m, 2H), 4.56–4.44 (m, 2H), 3.73–3.55 (m, 4H), 2.90–2.75 (m, 4H), 2.91–2.74 (m, 4H), 2.03–1.92 (m, 2H), 1.58 (d, <i>J</i> = 6.7 Hz, 12H), 1.50–1.37 (br m, 18H). MS (ESI): mass calcd for C<sub>14</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>, 280.19; found 281.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>tert</i>-Butyl 1-Isopropyl-1,4,6,7-tetrahydrothiopyrano[3,4-<i>d</i>][1,2,3]triazole (<b>25</b>)</h4><div class="NLM_p last">Isolated as an oily solid (13–24%). <sup>1</sup>H NMR (400, MHz, CDCl<sub>3</sub>) δ 4.52 (sept, <i>J</i> = 6.73 Hz, 1H), 3.85 (s, 2H), 2.93 (m, 4H), 1.60 (d, <i>J</i> = 6.75 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 139.50, 130.24, 50.95, 25.59, 23.64, 23.19, 22.36. HRMS calcd for C<sub>8</sub>H<sub>13</sub>N<sub>3</sub>S [M + H]<sup>+</sup> 184.0903, found 184.0908.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>S</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(6-methyl-1-phenyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (<b>26</b>)</h4><div class="NLM_p"><i>Step 1.</i> To a solution of (<i>S</i>)-<b>9a</b> obtained from two-step procedure A (170 mg, 0.54 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added 2 M HCl in diethyl ether (1.4 mL, 2.7 mmol). After stirring overnight at rt, the reaction was concentrated to give (<i>S</i>)-6-methyl-1-phenyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine as a light yellow solid (135 mg, 100%) and used directly in the next reaction. MS (ESI) mass calcd C<sub>12</sub>H<sub>14</sub>N<sub>4</sub>, 214.1; <i>m</i>/<i>z</i> found, 215.3 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 2. General Amide Coupling Conditions.</i> To a solution of (<i>S</i>)-6-methyl-1-phenyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (180 mg, 0.77 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) in triethylamine (0.3 mL, 2.3 mmol) was added 2-chloro-3-(trifluoromethyl)benzoyl chloride. After stirring for 15 min at rt, aqueous sodium bicarbonate was added (2 mL). The water layer was separated and extracted 2× with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were combined, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by flash chromatography (0–100% EtOAc/hexane over 15 min, 40 g column, 40 mL/min). The product was isolated as a colorless oil (172 mg, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.83–7.76 (m, 1H), 7.60–7.43 (m, 7H), 5.84 (dd, <i>J</i> = 16.9, 11.0 Hz, 0.5H), 5.71–5.63 (m, 0.5H), 4.66–4.34 (m, 1.5H), 4.12–4.06 (m, 0.75H), 3.41–3.26 (m, 0.75H), 3.06–2.98 (m, 0.15H), 2.77–2.52 (m, 0.85H), 1.34–1.13 (m, 3H). MS (ESI) mass calcd C<sub>20</sub>H<sub>16</sub>ClF<sub>3</sub>N<sub>4</sub>O, 420.1037; <i>m</i>/<i>z</i> found, 421.1041 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>S</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (<b>27</b>). Step 1. (<i>S</i>)-1-(5-Fluoropyrimidin-2-yl)-6-methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (<b>41</b>)</h4><div class="NLM_p">To a solution of (<i>S</i>)-<b>9b</b> + <b>10b</b> obtained from one-pot procedure B (9:1, 8.33 g, 24.9 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (125 mL) was added 4 M HCl in 1,4-dioxane (31 mL, 125 mmol). After stirring for 4 h, MeOH was added until the oils dissolved. The reaction stirred at rt for 3 d after which the solvents were evaporated in vacuo. The residue was stirred in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) and saturated sodium bicarbonate (200 mL) for 1 h. The layers were separated, and the water layer was extracted 2× with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were combined, dried (MgSO<sub>4</sub>), filtered, and concentrated. The residue was stirred in EtOAc (25 mL) at 40 °C overnight. The solids were collected by suction filtration to give pure <b>41</b> (1.3 g, 22%). The filtrate was concentrated and purified by preparative HPLC (Agilent, Waters XBridge C18 5 μm, 50 mm × 100 mm column, 5–60% MeCN/20 mM NH<sub>4</sub>OH over 13 min, 80 mL/min) to give a second crop of <b>41</b> (1.9 g, 31%) and isolate <b>42</b> (300 mg, 5%). <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.97–9.69 (m, 1H), 9.15 (s, 2H), 4.58–4.35 (m, 2H), 3.80–3.47 (m, 2H), 3.21–3.03 (m, 1H), 1.46 (d, <i>J</i> = 6.5 Hz, 3H). MS (ESI) mass calcd C<sub>10</sub>H<sub>11</sub>FN<sub>6</sub>, 234.23; <i>m</i>/<i>z</i> found, 235.1 [M + H]<sup>+</sup>. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 157.42, 155.67, 151.57, 151.55, 146.82, 146.67, 143.73, 132.90, 76.84, 48.95, 42.11, 32.80, 21.66. <sup>1</sup>H NMR of <b>27</b> (600 MHz, CDCl<sub>3</sub>) δ 8.72 (s, 2H), 4.24–4.17 (m, 1H), 3.41–3.34 (m, 1H), 3.19–3.10 (m, 2H), 3.06–2.98 (m, 1H), 1.58 (d, <i>J</i> = 6.7 Hz, 3H). MS (ESI) mass calcd C<sub>10</sub>H<sub>11</sub>FN<sub>6</sub>, 234.23; <i>m</i>/<i>z</i> found, 235.1 [M + H]<sup>+</sup>. <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 157.43, 155.68, 151.64 (d, <i>J</i> = 3.5 Hz), 147.97, 146.83, 146.68, 132.08, 77.03, 76.81, 48.20, 41.69, 25.77, 20.16.</div><div class="NLM_p"><i>Step 2</i>. Conducted using the general amide coupling conditions (192 mg, 57%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.81–8.69 (m, 2H), 7.82–7.74 (m, 1H), 7.59–7.40 (m, 2H), 5.90–5.79 (m, 0.5H), 5.71–5.60 (m, 0.5H), 4.68–4.31 (m, 1.5H), 4.12–4.06 (m, 0.5H), 3.57–3.07 (m, 2H), 1.39–1.31 (m, 3H). MS (ESI) mass calcd C<sub>18</sub>H<sub>13</sub>ClF<sub>4</sub>N<sub>6</sub>O, 440.0848; <i>m</i>/<i>z</i> found, 441.0861 [M + H]<sup>+</sup>.</div><div class="NLM_p">Compounds <b>28</b>, <b>29</b>, <b>35</b>–<b>38</b> were prepared from intermediate <b>41</b> using the general amide coupling conditions.</div><div class="NLM_p">Compounds <b>32</b>–<b>34</b>, <b>39</b>–<b>40</b> were synthesized using one-pot cycloaddition/Cope elimination procedure B followed by Boc deptrotection as described for <b>26</b> and general amide coupling conditions. Compounds <b>30</b> and <b>31</b> were synthesized using the former route employed prior to this methodology development. It is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p">Compounds <b>28</b>–<b>40</b> were isolated as a mixture of several rotamers. The NMR spectra are reported as a mixture of several rotamers. In most cases obtaining <sup>13</sup>C spectra required highly concentrated samples and resulted in >40 peaks. As such, <sup>13</sup>C data are generally not reported.</div><div class="NLM_p last">For compounds <b>35</b>–<b>40</b>, melting points are not given; these compounds were found to be amorphous by DSC and did not melt or resulted in a gradual melt with decomposition (30–300 °C).</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>S</i>)-1-(5-Fluoropyrimidin-2-yl)-6-methyl-5-{[2-methyl-3-(trifluoromethyl)phenyl]carbonyl}-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (<b>28</b>)</h4><div class="NLM_p last">Isolated as a white solid (98 mg, 52%). Mp 224.27–225.75 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.79–8.70 (m, 2H), 7.75–7.67 (m, 1H), 7.46–7.27 (m, 2H), 5.93–5.81 (m, 0.5H), 5.75–5.62 (m, 0.5H), 4.60–4.30 (m, 1.5H), 4.20–4.08 (m, 0.5H), 3.55–3.04 (m, 2H), 2.55–2.20 (m, 3H), 1.40–1.15 (m, 3H). MS (ESI) mass calcd for C<sub>19</sub>H<sub>16</sub>F<sub>4</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 421.1394; <i>m</i>/<i>z</i> found, 421.1403 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>S</i>)-1-(5-Fluoropyrimidin-2-yl)-5-{[2-fluoro-3-(trifluoromethyl)phenyl]carbonyl}-6-methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (<b>29</b>)</h4><div class="NLM_p"><i>Method I.</i> To a solution of <b>41</b> (213 mg, 0.91 mmol), Hunig’s base (0.3 mL, 1.8 mmol), 2-fluoro-3-(trifluoromethyl)benzoic acid (227 mg, 1.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added 2,4,6-ripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide (50% solution in CH<sub>2</sub>Cl<sub>2</sub>). The reaction was stirred for 3 d, and then water (10 mL) was added. The layers were separated and the organic layer was dried (MgSO<sub>4</sub>). Flash chromatography (0–10% (2 NH<sub>3</sub> in MeOH)/CH<sub>2</sub>Cl<sub>2</sub> gradient) provided the title compound as a white solid (238 mg, 62%). Mp 218.97–219.88 °C. HPLC <i>t</i><sub>R</sub> = 9.478 (stationary phase, CHIRALPAK AD-H 5 μm, 250 mm × 4.6 mm); mobile phase, 90% CO<sub>2</sub>, 10% EtOH).</div><div class="NLM_p last"><i>Method II.</i> To a 9:1 mixture of <b>41</b>/<b>42</b> (7.97 g, 29.4 mmol) and triethylamine (16 mL, 118 mmol) in CH<sub>2</sub>Cl<sub>2</sub> at 0 °C was added 2-fluoro-3-(trifluoromethyl)benzoyl chloride. After stirring for 2 h saturated NaHCO<sub>3</sub> (200 mL) was added. The layers were separated and the water layer was extracted 2× with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were combined and dried (MgSO<sub>4</sub>). The crude material was evaporated to dryness. MeOH (80 mL) was added and the slurry was sonicated and then stirred at 60 °C for 4 h. The solids were collected by suction filtration and allowed to air-dry overnight (5.5 g, 44%). Mp 216.79–218.55 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.79–8.68 (m, 2H), 7.79–7.54 (m, 2H), 7.46–7.30 (m, 1H), 5.97–5.55 (m, 1H), 4.77–4.19 (m, 2H), 3.58–3.11 (m, 2H), 1.43–1.14 (m, 3H). MS (ESI) mass calcd C<sub>18</sub>H<sub>13</sub>F<sub>5</sub>N<sub>6</sub>O, 424.1; <i>m</i>/<i>z</i> found, 424.8 [M + H]<sup>+</sup>. HPLC <i>t</i><sub>R</sub> = 9.478 (stationary phase, CHIRALPAK AD-H 5 μm, 250 mm × 4.6 mm); mobile phase, 90% CO<sub>2</sub>, 10% EtOH). The filtrate was concentrated and purified by SFC (stationary phase, diethylaminopropyl 5 μm, 150 mm × 21.2 mm); mobile phase, 95% CO<sub>2</sub>, 5% MeOH) (3.1 g, 65%). Mp 218.51–220.00 °C. Rotamer peaks were found to coalesce at 120 °C in DMSO-<i>d</i><sub>6</sub>. These data are reported for <b>29</b>: <sup>1</sup>H NMR (600 MHz, DMSO, 120 °C) δ 9.02–8.98 (s, 2H), 7.87–7.82 (m, 1H), 7.80–7.74 (m, 1H), 7.53–7.48 (m, 1H), 5.53–4.81 (m, 1H), 4.45–4.33 (d, <i>J</i> = 15.9 Hz, 1H), 3.30–3.20 (s, 1H), 3.18–3.09 (m, 1H), 1.58–1.44 (m, 1H), 1.23–1.14 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (151 MHz, DMSO, 120 °C) δ 163.49, 157.73, 155.99, 150.92, 150.89, 147.33, 147.18, 138.94, 133.21, 133.18, 130.73, 128.38, 128.35, 126.25, 126.13, 125.63, 125.60, 123.33, 121.53, 117.70, 117.62, 117.48, 117.40, 29.11, 17.43. MS (ESI) mass calcd for C<sub>18</sub>H<sub>13</sub>F<sub>5</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 425.1144; <i>m</i>/<i>z</i> found, 425.1145 [M + H]<sup>+</sup>. HPLC <i>t</i><sub>R</sub> = 9.480 (stationary phase, CHIRALPAK AD-H 5 μm, 250 mm × 4.6 mm); mobile phase, 90% CO<sub>2</sub>, 10% EtOH). Specific rotation: [α]<sup>20</sup><sub>D</sub> +34.3 (<i>c</i> 0.452, CH<sub>3</sub>OH).</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>S</i>*)-(2-Chloro-3-(trifluoromethyl)phenyl)(6-methyl-1-(pyridin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (<b>30</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.56–8.41 (m, 1H), 8.23–8.12 (m, 1H), 7.98–7.89 (m, 1H), 7.82–7.74 (m, 1H), 7.57–7.30 (m, 3H), 5.90–5.78 (m, 0.5H), 5.70–5.59 (m, 0.5H), 4.67–4.31 (m, 1.5H), 4.14–4.01 (m, 0.5H), 3.59–3.20 (m, 2H), 1.39–1.30 (m, 2.3H), 1.20 (d, <i>J</i> = 6.8 Hz, 0.7H). MS (ESI) mass calcd for C<sub>19</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>5</sub>O [M + H]<sup>+</sup>, 422.0990; <i>m</i>/<i>z</i> found, 422.1004 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>S</i>*)-(2-Chloro-3-(trifluoromethyl)phenyl)(6-methyl-1-(pyrazin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (<b>31</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.57–9.49 (m, 1H), 8.69–8.63 (m, 1H), 8.52–8.48 (m, 0.5H), 8.45–8.38 (m, 0.5H), 7.82–7.76 (m, 1H), 7.58–7.39 (m, 2H), 5.91–5.81 (m, 0.5H), 5.71–5.61 (m, 0.5H), 4.67–4.32 (m, 1.5H), 4.14–4.04 (m, 0.5H), 3.58–3.11 (m, 2H), 1.40–1.31 (m, 2.3H), 1.23–1.19 (m, 0.7H). MS (ESI) mass calcd for C<sub>18</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 423.0942; <i>m</i>/<i>z</i> found, 423.0948 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>S</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(1-ethyl-1<i>H</i>-pyrazol-3-yl)-6-methyl-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>32</b>)</h4><div class="NLM_p"><i>Step 1.</i> General procedure B was used to give intermediates <i>tert</i>-butyl (<i>S</i>)-1-(1-ethyl-1<i>H</i>-pyrazol-3-yl)-6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate and <i>tert</i>-butyl (<i>S</i>)-1-(1-ethyl-1<i>H</i>-pyrazol-3-yl)-4-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (284 mg, 60%, 1:1). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.47–7.42 (m, 1H), 6.66–6.61 (dd, <i>J</i> = 9.9, 2.4 Hz, 1H), 5.49–5.31 (s, 0.5H), 5.21–5.06 (m, 0.5H), 5.01–4.88 (m, 0.5H), 4.56–4.39 (m, 0.5H), 4.22–4.15 (m, 2.5H), 3.21–2.91 (m, 2.5H), 1.55–1.47 (m, 13.5H), 1.18–1.13 (d, <i>J</i> = 7.0 Hz, 1.5H). MS (ESI) mass calcd for C<sub>16</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 332.4; <i>m</i>/<i>z</i> found, 333.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Steps 2 and 3.</i> The title compound was prepared using the Boc deprotection and general amide coupling conditions as described for <b>26</b> (266 mg, 70% over 2 steps). Compound <b>32</b> was isolated from the regioisomer by SFC (stationary phase, CHIRALCEL OJ-H 5 μm, 250 mm × 20 mm); mobile phase, 85% CO<sub>2</sub>, 15% <i>i</i>-PrOH) (114 mg, 43%). Mp 67.78–71.37 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.82–7.72 (m, 1H), 7.57–7.38 (m, 3H), 6.72–6.63 (m, 1H), 5.86–5.61 (m, 1H), 4.62–4.03 (m, 4H), 3.42–2.91 (m, 2H), 1.58–1.47 (m, 3H), 1.37–1.16 (m, 3H). MS (ESI) mass calcd for C<sub>19</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 439.1255; <i>m</i>/<i>z</i> found, 439.1258 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>S</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(1-ethyl-1<i>H</i>-pyrazol-5-yl)-6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (<b>33</b>)</h4><div class="NLM_p last">The compound was prepared in analogy to <b>32</b>, and the regioisomers were separated by SFC (stationary phase, CHIRALCEL OJ-H 5 μm, 250 mm × 20 mm); mobile phase, 88% CO<sub>2</sub>, 12% <i>i</i>-PrOH). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.83–7.76 (m, lH), 7.67–7.60 (m, lH), 7.56–7.38 (m, 2H), 6.38–6.27 (m, lH), 5.89–5.61 (m, lH), 4.63–4.05 (m, 4H), 3.17–2.35 (m, 2H), 1.44–1.36 (m, 3H), 1.34–1.15 (m, 3H). MS (ESI) mass calcd C<sub>19</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>6</sub>O, 438.8; <i>m</i>/<i>z</i> found, 439.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>S</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(6-methyl-1-(thiophen-3-yl)-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>34</b>)</h4><div class="NLM_p"><i>Step 1</i>. General procedure B was conducted using 3-azidothiophene<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> to give the intermediates <i>tert</i>-butyl (<i>S</i>)-6-methyl-1-(thiophen-3-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate and <i>tert</i>-butyl (<i>S</i>)-4-methyl-1-(thiophen-3-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (80 mg crude, ∼5%), ratio of products is 2:3, which was carried forward crude.</div><div class="NLM_p last"><i>Steps 2 and 3.</i> A Boc deprotection and general amide coupling conditions were used as described for <b>26</b> (37 mg, 39% over 2 steps). Compound <b>34</b> was isolated from the regioisomer by SFC (stationary phase, CHIRALCEL OJ-H 5 μm, 250 mm × 20 mm); mobile phase, 80% CO<sub>2</sub>, 20% <i>i</i>-PrOH) (11 mg, 31%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.83–7.75 (m, 1H), 7.56–7.37 (m, 5H), 5.87–5.63 (m, 1H), 4.64–4.04 (m, 2H), 3.38–2.58 (m, 2H), 1.38–1.14 (m, 3H). MS (ESI) mass calcd for C<sub>18</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>4</sub>OS [M + H]<sup>+</sup>, 427.0602; <i>m</i>/<i>z</i> found, 427.0619 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>S</i>)-(3-Fluoro-2-(trifluoromethyl)pyridin-4-yl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>35</b>)</h4><div class="NLM_p last">To a solution of <b>41</b> (8.04 g, 34.3 mmol) and Hunig’s base (12 mL, 69 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (85 mL) and DMF (40 mL) were added 3-fluoro-2-(trifluoromethyl)isonicotinic acid (7.90 g, 37.8 mmol) and HATU (15.7 g, 41.1 mmol). The reaction was stirred for 30 min and then poured into ice–water (400 mL). Ethyl acetate was added (400 mL), and the layers were separated. The water layer was extracted with EtOAc (250 mL) 2×. The organic layers were combined and washed with 5% aqueous LiCl (100 mL) and then dried (MgSO<sub>4</sub>) and purified by flash chromatography (0–85% EtOAc/hexanes gradient) to give the title compound as a white powder (12.7 g, 87%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.84–8.69 (m, 2H), 8.68–8.57 (m, 1H), 7.71–7.49 (m, 1H), 5.90–5.68 (d, <i>J</i> = 16.4 Hz, 0.5H), 5.66–5.54 (m, 0.5H), 4.76–4.58 (d, <i>J</i> = 15.8 Hz, 0.5H), 4.58–4.48 (m, 0.5H), 4.45–4.33 (m, 0.5H), 4.20–4.09 (m, 0.5H), 3.56–3.12 (m, 2H), 1.48–1.18 (m, 3H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 162.35, 161.96, 157.73, 157.68, 155.96, 155.92, 153.35, 151.59, 151.57, 151.27, 151.25, 139.61, 139.11, 136.90, 136.81, 134.33, 134.23, 133.91, 133.80, 131.29, 129.78, 126.66, 121.30, 119.48, 117.65, 77.28, 49.35, 43.38, 40.13, 40.09, 36.24, 36.12, 30.46, 29.30, 18.64, 17.43. MS (ESI) mass calcd for C<sub>17</sub>H<sub>12</sub>F<sub>5</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 426.1096 <i>m</i>/<i>z</i> found, 426.1105 [M + H]<sup>+</sup>. Specific rotation: [α]<sup>20</sup><sub>D</sub> +32.1 (<i>c</i> 1.04, CH<sub>3</sub>OH).</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>S</i>)-(3-Chloro-2-(trifluoromethyl)pyridin-4-yl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>36</b>)</h4><div class="NLM_p last">The title compound was prepared as described for <b>35</b> (90 mg, 73%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.81–8.63 (m, 3H), 7.53–7.46 (m, 0.5H), 7.39 (d, <i>J</i> = 4.7 Hz, 0.5H), 5.87–5.77 (m, 0.5H), 5.68–5.58 (m, 0.5H), 4.69–4.62 (m, 0.3H), 4.50–4.35 (m, 1.2H), 4.08–3.96 (m, 0.5H), 3.56–3.12 (m, 2H), 1.43–1.18 (m, 3H). MS (ESI) mass calcd for C<sub>17</sub>H<sub>12</sub>ClF<sub>4</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 442.0801 <i>m</i>/<i>z</i> found, 442.0804 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>S</i>)-(1-(5-Fluoropyrimidin-2-yl)-6-methyl-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)(3-methyl-2-(trifluoromethyl)pyridin-4-yl)methanone (<b>37</b>)</h4><div class="NLM_p last">The title compound was prepared as described for <b>35</b> (32 mg, 27%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.81–8.71 (m, 2H), 8.68–8.55 (m, 1H), 7.40–7.19 (m, 1H), 5.91–5.77 (m, 0.5H), 5.71–5.60 (m, 0.5H), 4.52–4.32 (m, 1.5H), 4.11–3.99 (m, 0.5H), 3.54–3.09 (m, 2H), 2.57–2.20 (m, 3H), 1.40–1.22 (m, 3H). MS (ESI) mass calcd C<sub>18</sub>H<sub>15</sub>F<sub>4</sub>N<sub>7</sub>O, 421.1 <i>m</i>/<i>z</i> found, 422.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-(1-(5-Fluoropyrimidin-2-yl)-6-methyl-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)(3-methyl-2-(trifluoromethyl)pyridin-4-yl)methanone (<b>38</b>)</h4><div class="NLM_p last">The title compound was prepared as described for <b>35</b> (16 mg, 21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.80–8.70 (m, 2H), 8.68–8.55 (m, 1H), 7.40–7.20 (m, 1H), 5.92–5.81 (m, 0.5H), 5.71–5.59 (m, 0.5H), 4.53–4.32 (m, 1.5H), 4.12–3.97 (m, 0.5H), 3.54–3.10 (m, 2H), 2.58–2.19 (m, 3H), 1.41–1.22 (m, 3H). MS (ESI) mass calcd for C<sub>18</sub>H<sub>15</sub>F<sub>4</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 422.1347 <i>m</i>/<i>z</i> found, 422.1359 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>S</i>)-(3-Chloro-2-(trifluoromethyl)pyridin-4-yl)(1-(1-ethyl-1<i>H</i>-pyrazol-3-yl)-6-methyl-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>39</b>)</h4><div class="NLM_p last">The Boc deprotection and general amide coupling conditions were conducted as described for <b>26</b> from <i>tert</i>-butyl (<i>S</i>)-1-(1-ethyl-1<i>H</i>-pyrazol-3-yl)-6-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate and <i>tert</i>-butyl (<i>S</i>)-1-(1-ethyl-1<i>H</i>-pyrazol-3-yl)-4-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine-5-carboxylate (108 mg, 16% over 2 steps). Compound <b>39</b> was isolated from its regioisomer by SFC (stationary phase, CHIRALPAK AD-H 5 μm, 250 mm × 20 mm); mobile phase, 85% CO<sub>2</sub>, 15% MeOH) (52 mg, 48%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.72–8.61 (m, 1H), 7.51–7.35 (m, 2H), 6.73–6.65 (m, 1H), 5.85–5.57 (m, 1H), 4.65–3.95 (m, 4H), 3.43–2.97 (m, 2H), 1.57–1.20 (m, 6H). MS (ESI) mass calcd for C<sub>18</sub>H<sub>17</sub>ClF<sub>3</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 440.1208; <i>m</i>/<i>z</i> found, 440.1222 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>S</i>)-(3-Fluoro-2-(trifluoromethyl)pyridin-4-yl)(1-(5-hydroxypyrimidin-2-yl)-6-methyl-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>40</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.66–8.54 (m, 1H), 8.46–8.32 (m, 2H), 7.65–7.54 (m, 1H), 6.78–5.95 (br m, 1H), 5.75–5.49 (m, 1H), 4.70–4.04 (m, 2H), 3.44–3.09 (m, 2H), 1.39–1.14 (m, 3H). MS (ESI) mass calcd for C<sub>17</sub>H<sub>13</sub>F<sub>4</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 424.1140; <i>m</i>/<i>z</i> found, 424.1150 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Primary Pharmacological Assays</h3><div class="NLM_p last">Lipopolysaccharide (LPS)-primed, Bz-ATP induced IL-1β release from human peripheral blood mononuclear cells (PBMCs) was used as the primary screen to test for P2X7 antagonism and was conducted as previously described.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> Ca<sup>2+</sup> flux and radioligand binding assays were conducted with 1321N1 cells expressing the recombinant human P2X7 channel as previously described.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> DMPK. General Methods</h3><div class="NLM_p last">A 10 mM compound stock solution in DMSO further diluted in acetonitrile/water to yield a secondary 1 mM solution was used in all in vitro assays. Pooled human liver microsomes of mixed gender, mouse, rat, beagle dog, and cynomolgus monkey of male gender were purchased from BD Gentest (Woburn, MA). Plasma from various species was purchased from Bioreclamation, Inc. (Westbury, NY). All other commercially available reagents and solvents were either analytical or HPLC grade. In vitro and PK samples were analyzed by LC–MS/MS in the multiple reaction monitoring (MRM) scan mode with ESI. The following DMPK assays were conducted as previously reported:<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Caco-2 permeability, solubility in aqueous systems, Cocktail CYP inhibition assay, CYP3A TDI, plasma protein binding. Microsomal stability studies were conducted on a Biomek FX robotic liquid handling workstation (Beckman Coulter, Brea, CA) as previously described.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The ER was calculated by dividing the predicted hepatic clearance by species blood flow (<i>Q</i>), where <i>Q</i> is 55, 21, 31, and 44 mL min<sup>–1</sup> kg<sup>–1</sup> for rat, human, dog, and monkey, respectively.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> hERG QPatch</h3><div class="NLM_p last">Experiments were performed using CHO cells stably expressing the hERG potassium channel. Cells were grown at 37 °C and 5% CO<sub>2</sub> in culture flasks in Ham’s F12 medium supplemented with 10% heat-inactivated fetal calf serum, hygromycin B (100 μg/mL), and Geneticin (100 μg/mL). For use in the automated patch-clamp system QPatch (Sophion) cells were harvested to obtain cell suspension of single cells. Solutions: The bath solution contained (in mM) 145 NaCl, 4 KCl, 10 glucose, 10 HEPES, 2 CaCl<sub>2</sub>, and 1 MgCl<sub>2</sub> (pH 7.4 with NaOH). The pipet solution contained (in mM) 120 KCl, 10 EGTA, 10 HEPES, 5.374 CaCl<sub>2</sub>, and 1.75 MgCl<sub>2</sub> (pH 7.2 with KOH). Patch-clamp experiments were performed in the voltage-clamp mode, and whole-cell currents were recorded with an automated patch-clamp assay utilizing the QPatch system (Sophion). Current signals were amplified and digitized, stored, and analyzed by using the QPatch assay software. The holding potential was −80 mV. The hERG current (K<sup>+</sup>-selective outward current) was determined as the maximal tail current at −40 mV after a 2 s depolarization to +60 mV. Pulse cycling rate was 15 s. A short pulse (90 ms) to −40 mV served as a baseline step to calculate the tail current amplitude. After establishing whole-cell configuration and a stability period, the vehicle was applied for 5 min followed by the test substance by increasing concentrations of 10<sup>–7</sup> M, 3 × 10<sup>–7</sup> M, and 3 × 10<sup>–6</sup> M. Each concentration of the test substance was applied twice. The effect of each concentration was determined after 5 min as an average current of three sequential voltage pulses. To determine the extent of block, the residual current was compared with vehicle pretreatment. Data are presented as mean values ± standard error of the mean (SEM).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> In Vivo Pharmacokinetic Studies</h3><div class="NLM_p last">Single dose PK studies in preclinical species (male Balb/c mice, Sprague Dawley rats, beagle dogs, or cynomolgus monkeys) were conducted following iv and po administration as a solution in the vehicles indicated. Blood was sampled at predose and at 0.033 (iv), 0.083 (iv), 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h postdose. In dogs, instead of 6 and 8 h time points, blood was drawn at 7 h. Plasma concentrations were quantitated by LC–MS/MS. PK parameters were derived from noncompartmental analysis of the plasma concentration vs time data using WinNonlin software (Pharsight, Palo Alto, CA).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Ex Vivo Radioligand Binding Autoradiography</h3><div class="NLM_p last">Animal work was done in accordance with the Guide Care for and Use of Laboratory Animals adopted by the U.S. National Institutes of Health. Animals were allowed to acclimate for 7 days after receipt. They were group housed in accordance with institutional standards, received food and water ad libitum, and were maintained on a 12 h light/dark cycle. Male Sprague Daley rats approximately 300–400 g in body weight were used. For time course studies two animals per time point over three time points were used. For dose–response studies, three animals per dose over 7–10 doses were tested. Animals were euthanized with carbon dioxide and plasma and tissue removed. Tissue sections were prepared as previously described.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1- and 4-Day Repeat Dose Oral Toxicology Studies</h3><div class="NLM_p last">For the repeat dose toxicology group, animals were administered at oral doses described in the text for 4 days, with necropsy performed on day 5. The tissues from control and treated groups were embedded in paraffin, processed into slides by sectioning at 4 μm, stained with hematoxylin and eosin, and examined microscopically.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01279">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01279" class="ext-link">10.1021/acs.jmedchem.7b01279</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis of acid chloride, azide intermediates, <b>30</b>, <b>31</b>, and <b>40</b>, crystallography experiments for <b>29</b>, log <i>D</i> and p<i>K</i><sub>a</sub> measurements for <b>35</b>, CYP data for <b>29</b> and <b>35</b>, experimental protocols and data for HR-XPRD, digital imaging, DSC and TGMS for <b>29</b> and <b>35</b>, and thermal and shock stability screen results for 2-azido-5-fluoropyrimidine (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_001.pdf">jm7b01279_si_001.pdf (3.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_002.csv">jm7b01279_si_002.csv (4.89 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01279" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73817" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73817" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christa C. Chrovian</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4971-1538" title="Orcid link">http://orcid.org/0000-0002-4971-1538</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4724242f3528312e26072e3334692d292d6924282a"><span class="__cf_email__" data-cfemail="0360606b716c756a62436a77702d696d692d606c6e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akinola Soyode-Johnson</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander A. Peterson</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine F. Gelin</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaohu Deng</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Curt A. Dvorak</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas I. Carruthers</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Lord</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Fraser</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leah Aluisio</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin J. Coe</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Scott</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatiana Koudriakova</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Freddy Schoetens</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kia Sepassi</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Gallacher</span> - <span class="hlFld-Affiliation affiliation">Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anindya Bhattacharya</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Letavic</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7503-0189" title="Orcid link">http://orcid.org/0000-0002-7503-0189</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d351e5687-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Hong Ao and Xi Wang for in vitro pharmacology assays, Jennifer Ingram-Ross, Judith Herrlich, and Stewart Bryant for their work in the preclinical toleration studies, Brigitte Loenders and Vijay Urmaliya for their work in the preclinical cardiovascular safety studies, Heather Mcallister for analytical support, Curtis Moore for X-ray diffraction studies, Crystallics for polymorph screens, David Speybrouck for enabling the separation of regioisomers, Khoa Tran for HRMS data, Pascal Bonaventure for helpful manuscript suggestions, and Greg Chen, Jimmy Liang, and Dave Kummer for valuable reaction suggestions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> Abbreviations Used</h2><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">ALT</td><td class="NLM_def"><p class="first last">alanine aminotransferase</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BCS</td><td class="NLM_def"><p class="first last">Biopharmaceutical Classification System</p></td></tr><tr><td class="NLM_term">Bz-ATP</td><td class="NLM_def"><p class="first last">2′(3′)-O-(4-Benzoylbenzoyl)adenosine-5′-triphosphate</p></td></tr><tr><td class="NLM_term">CD</td><td class="NLM_def"><p class="first last">Crohn’s disease</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hampster ovary</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term"><i>m</i>-CPBA</td><td class="NLM_def"><p class="first last"><i>m</i>-chloroperbenzoic acid</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">EC</td><td class="NLM_def"><p class="first last">effective concentration</p></td></tr><tr><td class="NLM_term">ED</td><td class="NLM_def"><p class="first last">effective dose</p></td></tr><tr><td class="NLM_term">EGTA</td><td class="NLM_def"><p class="first last">ethylene glycol-bis(2-aminoethyl ether)-<i>N</i>,<i>N,N</i>′<i>,N</i>′-tetraacetic acid</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">extraction ratio</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">FIH</td><td class="NLM_def"><p class="first last">first in human</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">[(dimethylamino)-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridin-1-ylmethylene]-<i>N</i>-methylmethanaminium hexafluorophosphate <i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid</p></td></tr><tr><td class="NLM_term">Het</td><td class="NLM_def"><p class="first last">heterocycle</p></td></tr><tr><td class="NLM_term">HP-β-CD</td><td class="NLM_def"><p class="first last">(2-hydroxypropyl)-β-cyclodextrin</p></td></tr><tr><td class="NLM_term">IC</td><td class="NLM_def"><p class="first last">inhibitory concentration</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin-1β</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">NOAEL</td><td class="NLM_def"><p class="first last">no adverse event level</p></td></tr><tr><td class="NLM_term">PEG400</td><td class="NLM_def"><p class="first last">polyethylene glycol 400</p></td></tr><tr><td class="NLM_term">PFTBA</td><td class="NLM_def"><p class="first last">perfluorotributylamine</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">PoC</td><td class="NLM_def"><p class="first last">proof of concept</p></td></tr><tr><td class="NLM_term">q.d.</td><td class="NLM_def"><p class="first last">quaque die (once a day)</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time dependent inhibition</p></td></tr><tr><td class="NLM_term"><i>p</i>-TSA</td><td class="NLM_def"><p class="first last"><i>p</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">VT</td><td class="NLM_def"><p class="first last">variable temperature</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63033" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63033" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, C.</span><span> </span><span class="NLM_article-title">The role of the innate immune system in psychiatric disorders</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/j.mcn.2012.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.mcn.2012.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=23064447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1KjsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=52-62&author=K.+A.+Jonesauthor=C.+Thomsen&title=The+role+of+the+innate+immune+system+in+psychiatric+disorders&doi=10.1016%2Fj.mcn.2012.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the innate immune system in psychiatric disorders</span></div><div class="casAuthors">Jones, Kenneth A.; Thomsen, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-62</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is by now substantial clin. evidence for an assocn. between specific mood disorders and altered immune function.  More recently, a no. of hypotheses have been forwarded to explain how components of the innate immune system can regulate brain function at the cellular and systems levels and how these may underlie the pathol. of disorders such as depression, PTSD and bipolar disorder.  In this review we draw ref. to biochem., cellular and animal disease models, as well as clin. observations to elucidate the role of the innate immune system in psychiatric disorders.  Proinflammatory cytokines, such as IL-1β IL-6 and TNFα, which feature prominently in the immune response to pathogen in the periphery, have unique and specific actions on neurons and circuits within the central nervous system.  Effects of these signaling mols. on neurotransmission, memory, and glucocorticoid function, as well as animal behaviors such as social withdrawal and fear conditioning relevant to psychiatric disorders are elucidated.  Finally, we highlight future directions for studies, including the use of peripheral biomarkers, relevant for developing new therapeutic approaches for treating psychiatric illnesses.  This article is part of Special Issue entitled 'neuroinflammation in neurodegeneration and neurodysfunction'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqRtLUscaCg7Vg90H21EOLACvtfcHk0lgEMEcdVDmc5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1KjsbzP&md5=6faf9f834ec208a9c17e496476361556</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2012.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2012.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DThomsen%26aufirst%3DC.%26atitle%3DThe%2520role%2520of%2520the%2520innate%2520immune%2520system%2520in%2520psychiatric%2520disorders%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2013%26volume%3D53%26spage%3D52%26epage%3D62%26doi%3D10.1016%2Fj.mcn.2012.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Immunological and inflammatory functions of the interleukin-1 family</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span><span class="refDoi"> DOI: 10.1146/annurev.immunol.021908.132612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1146%2Fannurev.immunol.021908.132612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=19302047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=519-550&author=C.+A.+Dinarello&title=Immunological+and+inflammatory+functions+of+the+interleukin-1+family&doi=10.1146%2Fannurev.immunol.021908.132612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Immunological and inflammatory functions of the interleukin-1 family</span></div><div class="casAuthors">Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">519-550</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  More than any other cytokine family, the interleukin (IL)-1 family is closely linked to the innate immune response.  This linkage became evident upon the discovery that the cytoplasmic domain of the IL-1 receptor type I is highly homologous to the cytoplasmic domains of all Toll-like receptors (TLRs).  Thus, fundamental inflammatory responses such as the induction of cyclooxygenase type 2, increased expression of adhesion mols., or synthesis of nitric oxide are indistinguishable responses of both IL-1 and TLR ligands.  Both families nonspecifically affect antigen recognition and lymphocyte function.  IL-1β is the most studied member of the IL-1 family because of its role in mediating autoinflammatory diseases.  Although the TLR and IL-1 families evolved to assist in host defense against infection, unlike the TLR family, the IL-1 family also includes members that suppress inflammation, both specifically within the IL-1 family but also nonspecifically for TLR ligands and the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfzkGfyLhwPbVg90H21EOLACvtfcHk0lgEMEcdVDmc5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrc%253D&md5=4db7e2790608526a7ebefd417392e12c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132612%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DImmunological%2520and%2520inflammatory%2520functions%2520of%2520the%2520interleukin-1%2520family%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D519%26epage%3D550%26doi%3D10.1146%2Fannurev.immunol.021908.132612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoetens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceusters, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M.</span><span> </span><span class="NLM_article-title">JNJ-54175446, a CNS penetrant P2X7 antagonist in clinical development for mood disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">S289</span><span class="NLM_x">–</span> <span class="NLM_lpage">S454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=S289-S454&author=A.+Bhattacharyaauthor=B.+Savallauthor=B.+Lordauthor=P.+Bonaventureauthor=L.+Aluisioauthor=T.+Koudriakovaauthor=K.+Sepassiauthor=F.+Schoetensauthor=M.+Ceustersauthor=N.+Carruthersauthor=T.+Lovenbergauthor=M.+Letavic&title=JNJ-54175446%2C+a+CNS+penetrant+P2X7+antagonist+in+clinical+development+for+mood+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DSavall%26aufirst%3DB.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%26aulast%3DLetavic%26aufirst%3DM.%26atitle%3DJNJ-54175446%252C%2520a%2520CNS%2520penetrant%2520P2X7%2520antagonist%2520in%2520clinical%2520development%2520for%2520mood%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3DS289%26epage%3DS454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutheil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glasebrook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koester, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smagin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Psychological stress activates the inflammasome via release of ATP and stimulation of the P2X7 receptor</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2015.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.biopsych.2015.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=26831917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2murw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=12-22&author=M.+Iwataauthor=K.+T.+Otaauthor=X.-Y.+Liauthor=F.+Sakaueauthor=N.+Liauthor=S.+Dutheilauthor=M.+Banasrauthor=V.+Duricauthor=T.+Yamanashiauthor=K.+Kanekoauthor=K.+Rasmussenauthor=A.+Glasebrookauthor=A.+Koesterauthor=D.+Songauthor=K.+A.+Jonesauthor=S.+Zornauthor=G.+Smaginauthor=R.+S.+Duman&title=Psychological+stress+activates+the+inflammasome+via+release+of+ATP+and+stimulation+of+the+P2X7+receptor&doi=10.1016%2Fj.biopsych.2015.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor</span></div><div class="casAuthors">Iwata, Masaaki; Ota, Kristie T.; Li, Xiao-Yuan; Sakaue, Fumika; Li, Nanxin; Dutheil, Sophie; Banasr, Mounira; Duric, Vanja; Yamanashi, Takehiko; Kaneko, Koichi; Rasmussen, Kurt; Glasebrook, Andrew; Koester, Anja; Song, Dekun; Jones, Kenneth A.; Zorn, Stevin; Smagin, Gennady; Duman, Ronald S.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-22</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mechanisms underlying stress-induced inflammation that contribute to major depressive disorder are unknown.  We examine the role of the ATP (ATP)/purinergic type 2X7 receptor (P2X7R) pathway and the NLRP3 (nucleotide-binding, leucine-rich repeat, pyrin domain contg. 3) inflammasome in interleukin (IL)-1β and depressive behavioral responses to stress.  The influence of acute restraint stress on extracellular ATP, glutamate, IL-1β, and tumor necrosis factor alpha in hippocampus was detd. by microdialysis, and the influence of acute restraint stress on the NLRP3 inflammasome was detd. by Western blot anal.  The influence of P2X7R antagonist administration on IL-1β and tumor necrosis factor alpha and on anxiety and depressive behaviors was detd. in the chronic unpredictable stress rodent model.  The role of the NLRP3 inflammasome was detd. by anal. of Nlrp3 null mice.  Acute restraint stress rapidly increased extracellular ATP, an endogenous agonist of P2X7R; the inflammatory cytokine IL-1β; and the active form of the NLRP3 inflammasome in the hippocampus.  Administration of a P2X7R antagonist completely blocked the release of IL-1β and tumor necrosis factor alpha, another stress-induced cytokine, and activated NLRP3.  Moreover, P2X7R antagonist administration reversed the anhedonic and anxiety behaviors caused by chronic unpredictable stress exposure, and deletion of the Nlrp3 gene rendered mice resistant to development of depressive behaviors caused by chronic unpredictable stress.  These findings demonstrate that psychol. "stress" is sensed by the innate immune system in the brain via the ATP/P2X7R-NLRP3 inflammasome cascade, and they identify novel therapeutic targets for the treatment of stress-related mood disorders and comorbid illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPT4PeBplcG7Vg90H21EOLACvtfcHk0lgEMEcdVDmc5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2murw%253D&md5=f17ad7ff32906696e07f3b9e52a7591e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DOta%26aufirst%3DK.%2BT.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DSakaue%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DDutheil%26aufirst%3DS.%26aulast%3DBanasr%26aufirst%3DM.%26aulast%3DDuric%26aufirst%3DV.%26aulast%3DYamanashi%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DGlasebrook%26aufirst%3DA.%26aulast%3DKoester%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DZorn%26aufirst%3DS.%26aulast%3DSmagin%26aufirst%3DG.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DPsychological%2520stress%2520activates%2520the%2520inflammasome%2520via%2520release%2520of%2520ATP%2520and%2520stimulation%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D80%26spage%3D12%26epage%3D22%26doi%3D10.1016%2Fj.biopsych.2015.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lovenberg, T.; Aluisio, L.; Ceusters, M.; Letavic, M.; Bhattacharya, A.</span><span> </span><span class="NLM_article-title">Characterization of P2X7 antagonists in the rodent brain: Promise for a novel mechanism of action for mood disorder?</span> <span class="citation_source-book">Proceedings of the CINP Thematic Meeting on Stress, Inflammation and Depression: Focus on Novel Antidepressant Targets</span>, Dublin, Ireland, June 4–6,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=T.+Lovenberg&author=L.+Aluisio&author=M.+Ceusters&author=M.+Letavic&author=A.+Bhattacharya&title=Proceedings+of+the+CINP+Thematic+Meeting+on+Stress%2C+Inflammation+and+Depression%3A+Focus+on+Novel+Antidepressant+Targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLovenberg%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520P2X7%2520antagonists%2520in%2520the%2520rodent%2520brain%253A%2520Promise%2520for%2520a%2520novel%2520mechanism%2520of%2520action%2520for%2520mood%2520disorder%253F%26btitle%3DProceedings%2520of%2520the%2520CINP%2520Thematic%2520Meeting%2520on%2520Stress%252C%2520Inflammation%2520and%2520Depression%253A%2520Focus%2520on%2520Novel%2520Antidepressant%2520Targets%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Eser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelsang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braddock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinisch, W.</span><span> </span><span class="NLM_article-title">Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn’s disease: a randomized placebo-controlled, double-blind, phase IIa study</span> <span class="citation_source-journal">Inflamm. Bowel Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2253</span><span class="refDoi"> DOI: 10.1097/MIB.0000000000000514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1097%2FMIB.0000000000000514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=26197451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FltVSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2247-2253&author=A.+Eserauthor=J.-F.+Colombelauthor=P.+Rutgeertsauthor=S.+Vermeireauthor=H.+Vogelsangauthor=M.+Braddockauthor=T.+Perssonauthor=W.+Reinisch&title=Safety+and+efficacy+of+an+oral+inhibitor+of+the+purinergic+receptor+P2X7+in+adult+patients+with+moderately+to+severely+active+Crohn%E2%80%99s+disease%3A+a+randomized+placebo-controlled%2C+double-blind%2C+phase+IIa+study&doi=10.1097%2FMIB.0000000000000514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study</span></div><div class="casAuthors">Eser Alexander; Colombel Jean-Frederic; Rutgeerts Paul; Vermeire Severine; Vogelsang Harald; Braddock Martin; Persson Tore; Reinisch Walter</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2247-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  AZD9056 is a selective orally active inhibitor of the purinergic receptor P2X7, which is a key player in the generation and secretion of several proinflammatory cytokines involved in the pathogenesis of Crohn's disease (CD).  The aim of this phase IIa study was to assess the efficacy and safety of AZD9056 for the treatment of moderately to severely active CD.  METHODS:  We conducted a placebo-controlled, multicenter, double-blind phase IIa study in patients with moderately to severely active CD as defined by a CD Activity Index (CDAI) of at least 220.  Patients were randomized in a 2:1 mode either to 200 mg of AZD9056 administered orally as a tablet once daily for 28 days or matching placebo.  Primary endpoint was the change in CDAI from baseline at day 28, and secondary endpoints included clinical remission (CDAI < 150) and CDAI 70 response and improvement in the quality of life measures Short Form 36 and Inflammatory Bowel Disease Questionnaire.  Changes in serum C-reactive protein and fecal calprotectin were assessed.  RESULTS:  In total, 34 patients were enrolled, 24 to AZD9056 and 10 to placebo.  The CDAI dropped in AZD9056-treated subjects from a baseline mean of 311 to 242 and from 262 to 239 in placebo-treated subjects (P = 0.049).  Remission and response rates were numerically higher with AZD9056 versus placebo, (n = 5, 24% versus n = 1, 11%, P = 0.43 and n = 11, 52% versus n = 2, 22%, P = 0.13, respectively).  Marked decrease in disease activity was observed for the CDAI subcomponents, pain and general well-being.  Apart from a statistically significant improvement in the Mental Component Score of Short Form 36 for AZD9056 versus placebo (P = 0.017), no other differences in measurements of quality of life could be observed.  There was no decrease in concentrations of serum C-reactive protein and fecal calprotectin during treatment.  AZD9056 was well-tolerated, and no serious adverse events were reported.  CONCLUSIONS:  Our data suggest that the purinergic receptor P2X7 antagonist AZD9056 has the potential to improve symptoms in patients with moderate-to-severe CD combined with a beneficial risk profile.  Although the lack in change of inflammatory biomarkers questions its anti-inflammatory potential, the results obtained in this study rather suggest P2X7 antagonism for the treatment of chronic abdominal pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHjK0qgS5fO0g6wdEZmT2rfW6udTcc2eY0FFyUoA7n_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FltVSqtA%253D%253D&md5=8ade69d316c57adae49fb595e35ab2f7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2FMIB.0000000000000514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMIB.0000000000000514%26sid%3Dliteratum%253Aachs%26aulast%3DEser%26aufirst%3DA.%26aulast%3DColombel%26aufirst%3DJ.-F.%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DVogelsang%26aufirst%3DH.%26aulast%3DBraddock%26aufirst%3DM.%26aulast%3DPersson%26aufirst%3DT.%26aulast%3DReinisch%26aufirst%3DW.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520an%2520oral%2520inhibitor%2520of%2520the%2520purinergic%2520receptor%2520P2X7%2520in%2520adult%2520patients%2520with%2520moderately%2520to%2520severely%2520active%2520Crohn%25E2%2580%2599s%2520disease%253A%2520a%2520randomized%2520placebo-controlled%252C%2520double-blind%252C%2520phase%2520IIa%2520study%26jtitle%3DInflamm.%2520Bowel%2520Dis.%26date%3D2015%26volume%3D21%26spage%3D2247%26epage%3D2253%26doi%3D10.1097%2FMIB.0000000000000514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Keystone, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2011-143578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1136%2Fannrheumdis-2011-143578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=22966146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=1630-1635&author=E.+C.+Keystoneauthor=M.+M.+Wangauthor=M.+Laytonauthor=S.+Hollisauthor=I.+B.+McInnes&title=Clinical+evaluation+of+the+efficacy+of+the+P2X7+purinergic+receptor+antagonist+AZD9056+on+the+signs+and+symptoms+of+rheumatoid+arthritis+in+patients+with+active+disease+despite+treatment+with+methotrexate+or+sulphasalazine&doi=10.1136%2Fannrheumdis-2011-143578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span></div><div class="casAuthors">Keystone, Edward C.; Wang, Millie M.; Layton, Mark; Hollis, Sally; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1635</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: The P2X7 purinergic receptor antagonist AZD9056 was evaluated in a phase IIa study and subsequently in a phase IIb study to assess the effects of orally administered AZD9056 on the signs/symptoms of rheumatoid arthritis (RA), with American College of Rheumatol. 20% response criteria (ACR20) as the primary outcome.  Methods: Both studies were randomized, double-blind, placebo-controlled, parallel-group studies in patients with RA receiving methotrexate or sulphasalazine.  Phase IIa was an ascending-dose trial in two cohorts (n=75) using AZD9056 administered daily over 4 wk.  Phase IIb included an open-label etanercept treatment group.  Patients were randomized to receive treatment for 6 mo with 50, 100, 200 or 400 mg AZD9056 (oral, once a day) or matching placebo (oral, once a day), or s.c. etanercept (50 mg once a week).  Results: In phase IIa, 65% of AZD9056 recipients at 400 mg/day responded at the ACR20 level compared with 27% of placebo-treated patients.  A significant redn. in swollen and tender joint count was obsd. in the actively treated group compared with placebo, whereas no effect on acute-phase response was obsd.  Of 385 randomized patients in the phase IIb study, 383 received treatment.  AZD9056 (all doses) had no clin. or statistically significant effect on RA relative to placebo as measured by the proportion of patients meeting the ACR20 criteria at 6 mo and further supported by secondary end points.  In both studies AZD9056 was well tolerated up to 400 mg/day.  Conclusions: AZD9056 does not have significant efficacy in the treatment of RA, and the P2X7 receptor does not appear to be a therapeutically useful target in RA.  Trial registration no. ClinicalTrials.gov NCT00520572.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCebkc5d0gLVg90H21EOLACvtfcHk0ljrkQHqrShv6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL&md5=97ca48663327aa8578f11001fa96d8c0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2011-143578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2011-143578%26sid%3Dliteratum%253Aachs%26aulast%3DKeystone%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DClinical%2520evaluation%2520of%2520the%2520efficacy%2520of%2520the%2520P2X7%2520purinergic%2520receptor%2520antagonist%2520AZD9056%2520on%2520the%2520signs%2520and%2520symptoms%2520of%2520rheumatoid%2520arthritis%2520in%2520patients%2520with%2520active%2520disease%2520despite%2520treatment%2520with%2520methotrexate%2520or%2520sulphasalazine%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26volume%3D71%26spage%3D1630%26epage%3D1635%26doi%3D10.1136%2Fannrheumdis-2011-143578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Stock, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishaq, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, C. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.3899/jrheum.110874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.3899%2Fjrheum.110874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=22382341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=720-727&author=T.+C.+Stockauthor=B.+J.+Bloomauthor=N.+Weiauthor=S.+Ishaqauthor=W.+Parkauthor=X.+Wangauthor=P.+Guptaauthor=C.+A.+Mebus&title=Efficacy+and+safety+of+CE-224%2C535%2C+an+antagonist+of+P2X7+receptor%2C+in+treatment+of+patients+with+rheumatoid+arthritis+inadequately+controlled+by+methotrexate&doi=10.3899%2Fjrheum.110874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span></div><div class="casAuthors">Stock, Thomas C.; Bloom, Bradley J.; Wei, Nathan; Ishaq, Saliha; Park, Won; Wang, Xin; Gupta, Pankaj; Mebus, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">720-727</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">To evaluate efficacy and safety of CE-224,535, a selective P2X7 receptor antagonist, vs. placebo, in patients with active rheumatoid arthritis (RA) and inadequate response to methotrexate (MTX).  In our phase IIA study (ClinicalTrials.gov no. NCT00628095; A6341009), patients aged ≥ 18 years with active RA were randomized to receive either CE-224,535 (500 mg bid) or placebo for 12 wk; all patients continued a stable background dose of ≥ 7.5 mg MTX.  The American College of Rheumatol. 20% (ACR20) response rate (primary efficacy endpoint) was not significantly different from placebo for CE-224,535 (34.0% vs 36.2%; p = 0.591) at Week 12, or at any timepoint over the 12-wk treatment period.  There was no significant difference at Week 12 for the ACR20 response rate following subgroup analyses by age, sex, baseline disease activity, baseline duration of disease, geog. region, or concomitant use of steroids.  ACR50/ACR70 response rates and change from baseline in Disease Activity Score 28-joint C-reactive protein (DAS28-3-CRP) and Health Assessment Questionnaire-Disability Index for CE-224,535 were not significant at Week 12 vs. placebo.  Treatment-emergent adverse events (AE) were reported by 62.3% (CE-224,535) and 55.3% (placebo) of patients; the most common AE were nausea (11.3%, CE-224,535; 4.3%, placebo) and diarrhea (7.5%, CE-224,535; 4.3%, placebo).  The proportion of patients discontinuing due to an AE was 9.4% (CE-224,535) and 6.4% (placebo); no deaths were reported.  Serious AE occurred in 3.8% (CE-224,535) and 2.1% (placebo) of patients; none was considered treatment-related.  CE-224,535 was not efficacious, compared with placebo, for the treatment of RA in patients with an inadequate response to MTX.  CE-224,535 demonstrated an acceptable safety and tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorblWg-aNBNLVg90H21EOLACvtfcHk0lh0ZOsGq_ejwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D&md5=dc919436c3c6e7f3f624c57b77c5dbb2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.110874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.110874%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DT.%2BC.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DIshaq%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DMebus%26aufirst%3DC.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520CE-224%252C535%252C%2520an%2520antagonist%2520of%2520P2X7%2520receptor%252C%2520in%2520treatment%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520inadequately%2520controlled%2520by%2520methotrexate%26jtitle%3DJ.%2520Rheumatol.%26date%3D2012%26volume%3D39%26spage%3D720%26epage%3D727%26doi%3D10.3899%2Fjrheum.110874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceusters, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelin, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otieno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoetens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">4-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-c]pyridine-based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4559</span><span class="NLM_x">–</span> <span class="NLM_lpage">4572</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4559-4572&author=M.+A.+Letavicauthor=B.+M.+Savallauthor=B.+B.+Allisonauthor=L.+Aluisioauthor=J.+I.+Andresauthor=M.+De+Angelisauthor=H.+Aoauthor=D.+Beauchampauthor=P.+Bonaventureauthor=S.+Bryantauthor=N.+I.+Carruthersauthor=M.+Ceustersauthor=K.+Coeauthor=C.+A.+Dvorakauthor=I.+Fraserauthor=C.+F.+Gelinauthor=T.+Koudriakovaauthor=J.+Liangauthor=B.+Lordauthor=T.+Lovenbergauthor=M.+Otienoauthor=F.+Schoetensauthor=D.+Swansonauthor=X.+Wangauthor=A.+Wickendenauthor=A.+Bhattacharya&title=4-Methyl-6%2C7-dihydro-4H-triazolo%5B4%2C5-c%5Dpyridine-based+P2X7+receptor+antagonists%3A+optimization+of+pharmacokinetic+properties+leading+to+the+identification+of+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate</span></div><div class="casAuthors">Letavic, Michael A.; Savall, Brad M.; Allison, Brett D.; Aluisio, Leah; Andres, Jose Ignacio; De Angelis, Meri; Ao, Hong; Beauchamp, Derek A.; Bonaventure, Pascal; Bryant, Stewart; Carruthers, Nicholas I.; Ceusters, Marc; Coe, Kevin J.; Dvorak, Curt A.; Fraser, Ian C.; Gelin, Christine F.; Koudriakova, Tatiana; Liang, Jimmy; Lord, Brian; Lovenberg, Timothy W.; Otieno, Monicah A.; Schoetens, Freddy; Swanson, Devin M.; Wang, Qi; Wickenden, Alan D.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4559-4572</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and preclin. characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described.  Optimization efforts based on previously disclosed unsubstituted 6,7-dihydro-4H-triazolo[4,5-c]pyridines, Me substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazines, and several other series lead to the identification of a series of 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are selective P2X7 antagonists with potency at the rodent and human P2X7 ion channels.  These novel P2X7 antagonists have suitable physicochem. properties, and several analogs have an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing.  Improvements in metabolic stability led to the identification of JNJ-54175446 (I) as a candidate for clin. development.  The drug discovery efforts and strategies that resulted in the identification of the clin. candidate are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx8e5Sq5aYbVg90H21EOLACvtfcHk0lh0ZOsGq_ejwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D&md5=5b5465d8f64d527da6647997efe34aee</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00408%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DAllison%26aufirst%3DB.%2BB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBeauchamp%26aufirst%3DD.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DBryant%26aufirst%3DS.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DK.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLovenberg%26aufirst%3DT.%26aulast%3DOtieno%26aufirst%3DM.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DSwanson%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWickenden%26aufirst%3DA.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3D4-Methyl-6%252C7-dihydro-4H-triazolo%255B4%252C5-c%255Dpyridine-based%2520P2X7%2520receptor%2520antagonists%253A%2520optimization%2520of%2520pharmacokinetic%2520properties%2520leading%2520to%2520the%2520identification%2520of%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4559%26epage%3D4572%26doi%3D10.1021%2Facs.jmedchem.7b00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrovian, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo-[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3163</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.bmcl.2015.06.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3157-3163&author=D.+A.+Rudolphauthor=J.+Alcazarauthor=M.+K.+Ameriksauthor=A.+B.+Antonauthor=H.+Aoauthor=P.+Bonaventureauthor=N.+I.+Carruthersauthor=C.+C.+Chrovianauthor=M.+De+Angelisauthor=B.+Lordauthor=J.+C.+Rechauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=J.+I.+Andresauthor=M.+A.+Letavic&title=Novel+methyl+substituted+1-%285%2C6-dihydro-%5B1%2C2%2C4%5Dtriazolo-%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%29methanones+are+P2X7+antagonists&doi=10.1016%2Fj.bmcl.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAnton%26aufirst%3DA.%2BB.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520methyl%2520substituted%25201-%25285%252C6-dihydro-%255B1%252C2%252C4%255Dtriazolo-%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%2529methanones%2520are%2520P2X7%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3157%26epage%3D3163%26doi%3D10.1016%2Fj.bmcl.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Swanson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoetens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaptason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Identification of (R)-(2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a small molecule antagonist of the P2X7 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8535</span><span class="NLM_x">–</span> <span class="NLM_lpage">8548</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8535-8548&author=D.+M.+Swansonauthor=B.+M.+Savallauthor=K.+J.+Coeauthor=F.+Schoetensauthor=T.+Koudriakovaauthor=J.+Skaptasonauthor=J.+Wallauthor=J.+Rechauthor=X.+Dengauthor=M.+De+Angelisauthor=A.+Eversonauthor=B.+Lordauthor=Q.+Wangauthor=H.+Aoauthor=B.+Scottauthor=K.+Sepassiauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Identification+of+%28R%29-%282-chloro-3-%28trifluoromethyl%29phenyl%29%281-%285-fluoropyridin-2-yl%29-4-methyl-6%2C7-dihydro-1H-imidazo%5B4%2C5-c%5Dpyridin-5%284H%29-yl%29methanone+%28JNJ+54166060%29%2C+a+small+molecule+antagonist+of+the+P2X7+receptor&doi=10.1021%2Facs.jmedchem.6b00989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor</span></div><div class="casAuthors">Swanson, Devin M.; Savall, Brad M.; Coe, Kevin J.; Schoetens, Freddy; Koudriakova, Tatiana; Skaptason, Judith; Wall, Jessica; Rech, Jason; Deng, Xiahou; De Angelis, Meri; Everson, Anita; Lord, Brian; Wang, Qi; Ao, Hong; Scott, Brian; Sepassi, Kia; Lovenberg, Timothy W.; Carruthers, Nicholas I.; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8535-8548</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and SAR of a series of 4,5,6,7-tetrahydro-imidazo[4,5-c]pyridine P2X7 antagonists are described.  Addressing P2X7 affinity and liver microsomal stability issues encountered with this template afforded Me substituted 4,5,6,7-tetrahydro-imidazo[4,5-c]pyridines ultimately leading to the identification of JNJ 54166060.  JNJ 54166060 is a potent P2X7 antagonist with an ED50=2.3 mg/kg in rat, high oral bioavailability and low-moderate clearance in pre-clin. species, acceptable safety margins in rat, and a predicted human dose of 120 mg QD.  Addnl., JNJ 54166060 possesses a unique CYP profile and was found to be a regioselective inhibitor of midazolam CYP3A metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQfT4dUZEP6bVg90H21EOLACvtfcHk0ljJHS472ksvfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyqsr%252FO&md5=a48451477fca4bec1fd13df7d5a22ea8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00989%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DRech%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DEverson%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520%2528R%2529-%25282-chloro-3-%2528trifluoromethyl%2529phenyl%2529%25281-%25285-fluoropyridin-2-yl%2529-4-methyl-6%252C7-dihydro-1H-imidazo%255B4%252C5-c%255Dpyridin-5%25284H%2529-yl%2529methanone%2520%2528JNJ%252054166060%2529%252C%2520a%2520small%2520molecule%2520antagonist%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8535%26epage%3D8548%26doi%3D10.1021%2Facs.jmedchem.6b00989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chrovian, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soyode-Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacani, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Novel phenyl-substituted 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists with robust target engagement in rat brain</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=490-497&author=C.+C.+Chrovianauthor=A.+Soyode-Johnsonauthor=H.+Aoauthor=G.+M.+Bacaniauthor=N.+I.+Carruthersauthor=B.+Lordauthor=L.+Nguyenauthor=J.+C.+Rechauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Novel+phenyl-substituted+5%2C6-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+P2X7+antagonists+with+robust+target+engagement+in+rat+brain&doi=10.1021%2Facschemneuro.5b00303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat Brain</span></div><div class="casAuthors">Chrovian, Christa C.; Soyode-Johnson, Akinola; Ao, Hong; Bacani, Genesis M.; Carruthers, Nicholas I.; Lord, Brian; Nguyen, Leslie; Rech, Jason C.; Wang, Qi; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-497</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists were optimized to allow for good blood-brain barrier permeability and high P2X7 target engagement in the brain of rats.  Compd. I (huP2X7 IC50 = 9 nM; rat P2X7 IC50 = 42 nM) achieved 80% receptor occupancy for 6 h when dosed orally at 10 mg/kg in rats as measured by ex vivo radioligand binding autoradiog.  Structure-activity relationships within this series are described, as well as in vitro ADME results.  In vivo pharmacokinetic data for key compds. is also included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFc11o0pApUbVg90H21EOLACvtfcHk0ljJHS472ksvfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlGmsA%253D%253D&md5=a51ac05ebd3115489ddbabecf0cd1170</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00303%26sid%3Dliteratum%253Aachs%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DSoyode-Johnson%26aufirst%3DA.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBacani%26aufirst%3DG.%2BM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520phenyl-substituted%25205%252C6-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520P2X7%2520antagonists%2520with%2520robust%2520target%2520engagement%2520in%2520rat%2520brain%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D490%26epage%3D497%26doi%3D10.1021%2Facschemneuro.5b00303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Synthesis, SAR, and pharmacological characterization of brain penetrant P2X7 receptor antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00089</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=671-676&author=B.+M.+Savallauthor=D.+Wuauthor=M.+De+Angelisauthor=N.+I.+Carruthersauthor=H.+Aoauthor=Q.+Wangauthor=B.+Lordauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Synthesis%2C+SAR%2C+and+pharmacological+characterization+of+brain+penetrant+P2X7+receptor+antagonists&doi=10.1021%2Facsmedchemlett.5b00089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor Antagonists</span></div><div class="casAuthors">Savall, Brad M.; Wu, Duncan; De Angelis, Meri; Carruthers, Nicholas I.; Ao, Hong; Wang, Qi; Lord, Brian; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">671-676</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and SAR of 1,2,3-triazolopiperidines, e.g., I, as a novel series of potent, brain penetrant P2X7 antagonists was described.  Initial efforts yielded a series of potent human P2X7R antagonists with moderate to weak rodent potency, some CYP inhibition, poor metabolic stability, and low soly.  Further work in this series, which focused on the SAR of the N-linked heterocycle, not only increased the potency at the human P2X7R but also provided compds. with good potency at the rat P2X7R.  These efforts eventually delivered a potent rat and human P2X7R antagonist with good physicochem. properties, an excellent pharmacokinetic profile, good partitioning into the CNS, and demonstrated in vivo target engagement after oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfae7yM_oV1bVg90H21EOLACvtfcHk0ljJHS472ksvfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGisbo%253D&md5=11d93747bb8b71d0ca108a3946e3a758</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00089%26sid%3Dliteratum%253Aachs%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%252C%2520SAR%252C%2520and%2520pharmacological%2520characterization%2520of%2520brain%2520penetrant%2520P2X7%2520receptor%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D671%26epage%3D676%26doi%3D10.1021%2Facsmedchemlett.5b00089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.bmcl.2015.12.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=26707399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVKrtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=257-261&author=M.+K.+Ameriksauthor=H.+Aoauthor=N.+I.+Carruthersauthor=B.+Lordauthor=S.+Ravulaauthor=J.+C.+Rechauthor=B.+M.+Savallauthor=J.+L.+Wallauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Preclinical+characterization+of+substituted+6%2C7-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-8%285H%29-one+P2X7+receptor+antagonists&doi=10.1016%2Fj.bmcl.2015.12.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span></div><div class="casAuthors">Ameriks, Michael K.; Ao, Hong; Carruthers, Nicholas I.; Lord, Brian; Ravula, Suchitra; Rech, Jason C.; Savall, Brad M.; Wall, Jessica L.; Wang, Qi; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis, SAR, and preclin. characterization of a series of substituted 6,7-dihydro[1,2,4]triazolo[4,3]pyrazin-8(5H)-one P2X7 receptor antagonists are described.  Optimized leads from this series comprise some of the most potent human P2X7R antagonists reported to date (IC50s < 1 nM).  They also exhibit sufficient potency and oral bioavailability in rat to enable extensive in vivo profiling.  Although many of the disclosed compds. are peripherally restricted, compd. I is brain penetrant and upon oral administration demonstrated dose-dependent target engagement in rat hippocampus as detd. by ex vivo receptor occupancy with radiotracer II (ED50 = 0.8 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre9WCgWhiM_rVg90H21EOLACvtfcHk0li1YJiPCC7MFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVKrtbjL&md5=d1a36bd7f088f4533308ad49fee7fa5b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWall%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520substituted%25206%252C7-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-8%25285H%2529-one%2520P2X7%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D257%26epage%3D261%26doi%3D10.1016%2Fj.bmcl.2015.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ziff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span> </span><span class="NLM_article-title">Substituted 5,6-(dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 antagonists</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvVemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=498-504&author=J.+Ziffauthor=D.+A.+Rudolphauthor=B.+Stenneauthor=T.+Koudriakovaauthor=B.+Lordauthor=P.+Bonaventureauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavicauthor=B.+T.+Shireman&title=Substituted+5%2C6-%28dihydropyrido%5B3%2C4-d%5Dpyrimidin-7%288H%29-yl%29-methanones+as+P2X7+antagonists&doi=10.1021%2Facschemneuro.5b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 Antagonists</span></div><div class="casAuthors">Ziff, Jeannie; Rudolph, Dale A.; Stenne, Brice; Koudriakova, Tatiana; Lord, Brian; Bonaventure, Pascal; Lovenberg, Timothy W.; Carruthers, Nicholas I.; Bhattacharya, Anindya; Letavic, Michael A.; Shireman, Brock T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">498-504</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the synthesis of a novel class of brain penetrating P2X7 antagonists with high potency at both the rat and human P2X7 receptors.  Disclosed herein are druglike mols. with demonstrated target engagement of the rat P2X7 receptors after an oral dose.  Specifically, compd. 20 occupied the P2X7 receptors >80% over the 6 h time course as measured by an ex vivo radioligand binding expt.  In a dose-response assay, this mol. has a plasma EC50 of 8 ng/mL.  Overall, 20 has suitable druglike properties and pharmacokinetics in rat and dog.  This mol. and others disclosed herein will serve as addnl. tools to elucidate the role of the P2X7 receptor in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4iuRhC8lPbVg90H21EOLACvtfcHk0li1YJiPCC7MFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvVemsA%253D%253D&md5=7f3f1afa4dad4db259189b98d97c8ae9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00304%26sid%3Dliteratum%253Aachs%26aulast%3DZiff%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DStenne%26aufirst%3DB.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26atitle%3DSubstituted%25205%252C6-%2528dihydropyrido%255B3%252C4-d%255Dpyrimidin-7%25288H%2529-yl%2529-methanones%2520as%2520P2X7%2520antagonists%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D498%26epage%3D504%26doi%3D10.1021%2Facschemneuro.5b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Click chemistry: diverse chemical function from a few good reactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2021</span><span class="refDoi"> DOI: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=11433435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVOis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=2004-2021&author=H.+C.+Kolbauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Click+chemistry%3A+diverse+chemical+function+from+a+few+good+reactions&doi=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry: diverse chemical function from a few good reactions</span></div><div class="casAuthors">Kolb, Hartmuth C.; Finn, M. G.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2004-2021</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Review with > 88 refs.  Examn. of nature's favorite mols. reveals a striking preference for making carbon-heteroatom bonds over carbon-carbon bonds - surely no surprise given that carbon dioxide is nature's starting material and that most reactions are performed in water.  Nucleic acids, proteins, and polysaccharides are condensation polymers of small subunits stitched together by carbon-heteroatom bonds.  Even the 35 or so building blocks from which these crucial mols. are made each contain, at most, six contiguous C-C bonds, except for the three arom. amino acids.  Taking a cue from nature's approach, the development of a set of powerful, highly reliable, and selective reactions for the rapid synthesis of useful new compds. and combinatorial libraries through heteroatom links (C-X-C), an approach called "click chem." is addressed.  Click chem. is at once defined, enabled, and constrained by a handful of nearly perfect "spring-loaded" reactions.  The stringent criteria for a process to earn click chem. status are described along with examples of the mol. frameworks that are easily made using this spartan, but powerful, synthetic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptrjo9nxXNRrVg90H21EOLACvtfcHk0li1YJiPCC7MFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVOis78%253D&md5=61c28b416c42c87821bc8a5bc2fdec36</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820010601%252940%253A11%253C2004%253A%253AAID-ANIE2004%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DClick%2520chemistry%253A%2520diverse%2520chemical%2520function%2520from%2520a%2520few%2520good%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D2004%26epage%3D2021%26doi%3D10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N. S.</span><span> </span><span class="NLM_article-title">Allyl-assisted, Cu(I)-catalyzed azide-alkyne cycloaddition/allylation reaction: assembly of the [1,2,3]triazolo-4,5,6,7-tetrahydropyridine core structure</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">11003</span><span class="NLM_x">–</span> <span class="NLM_lpage">11012</span><span class="refDoi"> DOI: 10.1021/acs.joc.5b02174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b02174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=11003-11012&author=X.+Dengauthor=J.+Liangauthor=B.+B.+Allisonauthor=C.+Dvorakauthor=H.+McAllisterauthor=B.+M.+Savallauthor=N.+S.+Mani&title=Allyl-assisted%2C+Cu%28I%29-catalyzed+azide-alkyne+cycloaddition%2Fallylation+reaction%3A+assembly+of+the+%5B1%2C2%2C3%5Dtriazolo-4%2C5%2C6%2C7-tetrahydropyridine+core+structure&doi=10.1021%2Facs.joc.5b02174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b02174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b02174%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DAllison%26aufirst%3DB.%2BB.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DMcAllister%26aufirst%3DH.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DMani%26aufirst%3DN.%2BS.%26atitle%3DAllyl-assisted%252C%2520Cu%2528I%2529-catalyzed%2520azide-alkyne%2520cycloaddition%252Fallylation%2520reaction%253A%2520assembly%2520of%2520the%2520%255B1%252C2%252C3%255Dtriazolo-4%252C5%252C6%252C7-tetrahydropyridine%2520core%2520structure%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26spage%3D11003%26epage%3D11012%26doi%3D10.1021%2Facs.joc.5b02174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span> </span><span class="NLM_article-title">Aryne click chemistry: synthesis of oxadisilole fused benzotriazoles or naphthotriazoles from arynes and azides</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">856</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span><span class="refDoi"> DOI: 10.1016/j.tet.2010.12.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.tet.2010.12.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=856-859&author=Y.+Linauthor=Y.+Chenauthor=X.+Maauthor=D.+Xuauthor=W.+Caoauthor=J.+Chen&title=Aryne+click+chemistry%3A+synthesis+of+oxadisilole+fused+benzotriazoles+or+naphthotriazoles+from+arynes+and+azides&doi=10.1016%2Fj.tet.2010.12.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.12.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.12.039%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DAryne%2520click%2520chemistry%253A%2520synthesis%2520of%2520oxadisilole%2520fused%2520benzotriazoles%2520or%2520naphthotriazoles%2520from%2520arynes%2520and%2520azides%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26spage%3D856%26epage%3D859%26doi%3D10.1016%2Fj.tet.2010.12.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, J. E.</span><span> </span><span class="NLM_article-title">Benzyne click chemistry with in situ generated aromatic azides</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span><span class="refDoi"> DOI: 10.1021/ol9002338</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9002338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXislKqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1587-1590&author=F.+Zhangauthor=J.+E.+Moses&title=Benzyne+click+chemistry+with+in+situ+generated+aromatic+azides&doi=10.1021%2Fol9002338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Benzyne Click Chemistry with in Situ Generated Aromatic Azides</span></div><div class="casAuthors">Zhang, Fengzhi; Moses, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1587-1590</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient synthesis of substituted benzotriazoles using an azide-alkyne 1,3-dipolar cycloaddn. "click reaction" is described.  Key to the procedure is the in situ generation of the reactive arom. azide and benzyne reaction partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox7AhODpK6OLVg90H21EOLACvtfcHk0liHKO-RxYJ-7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXislKqsbo%253D&md5=dc8c13a747972c04e718a612096ddc68</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fol9002338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9002338%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26atitle%3DBenzyne%2520click%2520chemistry%2520with%2520in%2520situ%2520generated%2520aromatic%2520azides%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D1587%26epage%3D1590%26doi%3D10.1021%2Fol9002338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Continuous-flow synthesis of 1-substituted benzotriazoles from chloronitrobenzenes and amines in a C-N bond formation /hydrogenation/diazotization/cyclization sequence</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4247</span><span class="NLM_x">–</span> <span class="NLM_lpage">4250</span><span class="refDoi"> DOI: 10.1002/anie.201300615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2Fanie.201300615" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=4247-4250&author=M.+Chenauthor=S.+L.+Buchwald&title=Continuous-flow+synthesis+of+1-substituted+benzotriazoles+from+chloronitrobenzenes+and+amines+in+a+C-N+bond+formation+%2Fhydrogenation%2Fdiazotization%2Fcyclization+sequence&doi=10.1002%2Fanie.201300615"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fanie.201300615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201300615%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DContinuous-flow%2520synthesis%2520of%25201-substituted%2520benzotriazoles%2520from%2520chloronitrobenzenes%2520and%2520amines%2520in%2520a%2520C-N%2520bond%2520formation%2520%252Fhydrogenation%252Fdiazotization%252Fcyclization%2520sequence%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D4247%26epage%3D4250%26doi%3D10.1002%2Fanie.201300615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Huisgen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeimies, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobius, L.</span><span> </span><span class="NLM_article-title">K1.3-Dipolare cycloadditionen, XXXII. Kinetik der additionen organischer azide an CC-mehrfachbindungen</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2494</span><span class="NLM_x">–</span> <span class="NLM_lpage">2507</span><span class="refDoi"> DOI: 10.1002/cber.19671000806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2Fcber.19671000806" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1967&pages=2494-2507&author=R.+Huisgenauthor=G.+Szeimiesauthor=L.+Mobius&title=K1.3-Dipolare+cycloadditionen%2C+XXXII.+Kinetik+der+additionen+organischer+azide+an+CC-mehrfachbindungen&doi=10.1002%2Fcber.19671000806"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fcber.19671000806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.19671000806%26sid%3Dliteratum%253Aachs%26aulast%3DHuisgen%26aufirst%3DR.%26aulast%3DSzeimies%26aufirst%3DG.%26aulast%3DMobius%26aufirst%3DL.%26atitle%3DK1.3-Dipolare%2520cycloadditionen%252C%2520XXXII.%2520Kinetik%2520der%2520additionen%2520organischer%2520azide%2520an%2520CC-mehrfachbindungen%26jtitle%3DChem.%2520Ber.%26date%3D1967%26volume%3D100%26spage%3D2494%26epage%3D2507%26doi%3D10.1002%2Fcber.19671000806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ramachary, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakumar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, V. V.</span><span> </span><span class="NLM_article-title">Amino acid-catalyzed cascade [3+2]-cycloaddition/hydrolysis reactions based on the push-pull dienamine platform: synthesis of highly functionalized NH-1,2,3-triazoles</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">9143</span><span class="NLM_x">–</span> <span class="NLM_lpage">9147</span><span class="refDoi"> DOI: 10.1002/chem.200801325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2Fchem.200801325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=18767077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlKmtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=9143-9147&author=D.+B.+Ramacharyauthor=K.+Ramakumarauthor=V.+V.+Narayana&title=Amino+acid-catalyzed+cascade+%5B3%2B2%5D-cycloaddition%2Fhydrolysis+reactions+based+on+the+push-pull+dienamine+platform%3A+synthesis+of+highly+functionalized+NH-1%2C2%2C3-triazoles&doi=10.1002%2Fchem.200801325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Amino acid-catalyzed cascade [3+2]-cycloaddition/hydrolysis reactions based on the push-pull dienamine platform: synthesis of highly functionalized NH-1,2,3-triazoles</span></div><div class="casAuthors">Ramachary, Dhevalapally B.; Ramakumar, Kinthada; Narayana, Vidadala V.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9143-9147</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A practical and environmentally friendly amino acid catalyzed cascade process for the synthesis of highly substituted NH-1,2,3-triazoles was achieved through cascade [3+2]-cycloaddn./hydrolysis of Hagemann's esters with p-toluenesulfonyl azide (TsN3) in the presence of a catalytic amt. of proline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmoR0fp2ctkbVg90H21EOLACvtfcHk0lgsZZI_XuP9Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlKmtbbL&md5=2fdf6d7eacd0175f6eacea69007311c1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fchem.200801325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200801325%26sid%3Dliteratum%253Aachs%26aulast%3DRamachary%26aufirst%3DD.%2BB.%26aulast%3DRamakumar%26aufirst%3DK.%26aulast%3DNarayana%26aufirst%3DV.%2BV.%26atitle%3DAmino%2520acid-catalyzed%2520cascade%2520%255B3%252B2%255D-cycloaddition%252Fhydrolysis%2520reactions%2520based%2520on%2520the%2520push-pull%2520dienamine%2520platform%253A%2520synthesis%2520of%2520highly%2520functionalized%2520NH-1%252C2%252C3-triazoles%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D9143%26epage%3D9147%26doi%3D10.1002%2Fchem.200801325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Belkheira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Abed, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bressy, C.</span><span> </span><span class="NLM_article-title">Organocatalytic synthesis of 1,2,3-triazoles from unactivated ketones and arylazides</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">12917</span><span class="NLM_x">–</span> <span class="NLM_lpage">12921</span><span class="refDoi"> DOI: 10.1002/chem.201102046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2Fchem.201102046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=21984230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yjsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=12917-12921&author=M.+Belkheiraauthor=D.+El+Abedauthor=J.-M.+Ponsauthor=C.+Bressy&title=Organocatalytic+synthesis+of+1%2C2%2C3-triazoles+from+unactivated+ketones+and+arylazides&doi=10.1002%2Fchem.201102046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Organocatalytic Synthesis of 1,2,3-Triazoles from Unactivated Ketones and Arylazides</span></div><div class="casAuthors">Belkheira, Mokhtaria; El Abed, Douniazad; Pons, Jean-Marc; Bressy, Cyril</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">12917-12921, S12917/1-S12917/33</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel organocatalytic synthesis of highly substituted 1,2,3-triazoles from unactivated ketones and arylazides is presented.  Proline was established as an excellent organocatalyst for this reaction, with the acid moiety being crucial for the elimination step.  While the reaction needed to be run for a prolonged time under thermal conditions, a dramatic acceleration was obsd. by using microwave activation.  A wide range of arylazides and ketones could be used, with cyclic ketones giving the best results.  Finally, high levels of regio- and chemoselectivity were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdeBj1N6vHsrVg90H21EOLACvtfcHk0lgsZZI_XuP9Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yjsrjK&md5=f9d7ab62a6182f5055a21dcbb5c2cb66</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fchem.201102046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201102046%26sid%3Dliteratum%253Aachs%26aulast%3DBelkheira%26aufirst%3DM.%26aulast%3DEl%2BAbed%26aufirst%3DD.%26aulast%3DPons%26aufirst%3DJ.-M.%26aulast%3DBressy%26aufirst%3DC.%26atitle%3DOrganocatalytic%2520synthesis%2520of%25201%252C2%252C3-triazoles%2520from%2520unactivated%2520ketones%2520and%2520arylazides%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D12917%26epage%3D12921%26doi%3D10.1002%2Fchem.201102046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Dean, D. K.; Munoz-Muriedas, J.; Sime, M.; Steadman, J. G. A.; Thewlis, R. E. A.; Trani, G.; Walter, D. S.</span><span> </span><span class="NLM_article-title">5,6,7,8-Tetrahydro[1,2,4]triazolo[4,3-a]pyrazine derivatives as P2X7 modulators</span>. WO 2010125102 A1, November 4,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+K.+Dean&author=J.+Munoz-Muriedas&author=M.+Sime&author=J.+G.+A.+Steadman&author=R.+E.+A.+Thewlis&author=G.+Trani&author=D.+S.+Walter&title=5%2C6%2C7%2C8-Tetrahydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+derivatives+as+P2X7+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DD.%2BK.%26atitle%3D5%252C6%252C7%252C8-Tetrahydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520derivatives%2520as%2520P2X7%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Parsons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, H. D.</span><span> </span><span class="NLM_article-title">Precise absolute-structure determination in light-atom crystals</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">s61</span><span class="refDoi"> DOI: 10.1107/S0108767304098800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1107%2FS0108767304098800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=14684893" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=s61&author=S.+Parsonsauthor=H.+D.+Flack&title=Precise+absolute-structure+determination+in+light-atom+crystals&doi=10.1107%2FS0108767304098800"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0108767304098800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767304098800%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DFlack%26aufirst%3DH.%2BD.%26atitle%3DPrecise%2520absolute-structure%2520determination%2520in%2520light-atom%2520crystals%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3Ds61%26doi%3D10.1107%2FS0108767304098800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Discovery-stage recrystallization techniques employed the following: cooling–evaporation crystallization (25 solvent pairs), cooling crystallization with hot filtration (14 solvent pairs), crash-crystallization by antisolvent addition (15 solvent pairs), evaporative crystallization (15 solvent pairs), long-term slurry conversion (10 solvents), and thermocycling (15 solvents). Vapor diffusion techniques and thermocycling and polymer assisted crystallization were also attempted.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mahmood, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balian, J. D.</span><span> </span><span class="NLM_article-title">Interspecies scaling: predicting clearance of drugs in humans: three different approaches</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span><span class="refDoi"> DOI: 10.3109/00498259609052491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.3109%2F00498259609052491" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=887-895&author=I.+Mahmoodauthor=J.+D.+Balian&title=Interspecies+scaling%3A+predicting+clearance+of+drugs+in+humans%3A+three+different+approaches&doi=10.3109%2F00498259609052491"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3109%2F00498259609052491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498259609052491%26sid%3Dliteratum%253Aachs%26aulast%3DMahmood%26aufirst%3DI.%26aulast%3DBalian%26aufirst%3DJ.%2BD.%26atitle%3DInterspecies%2520scaling%253A%2520predicting%2520clearance%2520of%2520drugs%2520in%2520humans%253A%2520three%2520different%2520approaches%26jtitle%3DXenobiotica%26date%3D1996%26volume%3D26%26spage%3D887%26epage%3D895%26doi%3D10.3109%2F00498259609052491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoblock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepomuceno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1111/bph.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1111%2Fbph.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=23889535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=624-640&author=A.+Bhattacharyaauthor=Q.+Wangauthor=H.+Aoauthor=J.+R.+Shoblockauthor=B.+Lordauthor=L.+Aluisioauthor=I.+Fraserauthor=D.+Nepomucenoauthor=R.+A.+Neffauthor=N.+Weltyauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=A.+D.+Wickendenauthor=M.+A.+Letavic&title=Pharmacological+characterization+of+a+novel+centrally+permeable+P2X7+receptor+antagonist%3A+JNJ-47965567&doi=10.1111%2Fbph.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span></div><div class="casAuthors">Bhattacharya, Anindya; Wang, Qi; Ao, Hong; Shoblock, James R.; Lord, Brian; Aluisio, Leah; Fraser, Ian; Nepomuceno, Diane; Neff, Robert A.; Welty, Natalie; Lovenberg, Timothy W.; Bonaventure, Pascal; Wickenden, Alan D.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">624-640</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : An increasing body of evidence suggests that the purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7) in the CNS may play a key role in neuropsychiatry, neurodegeneration and chronic pain.  In this study, we characterized JNJ-47965567, a centrally permeable, high-affinity, selective P2X7 antagonist.  Exptl. Approach : We have used a combination of in vitro assays (calcium flux, radioligand binding, electrophysiol., IL-1β release) in both recombinant and native systems.  Target engagement of JNJ-47965567 was demonstrated by ex vivo receptor binding autoradiog. and in vivo blockade of Bz-ATP induced IL-1β release in the rat brain.  Finally, the efficacy of JNJ-47965567 was tested in std. models of depression, mania and neuropathic pain.  Key Results : JNJ-47965567 is potent high affinity (pKi 7.9 ± 0.07), selective human P2X7 antagonist, with no significant obsd. speciation.  In native systems, the potency of the compd. to attenuate IL-1β release was 6.7 ± 0.07 (human blood), 7.5 ± 0.07 (human monocytes) and 7.1 ± 0.1 (rat microglia).  JNJ-47965567 exhibited target engagement in rat brain, with a brain EC50 of 78 ± 19 ng·mL-1 (P2X7 receptor autoradiog.) and functional block of Bz-ATP induced IL-1β release.  JNJ-47965567 (30 mg·kg-1) attenuated amphetamine-induced hyperactivity and exhibited modest, yet significant efficacy in the rat model of neuropathic pain.  No efficacy was obsd. in forced swim test.  Conclusion and Implications : JNJ-47965567 is centrally permeable, high affinity P2X7 antagonist that can be used to probe the role of central P2X7 in rodent models of CNS pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS_bU7fI8KzLVg90H21EOLACvtfcHk0lgrXzffQFu2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI&md5=29d3bc1d3ecedda01f3d33b53d96c289</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fbph.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12314%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DWelty%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520novel%2520centrally%2520permeable%2520P2X7%2520receptor%2520antagonist%253A%2520JNJ-47965567%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26spage%3D624%26epage%3D640%26doi%3D10.1111%2Fbph.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourgeaud, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vliegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verluyten, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haspeslagh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">A novel radioligand for the ATP-gated ionchannel P2X7:[<sup>3</sup>H] JNJ-54232334</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">765</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.ejphar.2015.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=26386289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFOrs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=765&publication_year=2015&pages=551-559&author=B.+Lordauthor=M.+K.+Ameriksauthor=Q.+Wangauthor=L.+Fourgeaudauthor=M.+Vliegenauthor=W.+Verluytenauthor=P.+Haspeslaghauthor=N.+I.+Carruthersauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=M.+A.+Letavicauthor=A.+Bhattacharya&title=A+novel+radioligand+for+the+ATP-gated+ionchannel+P2X7%3A%5B3H%5D+JNJ-54232334&doi=10.1016%2Fj.ejphar.2015.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334</span></div><div class="casAuthors">Lord, Brian; Ameriks, Michael K.; Wang, Qi; Fourgeaud, Lawrence; Vliegen, Maarten; Verluyten, Willy; Haspeslagh, Pieter; Carruthers, Nicholas I.; Lovenberg, Timothy W.; Bonaventure, Pascal; Letavic, Michael A.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">765</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">551-559</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ATP-gated ion channel P2X7 has emerged as a potential central nervous system (CNS) drug target based on the hypotheses that pro-inflammatory cytokines such as IL-1β that are released by microglia, may contribute to the etiol. of various disorders of the CNS including depression.  In this study, we identified two closely related P2X7 antagonists, JNJ-54232334 and JNJ-54140515, and then tritium labeled the former to produce a new radioligand for P2X7.  JNJ-54232334 is a high affinity ligand for the rat P2X7 with a pKi of 9.3±0.1.  In rat cortical membranes, [3H] JNJ-54232334 reached saturable binding with equil. dissocn. (Kd) const. of 4.9±1.3 nM.  The compd. displayed monophasic assocn. and dissocn. kinetics with fast on and off rates.  In rat brain sections, specific binding of [3H] JNJ-54232334 was markedly improved compared to the previously described P2X7 radioligand, [3H] A-804598.  In P2X7 knockout mouse brain sections, [3H] A-804598 bound to non-P2X7 binding sites in contrast to [3H] JNJ-54232334.  In rat or wild type mouse brain sections [3H] JNJ-54232334 bound in a more homogenous and region independent manner.  The ubiquitous expression of P2X7 receptors was confirmed with immunohistochem. in rat brain sections.  The partial displacement of [3H] A-804598 binding resulted in the underestimation of the level of ex vivo P2X7 occupancy for JNJ-54140515.  Higher levels of P2X7 ex vivo occupancy were measured using [3H] JNJ-54232334 due to less non-specific binding.  In summary, we describe [3H] JNJ-54232334 as a novel P2X7 radioligand, with improved properties over [3H] A-804598.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqr6Nqq14QSLVg90H21EOLACvtfcHk0lgrXzffQFu2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFOrs7zP&md5=b7d9da772882fa3d9e405fa54444d0f3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DFourgeaud%26aufirst%3DL.%26aulast%3DVliegen%26aufirst%3DM.%26aulast%3DVerluyten%26aufirst%3DW.%26aulast%3DHaspeslagh%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DA%2520novel%2520radioligand%2520for%2520the%2520ATP-gated%2520ionchannel%2520P2X7%253A%255B3H%255D%2520JNJ-54232334%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D765%26spage%3D551%26epage%3D559%26doi%3D10.1016%2Fj.ejphar.2015.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Potratz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bäuerle, P.</span><span> </span><span class="NLM_article-title">Thiophene-based donor–acceptor co-oligomers by copper-catalyzed 1,3-dipolar cycloaddition</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.3762/bjoc.8.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.3762%2Fbjoc.8.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=23015814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVGisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=683-692&author=S.+Potratzauthor=A.+Mishraauthor=P.+B%C3%A4uerle&title=Thiophene-based+donor%E2%80%93acceptor+co-oligomers+by+copper-catalyzed+1%2C3-dipolar+cycloaddition&doi=10.3762%2Fbjoc.8.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Thiophene-based donor-acceptor co-oligomers by copper-catalyzed 1,3-dipolar cycloaddition</span></div><div class="casAuthors">Potratz, Stefanie; Mishra, Amaresh; Baeuerle, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">683-692, No. 76</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">Herein the authors present a three-component one-pot procedure to synthesize oligomers of a donor-acceptor-donor type (charge transfer complexes) in which thiophene moieties work as donor groups and 1,2,3-triazole derivs. as acceptor units.  In this respect, terminal alkyne (oligo)thiophene derivs. were coupled to halogenated (oligo)thiophenes in the presence of sodium azide and a copper catalyst.  The optoelectronic properties of various thiophene-1,2,3-triazole oligomers were investigated by UV-vis spectroscopy and cyclic voltammetry.  Several co-oligomers were subjected to electrochem. polymn. to form corresponding conjugated polymers.  The synthesis of the target compds. was achieved by a systematic variation of reactants and the title compds. thus formed included a bithiophene-triazole deriv. (I) which was obtained as red-colored monomer, which formed a blue-colored polymer film upon electrochem. polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgMnsrqzi1N7Vg90H21EOLACvtfcHk0lgrXzffQFu2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVGisb0%253D&md5=1647fbf90f8aeba52bbada779bb6a3e7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.8.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.8.76%26sid%3Dliteratum%253Aachs%26aulast%3DPotratz%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DB%25C3%25A4uerle%26aufirst%3DP.%26atitle%3DThiophene-based%2520donor%25E2%2580%2593acceptor%2520co-oligomers%2520by%2520copper-catalyzed%25201%252C3-dipolar%2520cycloaddition%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2012%26volume%3D8%26spage%3D683%26epage%3D692%26doi%3D10.3762%2Fbjoc.8.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Francesco Calzaferri, Paloma Narros-Fernández, Ricardo de Pascual, Antonio M.G. de Diego, Annette Nicke, Javier Egea, Antonio G. García, <span class="NLM_string-name hlFld-ContribAuthor">Cristóbal de los Ríos</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 2272-2290. <a href="https://doi.org/10.1021/acs.jmedchem.0c02145" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02145%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BPharmacological%252BEvaluation%252Bof%252BNovel%252BNon-nucleotide%252BPurine%252BDerivatives%252Bas%252BP2X7%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BNeuroinflammation%26aulast%3DCalzaferri%26aufirst%3DFrancesco%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D11122020%26date%3D09022021%26volume%3D64%26issue%3D4%26spage%3D2272%26epage%3D2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christa C. Chrovian, Akinola Soyode-Johnson, Brice Stenne, Daniel J. Pippel, Jeffrey Schoellerman, Brian Lord, Alexandra S. Needham, Chungfang Xia, Kevin J. Coe, Kia Sepassi, Freddy Schoetens, Brian Scott, Leslie Nguyen, Xiaohui Jiang, Tatiana Koudriakova, Bartosz Balana, <span class="NLM_string-name hlFld-ContribAuthor">Michael A. Letavic</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Preclinical Evaluation of 3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9181-9196. <a href="https://doi.org/10.1021/acs.jmedchem.9b02113" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02113%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPreclinical%252BEvaluation%252Bof%252B3-Methyl-6-%2525285-thiophenyl%252529-1%25252C3-dihydro-imidazo%25255B4%25252C5-b%25255Dpyridin-2-ones%252Bas%252BSelective%252BGluN2B%252BNegative%252BAllosteric%252BModulators%252Bfor%252Bthe%252BTreatment%252Bof%252BMood%252BDisorders%26aulast%3DChrovian%26aufirst%3DChrista%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06022020%26date%3D28082020%26date%3D31072020%26volume%3D63%26issue%3D17%26spage%3D9181%26epage%3D9196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Drill</span>, <span class="hlFld-ContribAuthor ">Nigel C.  Jones</span>, <span class="hlFld-ContribAuthor ">Martin  Hunn</span>, <span class="hlFld-ContribAuthor ">Terence J.  O’Brien</span>, <span class="hlFld-ContribAuthor ">Mastura  Monif</span>. </span><span class="cited-content_cbyCitation_article-title">Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer. </span><span class="cited-content_cbyCitation_journal-name">Purinergic Signalling</span><span> <strong>2021,</strong> <em>17 </em>
                                    (2)
                                     , 215-227. <a href="https://doi.org/10.1007/s11302-021-09776-9" title="DOI URL">https://doi.org/10.1007/s11302-021-09776-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11302-021-09776-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11302-021-09776-9%26sid%3Dliteratum%253Aachs%26jtitle%3DPurinergic%2520Signalling%26atitle%3DAntagonism%252Bof%252Bthe%252BATP-gated%252BP2X7%252Breceptor%25253A%252Ba%252Bpotential%252Btherapeutic%252Bstrategy%252Bfor%252Bcancer%26aulast%3DDrill%26aufirst%3DMatthew%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D2%26spage%3D215%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul R.  Territo</span>, <span class="hlFld-ContribAuthor ">Hamideh  Zarrinmayeh</span>. </span><span class="cited-content_cbyCitation_article-title">P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular Neuroscience</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.3389/fncel.2021.617036" title="DOI URL">https://doi.org/10.3389/fncel.2021.617036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fncel.2021.617036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffncel.2021.617036%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520Neuroscience%26atitle%3DP2X7%252BReceptors%252Bin%252BNeurodegeneration%25253A%252BPotential%252BTherapeutic%252BApplications%252BFrom%252BBasic%252Bto%252BClinical%252BApproaches%26aulast%3DTerrito%26aufirst%3DPaul%2BR.%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wai Lean  Koay</span>, <span class="hlFld-ContribAuthor ">Guang-Jian  Mei</span>, <span class="hlFld-ContribAuthor ">Yixin  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Facile access to benzofuran-fused tetrahydropyridines
              via
              catalytic asymmetric [4 + 2] cycloaddition of aurone-derived 1-azadienes with 3-vinylindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (5)
                                     , 968-974. <a href="https://doi.org/10.1039/D0QO01236J" title="DOI URL">https://doi.org/10.1039/D0QO01236J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01236J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01236J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DFacile%252Baccess%252Bto%252Bbenzofuran-fused%252Btetrahydropyridines%252Bvia%252Bcatalytic%252Basymmetric%252B%25255B4%252B%25252B%252B2%25255D%252Bcycloaddition%252Bof%252Baurone-derived%252B1-azadienes%252Bwith%252B3-vinylindoles%26aulast%3DKoay%26aufirst%3DWai%2BLean%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D5%26spage%3D968%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Miscellaneous Reactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 161-291. <a href="https://doi.org/10.1002/9783527828166.ch4" title="DOI URL">https://doi.org/10.1002/9783527828166.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527828166.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527828166.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DMiscellaneous%252BReactions%26date%3D2021%26date%3D2020%26spage%3D161%26epage%3D291%26pub%3DWiley%26atitle%3DApplied%252BOrganic%252BChemistry%26aulast%3DDe%26aufirst%3DSurya%2BK.%26date%3D2021%26date%3D2020%26volume%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie Jack  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Cope Elimination. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 112-114. <a href="https://doi.org/10.1007/978-3-030-50865-4_32" title="DOI URL">https://doi.org/10.1007/978-3-030-50865-4_32</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-50865-4_32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-50865-4_32%26sid%3Dliteratum%253Aachs%26atitle%3DCope%252BElimination%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2021%26date%3D2021%26spage%3D112%26epage%3D114%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DName%252BReactions%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2021%26volume%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xue  Cui</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Tingting  Zeng</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yinfeng  Tan</span>, <span class="hlFld-ContribAuthor ">Dongyan  Liu</span>, <span class="hlFld-ContribAuthor ">Xuesong  Wang</span>, <span class="hlFld-ContribAuthor ">Youbin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Base‐Promoted Regiospecific Synthesis of Fully Substituted 1,2,3‐Triazoles and 1,5‐Disubstituted 1,2,3‐Triazoles. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 2176-2183. <a href="https://doi.org/10.1002/ajoc.202000479" title="DOI URL">https://doi.org/10.1002/ajoc.202000479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202000479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202000479%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DBase%2525E2%252580%252590Promoted%252BRegiospecific%252BSynthesis%252Bof%252BFully%252BSubstituted%252B1%25252C2%25252C3%2525E2%252580%252590Triazoles%252Band%252B1%25252C5%2525E2%252580%252590Disubstituted%252B1%25252C2%25252C3%2525E2%252580%252590Triazoles%26aulast%3DZhang%26aufirst%3DXueying%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D2176%26epage%3D2183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriel P.  Costa</span>, <span class="hlFld-ContribAuthor ">Mariana F.  Bach</span>, <span class="hlFld-ContribAuthor ">Maiara C.  Moraes</span>, <span class="hlFld-ContribAuthor ">Thiago  Barcellos</span>, <span class="hlFld-ContribAuthor ">Eder J.  Lenardão</span>, <span class="hlFld-ContribAuthor ">Márcio S.  Silva</span>, <span class="hlFld-ContribAuthor ">Diego  Alves</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential Organocatalytic Synthesis of [1,2,3]Triazolo[1,5‐
              a
              ]quinolines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (22)
                                     , 5044-5055. <a href="https://doi.org/10.1002/adsc.202000887" title="DOI URL">https://doi.org/10.1002/adsc.202000887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000887%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSequential%252BOrganocatalytic%252BSynthesis%252Bof%252B%25255B1%25252C2%25252C3%25255DTriazolo%25255B1%25252C5%2525E2%252580%252590%252Ba%252B%25255Dquinolines%26aulast%3DCosta%26aufirst%3DGabriel%2BP.%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D22%26spage%3D5044%26epage%3D5055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Calzaferri</span>, <span class="hlFld-ContribAuthor ">Cristina  Ruiz‐Ruiz</span>, <span class="hlFld-ContribAuthor ">Antonio M. G.  Diego</span>, <span class="hlFld-ContribAuthor ">Ricardo  Pascual</span>, <span class="hlFld-ContribAuthor ">Iago  Méndez‐López</span>, <span class="hlFld-ContribAuthor ">María F.  Cano‐Abad</span>, <span class="hlFld-ContribAuthor ">Victoria  Maneu</span>, <span class="hlFld-ContribAuthor ">Cristóbal  Ríos</span>, <span class="hlFld-ContribAuthor ">Luis  Gandía</span>, <span class="hlFld-ContribAuthor ">Antonio G.  García</span>. </span><span class="cited-content_cbyCitation_article-title">The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (6)
                                     , 2427-2465. <a href="https://doi.org/10.1002/med.21710" title="DOI URL">https://doi.org/10.1002/med.21710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21710%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DThe%252Bpurinergic%252BP2X7%252Breceptor%252Bas%252Ba%252Bpotential%252Bdrug%252Btarget%252Bto%252Bcombat%252Bneuroinflammation%252Bin%252Bneurodegenerative%252Bdiseases%26aulast%3DCalzaferri%26aufirst%3DFrancesco%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D6%26spage%3D2427%26epage%3D2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasper  Recourt</span>, <span class="hlFld-ContribAuthor ">Jasper  van der Aart</span>, <span class="hlFld-ContribAuthor ">Gabriel  Jacobs</span>, <span class="hlFld-ContribAuthor ">Marieke  de Kam</span>, <span class="hlFld-ContribAuthor ">Wayne  Drevets</span>, <span class="hlFld-ContribAuthor ">Luc  van Nueten</span>, <span class="hlFld-ContribAuthor ">Kawita  Kanhai</span>, <span class="hlFld-ContribAuthor ">Pieter  Siebenga</span>, <span class="hlFld-ContribAuthor ">Rob  Zuiker</span>, <span class="hlFld-ContribAuthor ">Paulien  Ravenstijn</span>, <span class="hlFld-ContribAuthor ">Maarten  Timmers</span>, <span class="hlFld-ContribAuthor ">Joop  van Gerven</span>, <span class="hlFld-ContribAuthor ">Peter  de Boer</span>. </span><span class="cited-content_cbyCitation_article-title">Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2020,</strong> <em>34 </em>
                                    (9)
                                     , 1030-1042. <a href="https://doi.org/10.1177/0269881120914206" title="DOI URL">https://doi.org/10.1177/0269881120914206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881120914206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881120914206%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DCharacterisation%252Bof%252Bthe%252Bpharmacodynamic%252Beffects%252Bof%252Bthe%252BP2X7%252Breceptor%252Bantagonist%252BJNJ-54175446%252Busing%252Ban%252Boral%252Bdexamphetamine%252Bchallenge%252Bmodel%252Bin%252Bhealthy%252Bmales%252Bin%252Ba%252Brandomised%25252C%252Bdouble-blind%25252C%252Bplacebo-controlled%25252C%252Bmultiple%252Bascending%252Bdose%252Btrial%26aulast%3DRecourt%26aufirst%3DKasper%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D9%26spage%3D1030%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberta  Andrejew</span>, <span class="hlFld-ContribAuthor ">Ágatha  Oliveira-Giacomelli</span>, <span class="hlFld-ContribAuthor ">Deidiane Elisa  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Talita  Glaser</span>, <span class="hlFld-ContribAuthor ">Vanessa Fernandes  Arnaud-Sampaio</span>, <span class="hlFld-ContribAuthor ">Claudiana  Lameu</span>, <span class="hlFld-ContribAuthor ">Henning  Ulrich</span>. </span><span class="cited-content_cbyCitation_article-title">The P2X7 Receptor: Central Hub of Brain Diseases. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2020,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnmol.2020.00124" title="DOI URL">https://doi.org/10.3389/fnmol.2020.00124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2020.00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2020.00124%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DThe%252BP2X7%252BReceptor%25253A%252BCentral%252BHub%252Bof%252BBrain%252BDiseases%26aulast%3DAndrejew%26aufirst%3DRoberta%26date%3D2020%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G.  Surendra Reddy</span>, <span class="hlFld-ContribAuthor ">A.  Suresh Kumar</span>, <span class="hlFld-ContribAuthor ">Dhevalapally B.  Ramachary</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalytic enone-azide [3 + 2]-cycloaddition: synthesis of functionally rich
              C
              /
              N
              -double vinyl 1,2,3-triazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (23)
                                     , 4470-4478. <a href="https://doi.org/10.1039/D0OB00848F" title="DOI URL">https://doi.org/10.1039/D0OB00848F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00848F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00848F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DOrganocatalytic%252Benone-azide%252B%25255B3%252B%25252B%252B2%25255D-cycloaddition%25253A%252Bsynthesis%252Bof%252Bfunctionally%252Brich%252BC%252B%25252F%252BN%252B-double%252Bvinyl%252B1%25252C2%25252C3-triazoles%26aulast%3DSurendra%2BReddy%26aufirst%3DG.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D23%26spage%3D4470%26epage%3D4478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Ruiz-Ruiz</span>, <span class="hlFld-ContribAuthor ">Francesco  Calzaferri</span>, <span class="hlFld-ContribAuthor ">Antonio G.  García</span>. </span><span class="cited-content_cbyCitation_article-title">P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2020,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnmol.2020.00093" title="DOI URL">https://doi.org/10.3389/fnmol.2020.00093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2020.00093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2020.00093%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DP2X7%252BReceptor%252BAntagonism%252Bas%252Ba%252BPotential%252BTherapy%252Bin%252BAmyotrophic%252BLateral%252BSclerosis%26aulast%3DRuiz-Ruiz%26aufirst%3DCristina%26date%3D2020%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manoj  Dhameja</span>, <span class="hlFld-ContribAuthor ">Hariom  Kumar</span>, <span class="hlFld-ContribAuthor ">Preeti  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral Fused 1,2,3‐Triazoles: A Synthetic Overview. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>9 </em>
                                    (5)
                                     , 721-748. <a href="https://doi.org/10.1002/ajoc.202000021" title="DOI URL">https://doi.org/10.1002/ajoc.202000021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202000021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202000021%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DChiral%252BFused%252B1%25252C2%25252C3%2525E2%252580%252590Triazoles%25253A%252BA%252BSynthetic%252BOverview%26aulast%3DDhameja%26aufirst%3DManoj%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D5%26spage%3D721%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sedef  Karabiyikoglu</span>, <span class="hlFld-ContribAuthor ">Alexandre V.  Brethomé</span>, <span class="hlFld-ContribAuthor ">Thomas  Palacin</span>, <span class="hlFld-ContribAuthor ">Robert S.  Paton</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Fletcher</span>. </span><span class="cited-content_cbyCitation_article-title">Enantiomerically enriched tetrahydropyridine allyl chlorides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (16)
                                     , 4125-4130. <a href="https://doi.org/10.1039/D0SC00377H" title="DOI URL">https://doi.org/10.1039/D0SC00377H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC00377H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC00377H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DEnantiomerically%252Benriched%252Btetrahydropyridine%252Ballyl%252Bchlorides%26aulast%3DKarabiyikoglu%26aufirst%3DSedef%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D16%26spage%3D4125%26epage%3D4130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederick A.  Luzzio</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and reactivity of fluorinated heterocycles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-84. <a href="https://doi.org/10.1016/bs.aihch.2020.02.001" title="DOI URL">https://doi.org/10.1016/bs.aihch.2020.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2020.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2020.02.001%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Band%252Breactivity%252Bof%252Bfluorinated%252Bheterocycles%26aulast%3DLuzzio%26aufirst%3DFrederick%2BA.%26date%3D2020%26spage%3D1%26epage%3D84%26pub%3DElsevier%26date%3D2020%26volume%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine F.  Gelin</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Michael A.  Letavic</span>. </span><span class="cited-content_cbyCitation_article-title">P2X7 receptor antagonists for the treatment of systemic inflammatory disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 63-99. <a href="https://doi.org/10.1016/bs.pmch.2019.11.002" title="DOI URL">https://doi.org/10.1016/bs.pmch.2019.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2019.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2019.11.002%26sid%3Dliteratum%253Aachs%26atitle%3DP2X7%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bsystemic%252Binflammatory%252Bdisorders%26aulast%3DGelin%26aufirst%3DChristine%2BF.%26date%3D2020%26spage%3D63%26epage%3D99%26pub%3DElsevier%26date%3D2020%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Marc  Ceusters</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2020,</strong> <em>45 </em>
                                    (1)
                                     , 234-235. <a href="https://doi.org/10.1038/s41386-019-0502-9" title="DOI URL">https://doi.org/10.1038/s41386-019-0502-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-019-0502-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-019-0502-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DTargeting%252Bneuroinflammation%252Bwith%252Bbrain%252Bpenetrant%252BP2X7%252Bantagonists%252Bas%252Bnovel%252Btherapeutics%252Bfor%252Bneuropsychiatric%252Bdisorders%26aulast%3DBhattacharya%26aufirst%3DAnindya%26date%3D2020%26date%3D2019%26volume%3D45%26issue%3D1%26spage%3D234%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G.  Surendra Reddy</span>, <span class="hlFld-ContribAuthor ">Dhevalapally B.  Ramachary</span>. </span><span class="cited-content_cbyCitation_article-title">Reaction engineering and photophysical studies of fully enriched
              C
              -vinyl-1,2,3-triazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (21)
                                     , 3620-3628. <a href="https://doi.org/10.1039/C9QO00864K" title="DOI URL">https://doi.org/10.1039/C9QO00864K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QO00864K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QO00864K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DReaction%252Bengineering%252Band%252Bphotophysical%252Bstudies%252Bof%252Bfully%252Benriched%252BC%252B-vinyl-1%25252C2%25252C3-triazoles%26aulast%3DSurendra%2BReddy%26aufirst%3DG.%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D21%26spage%3D3620%26epage%3D3628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lumei  Huang</span>, <span class="hlFld-ContribAuthor ">Lilla  Otrokocsi</span>, <span class="hlFld-ContribAuthor ">Beáta  Sperlágh</span>. </span><span class="cited-content_cbyCitation_article-title">Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2019,</strong> <em>151 </em>, 55-64. <a href="https://doi.org/10.1016/j.brainresbull.2019.01.030" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2019.01.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2019.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2019.01.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DRole%252Bof%252BP2%252Breceptors%252Bin%252Bnormal%252Bbrain%252Bdevelopment%252Band%252Bin%252Bneurodevelopmental%252Bpsychiatric%252Bdisorders%26aulast%3DHuang%26aufirst%3DLumei%26date%3D2019%26volume%3D151%26spage%3D55%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenhua  Liu</span>, <span class="hlFld-ContribAuthor ">Wenjing  Hao</span>, <span class="hlFld-ContribAuthor ">Wen  Gao</span>, <span class="hlFld-ContribAuthor ">Guangyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Lili  Tong</span>, <span class="hlFld-ContribAuthor ">Bo  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Silver-catalyzed three-component reaction: synthesis of N2-substituted 1,2,3-triazoles via direct benzylic amination. </span><span class="cited-content_cbyCitation_journal-name">Science China Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 1001-1006. <a href="https://doi.org/10.1007/s11426-019-9455-0" title="DOI URL">https://doi.org/10.1007/s11426-019-9455-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11426-019-9455-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11426-019-9455-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520China%2520Chemistry%26atitle%3DSilver-catalyzed%252Bthree-component%252Breaction%25253A%252Bsynthesis%252Bof%252BN2-substituted%252B1%25252C2%25252C3-triazoles%252Bvia%252Bdirect%252Bbenzylic%252Bamination%26aulast%3DLiu%26aufirst%3DZhenhua%26date%3D2019%26date%3D2019%26volume%3D62%26issue%3D8%26spage%3D1001%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khurshed  Bozorov</span>, <span class="hlFld-ContribAuthor ">Jiangyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Haji A.  Aisa</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3511-3531. <a href="https://doi.org/10.1016/j.bmc.2019.07.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.07.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.07.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C3-Triazole-containing%252Bhybrids%252Bas%252Bleads%252Bin%252Bmedicinal%252Bchemistry%25253A%252BA%252Brecent%252Boverview%26aulast%3DBozorov%26aufirst%3DKhurshed%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3511%26epage%3D3531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hartmuth C.  Kolb</span>, <span class="hlFld-ContribAuthor ">Olivier  Barret</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Cristian  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Chaofeng  Huang</span>, <span class="hlFld-ContribAuthor ">Michael  Letavic</span>, <span class="hlFld-ContribAuthor ">Gilles  Tamagnan</span>, <span class="hlFld-ContribAuthor ">Chunfang A.  Xia</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Anna Katrin  Szardenings</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
              18
              F-JNJ-64413739, a PET Radioligand for P2X7 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2019,</strong> <em>60 </em>
                                    (8)
                                     , 1154-1159. <a href="https://doi.org/10.2967/jnumed.118.212696" title="DOI URL">https://doi.org/10.2967/jnumed.118.212696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.212696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.212696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DPreclinical%252BEvaluation%252Band%252BNonhuman%252BPrimate%252BReceptor%252BOccupancy%252BStudy%252Bof%252B18%252BF-JNJ-64413739%25252C%252Ba%252BPET%252BRadioligand%252Bfor%252BP2X7%252BReceptors%26aulast%3DKolb%26aufirst%3DHartmuth%2BC.%26date%3D2019%26date%3D2019%26volume%3D60%26issue%3D8%26spage%3D1154%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yufang  Xiao</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Karra</span>, <span class="hlFld-ContribAuthor ">Andreas  Goutopoulos</span>, <span class="hlFld-ContribAuthor ">Noune Tahmassian  Morse</span>, <span class="hlFld-ContribAuthor ">Susan  Zhang</span>, <span class="hlFld-ContribAuthor ">Mohanraj  Dhanabal</span>, <span class="hlFld-ContribAuthor ">Hui  Tian</span>, <span class="hlFld-ContribAuthor ">Jeyaprakashnarayanan  Seenisamy</span>, <span class="hlFld-ContribAuthor ">Jayashankaran  Jayadevan</span>, <span class="hlFld-ContribAuthor ">Richard  Caldwell</span>, <span class="hlFld-ContribAuthor ">Justin  Potnick</span>, <span class="hlFld-ContribAuthor ">Matthew  Bleich</span>, <span class="hlFld-ContribAuthor ">Eugene  Chekler</span>, <span class="hlFld-ContribAuthor ">Brian  Sherer</span>, <span class="hlFld-ContribAuthor ">Venkataraman  Sriraman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (13)
                                     , 1660-1664. <a href="https://doi.org/10.1016/j.bmcl.2019.04.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bdevelopment%252Bof%252Bquinoline%252Banalogs%252Bas%252Bnovel%252BP2X7%252Breceptor%252Bantagonists%26aulast%3DXiao%26aufirst%3DYufang%26date%3D2019%26volume%3D29%26issue%3D13%26spage%3D1660%26epage%3D1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenhua  Liu</span>, <span class="hlFld-ContribAuthor ">Wenjing  Hao</span>, <span class="hlFld-ContribAuthor ">Zhixian  Liu</span>, <span class="hlFld-ContribAuthor ">Wen  Gao</span>, <span class="hlFld-ContribAuthor ">Zhihai  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Lili  Tong</span>, <span class="hlFld-ContribAuthor ">Bo  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Bimetal‐Catalyzed Cascade Reaction for Efficient Synthesis of
              N
              ‐Isopropenyl 1,2,3‐Triazoles via In‐Situ Generated 2‐Azidopropenes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – An Asian Journal</span><span> <strong>2019,</strong> <em>14 </em>
                                    (12)
                                     , 2149-2154. <a href="https://doi.org/10.1002/asia.201900402" title="DOI URL">https://doi.org/10.1002/asia.201900402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201900402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201900402%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DBimetal%2525E2%252580%252590Catalyzed%252BCascade%252BReaction%252Bfor%252BEfficient%252BSynthesis%252Bof%252BN%252B%2525E2%252580%252590Isopropenyl%252B1%25252C2%25252C3%2525E2%252580%252590Triazoles%252Bvia%252BIn%2525E2%252580%252590Situ%252BGenerated%252B2%2525E2%252580%252590Azidopropenes%26aulast%3DLiu%26aufirst%3DZhenhua%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D12%26spage%3D2149%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michel  Koole</span>, <span class="hlFld-ContribAuthor ">Mark E.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Anja  Hijzen</span>, <span class="hlFld-ContribAuthor ">Paulien  Ravenstijn</span>, <span class="hlFld-ContribAuthor ">Corinne  Vandermeulen</span>, <span class="hlFld-ContribAuthor ">Donatienne  Van Weehaeghe</span>, <span class="hlFld-ContribAuthor ">Kim  Serdons</span>, <span class="hlFld-ContribAuthor ">Sofie  Celen</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>, <span class="hlFld-ContribAuthor ">Marc  Ceusters</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Luc  Van Nueten</span>, <span class="hlFld-ContribAuthor ">Hartmuth  Kolb</span>, <span class="hlFld-ContribAuthor ">Jan  de Hoon</span>, <span class="hlFld-ContribAuthor ">Koen  Van Laere</span>. </span><span class="cited-content_cbyCitation_article-title">18
              F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2019,</strong> <em>60 </em>
                                    (5)
                                     , 683-690. <a href="https://doi.org/10.2967/jnumed.118.216747" title="DOI URL">https://doi.org/10.2967/jnumed.118.216747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.216747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.216747%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3D18%252BF-JNJ-64413739%25252C%252Ba%252BNovel%252BPET%252BLigand%252Bfor%252Bthe%252BP2X7%252BIon%252BChannel%25253A%252BRadiation%252BDosimetry%25252C%252BKinetic%252BModeling%25252C%252BTest-Retest%252BVariability%25252C%252Band%252BOccupancy%252Bof%252Bthe%252BP2X7%252BAntagonist%252BJNJ-54175446%26aulast%3DKoole%26aufirst%3DMichel%26date%3D2019%26date%3D2018%26volume%3D60%26issue%3D5%26spage%3D683%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baban S.  Thawkar</span>, <span class="hlFld-ContribAuthor ">Ginpreet  Kaur</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroimmunology</span><span> <strong>2019,</strong> <em>326 </em>, 62-74. <a href="https://doi.org/10.1016/j.jneuroim.2018.11.010" title="DOI URL">https://doi.org/10.1016/j.jneuroim.2018.11.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jneuroim.2018.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jneuroim.2018.11.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroimmunology%26atitle%3DInhibitors%252Bof%252BNF-%2525CE%2525BAB%252Band%252BP2X7%25252FNLRP3%25252FCaspase%252B1%252Bpathway%252Bin%252Bmicroglia%25253A%252BNovel%252Btherapeutic%252Bopportunities%252Bin%252Bneuroinflammation%252Binduced%252Bearly-stage%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DThawkar%26aufirst%3DBaban%2BS.%26date%3D2019%26volume%3D326%26spage%3D62%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun-kai  Chen</span>, <span class="hlFld-ContribAuthor ">Ye  Tao</span>, <span class="hlFld-ContribAuthor ">Yu-qi  Ma</span>, <span class="hlFld-ContribAuthor ">Xu-hong  Pang</span>, <span class="hlFld-ContribAuthor ">He-dong  Bian</span>, <span class="hlFld-ContribAuthor ">Han-Fu  Liu</span>, <span class="hlFld-ContribAuthor ">Fu-ping  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">The positional isomeric effect and structural difference in coordination assemblies system of CoII with 3/4-pmpt ligands. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2018,</strong> <em>156 </em>, 231-244. <a href="https://doi.org/10.1016/j.poly.2018.09.018" title="DOI URL">https://doi.org/10.1016/j.poly.2018.09.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2018.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2018.09.018%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DThe%252Bpositional%252Bisomeric%252Beffect%252Band%252Bstructural%252Bdifference%252Bin%252Bcoordination%252Bassemblies%252Bsystem%252Bof%252BCoII%252Bwith%252B3%25252F4-pmpt%252Bligands%26aulast%3DChen%26aufirst%3DYun-kai%26date%3D2018%26volume%3D156%26spage%3D231%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Declan N.C  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders. </span><span class="cited-content_cbyCitation_journal-name">Psychoneuroendocrinology</span><span> <strong>2018,</strong> <em>98 </em>, 95-100. <a href="https://doi.org/10.1016/j.psyneuen.2018.08.015" title="DOI URL">https://doi.org/10.1016/j.psyneuen.2018.08.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.psyneuen.2018.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.psyneuen.2018.08.015%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychoneuroendocrinology%26atitle%3DEmerging%252Brole%252Bof%252Bthe%252BP2X7-NLRP3-IL1%2525CE%2525B2%252Bpathway%252Bin%252Bmood%252Bdisorders%26aulast%3DBhattacharya%26aufirst%3DAnindya%26date%3D2018%26volume%3D98%26spage%3D95%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Brian  Lord</span>, <span class="hlFld-ContribAuthor ">Jan-Sebastian  Grigoleit</span>, <span class="hlFld-ContribAuthor ">Yingbo  He</span>, <span class="hlFld-ContribAuthor ">Ian  Fraser</span>, <span class="hlFld-ContribAuthor ">Shannon N.  Campbell</span>, <span class="hlFld-ContribAuthor ">Natalie  Taylor</span>, <span class="hlFld-ContribAuthor ">Leah  Aluisio</span>, <span class="hlFld-ContribAuthor ">Jason C.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Mariusz  Papp</span>, <span class="hlFld-ContribAuthor ">Christa  Chrovian</span>, <span class="hlFld-ContribAuthor ">Nicholas  Carruthers</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Lovenberg</span>, <span class="hlFld-ContribAuthor ">Michael A.  Letavic</span>. </span><span class="cited-content_cbyCitation_article-title">Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2018,</strong> <em>43 </em>
                                    (13)
                                     , 2586-2596. <a href="https://doi.org/10.1038/s41386-018-0141-6" title="DOI URL">https://doi.org/10.1038/s41386-018-0141-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0141-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0141-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DNeuropsychopharmacology%252Bof%252BJNJ-55308942%25253A%252Bevaluation%252Bof%252Ba%252Bclinical%252Bcandidate%252Btargeting%252BP2X7%252Bion%252Bchannels%252Bin%252Banimal%252Bmodels%252Bof%252Bneuroinflammation%252Band%252Banhedonia%26aulast%3DBhattacharya%26aufirst%3DAnindya%26date%3D2018%26date%3D2018%26volume%3D43%26issue%3D13%26spage%3D2586%26epage%3D2596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maarten  Timmers</span>, <span class="hlFld-ContribAuthor ">Paulien  Ravenstijn</span>, <span class="hlFld-ContribAuthor ">Liwen  Xi</span>, <span class="hlFld-ContribAuthor ">Gallen  Triana-Baltzer</span>, <span class="hlFld-ContribAuthor ">Maura  Furey</span>, <span class="hlFld-ContribAuthor ">Sandy  Van Hemelryck</span>, <span class="hlFld-ContribAuthor ">Jeike  Biewenga</span>, <span class="hlFld-ContribAuthor ">Marc  Ceusters</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Maarten  van den Boer</span>, <span class="hlFld-ContribAuthor ">Luc  van Nueten</span>, <span class="hlFld-ContribAuthor ">Peter  de Boer</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2018,</strong> <em>32 </em>
                                    (12)
                                     , 1341-1350. <a href="https://doi.org/10.1177/0269881118800067" title="DOI URL">https://doi.org/10.1177/0269881118800067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881118800067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881118800067%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DClinical%252Bpharmacokinetics%25252C%252Bpharmacodynamics%25252C%252Bsafety%25252C%252Band%252Btolerability%252Bof%252BJNJ-54175446%25252C%252Ba%252Bbrain%252Bpermeable%252BP2X7%252Bantagonist%25252C%252Bin%252Ba%252Brandomised%252Bsingle-ascending%252Bdose%252Bstudy%252Bin%252Bhealthy%252Bparticipants%26aulast%3DTimmers%26aufirst%3DMaarten%26date%3D2018%26date%3D2018%26volume%3D32%26issue%3D12%26spage%3D1341%26epage%3D1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linyu  Wei</span>, <span class="hlFld-ContribAuthor ">Sharifah A  Syed Mortadza</span>, <span class="hlFld-ContribAuthor ">Jing  Yan</span>, <span class="hlFld-ContribAuthor ">Libin  Zhang</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Yaling  Yin</span>, <span class="hlFld-ContribAuthor ">Chaokun  Li</span>, <span class="hlFld-ContribAuthor ">Sylvie  Chalon</span>, <span class="hlFld-ContribAuthor ">Patrick  Emond</span>, <span class="hlFld-ContribAuthor ">Catherine  Belzung</span>, <span class="hlFld-ContribAuthor ">Dongliang  Li</span>, <span class="hlFld-ContribAuthor ">Chengbiao  Lu</span>, <span class="hlFld-ContribAuthor ">Sebastien  Roger</span>, <span class="hlFld-ContribAuthor ">Lin-Hua  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience & Biobehavioral Reviews</span><span> <strong>2018,</strong> <em>87 </em>, 192-205. <a href="https://doi.org/10.1016/j.neubiorev.2018.02.005" title="DOI URL">https://doi.org/10.1016/j.neubiorev.2018.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neubiorev.2018.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neubiorev.2018.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520%2526%2520Biobehavioral%2520Reviews%26atitle%3DATP-activated%252BP2X7%252Breceptor%252Bin%252Bthe%252Bpathophysiology%252Bof%252Bmood%252Bdisorders%252Band%252Bas%252Ban%252Bemerging%252Btarget%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnovel%252Bantidepressant%252Btherapeutics%26aulast%3DWei%26aufirst%3DLinyu%26date%3D2018%26volume%3D87%26spage%3D192%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphar.2018.00030" title="DOI URL">https://doi.org/10.3389/fphar.2018.00030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2018.00030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2018.00030%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DRecent%252BAdvances%252Bin%252BCNS%252BP2X7%252BPhysiology%252Band%252BPharmacology%25253A%252BFocus%252Bon%252BNeuropsychiatric%252BDisorders%26aulast%3DBhattacharya%26aufirst%3DAnindya%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Fused Triazole and Pyrimidine Core P2X7 Antagonists Containing a C-Methyl or -Phenyl Substituent in the Piperidine or Piperazine Ring</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Methods for the Preparation of 1-Het-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridines</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Fused 1,2,3-Triazoles by an Enamine Amination/Elimination Followed by [3 + 2]-Cycloaddition/Hydrolysis Organocatalytic Cascade</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Pyrrolidine Adduct Elimination via Oxidation and Cope Elimination</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dose dependency of P2X7 occupancy of <b>29</b> (0.5% HPMC suspension) and <b>35</b> (20% HP-β-cyclodextrin solution) as measured 2 h after oral administration, as measured in rat brain sections using ex vivo receptor autoradiography. Shown are the mean ± SEM (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Route Used for Both Medicinal Chemistry and Scale-Up Syntheses of <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) pyrrolidine, toluene, 110 °C, 4 h; <i>m-</i>CPBA, NaHCO<sub>3</sub>, rt, 10 min (58–71%, <b>9b</b>/<b>10b</b> = 9:1); (b) HCl in dioxane, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (<b>41</b>/<b>42</b> = 9:1); (c) 2-fluoro-3-(trifluoromethyl)benzoyl chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h (85% over 2 steps); (d) stir in MeOH, 60 °C, 24 h (55%, >99% ee).</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Single crystal structure and stereochemical assignment of <b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Scale-Up Route for the Synthesis of <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) oxalyl chloride, DMF, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (b) (<i>S</i>)-2-methyl-4-oxopiperidine, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h (77% over 2 steps); (c) 2-azido-5-fluoropyrimidine, pyrrolidine, <i>p-</i>TSA, toluene, Dean–Stark, 110 °C, 4 h; <i>m-</i>CPBA, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2,</sub> rt, 2 h (69%, <b>35</b>/<b>30</b> = 10:1); (d) SFC separation, 75%.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Simulated human plasma concentration profile of <b>29</b> at a dose of 76 mg twice daily over 5 days of administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Simulated human plasma concentration profile of <b>35</b> at a dose of 6 mg once daily over 6 days of administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/medium/jm-2017-01279f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo microdialysis assay to measure brain IL-1β levels in freely moving rats after oral administration of 10 mg/kg <b>35</b>. IL-1β release was triggered by 2′(3′)-<i>O</i>-(4-benzoylbenzoyl)adenosine-5′-triphosphate (Bz-ATP) infusion (100 mM) in rat hippocampus. Solid line indicates time of Bz-ATP infusion (between the 4 and 6 h time points). IL-1β concentrations are given as mean values ± SEM (<i>n</i> = 7); <i>P</i> < 0.05. Robust <i>t</i> test at 5 and 6 h time points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01279/20180110/images/large/jm-2017-01279f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01279&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, C.</span><span> </span><span class="NLM_article-title">The role of the innate immune system in psychiatric disorders</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/j.mcn.2012.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.mcn.2012.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=23064447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1KjsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=52-62&author=K.+A.+Jonesauthor=C.+Thomsen&title=The+role+of+the+innate+immune+system+in+psychiatric+disorders&doi=10.1016%2Fj.mcn.2012.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the innate immune system in psychiatric disorders</span></div><div class="casAuthors">Jones, Kenneth A.; Thomsen, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-62</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is by now substantial clin. evidence for an assocn. between specific mood disorders and altered immune function.  More recently, a no. of hypotheses have been forwarded to explain how components of the innate immune system can regulate brain function at the cellular and systems levels and how these may underlie the pathol. of disorders such as depression, PTSD and bipolar disorder.  In this review we draw ref. to biochem., cellular and animal disease models, as well as clin. observations to elucidate the role of the innate immune system in psychiatric disorders.  Proinflammatory cytokines, such as IL-1β IL-6 and TNFα, which feature prominently in the immune response to pathogen in the periphery, have unique and specific actions on neurons and circuits within the central nervous system.  Effects of these signaling mols. on neurotransmission, memory, and glucocorticoid function, as well as animal behaviors such as social withdrawal and fear conditioning relevant to psychiatric disorders are elucidated.  Finally, we highlight future directions for studies, including the use of peripheral biomarkers, relevant for developing new therapeutic approaches for treating psychiatric illnesses.  This article is part of Special Issue entitled 'neuroinflammation in neurodegeneration and neurodysfunction'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqRtLUscaCg7Vg90H21EOLACvtfcHk0li4F2flYPWc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1KjsbzP&md5=6faf9f834ec208a9c17e496476361556</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2012.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2012.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DThomsen%26aufirst%3DC.%26atitle%3DThe%2520role%2520of%2520the%2520innate%2520immune%2520system%2520in%2520psychiatric%2520disorders%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2013%26volume%3D53%26spage%3D52%26epage%3D62%26doi%3D10.1016%2Fj.mcn.2012.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Immunological and inflammatory functions of the interleukin-1 family</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span><span class="refDoi"> DOI: 10.1146/annurev.immunol.021908.132612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1146%2Fannurev.immunol.021908.132612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=19302047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=519-550&author=C.+A.+Dinarello&title=Immunological+and+inflammatory+functions+of+the+interleukin-1+family&doi=10.1146%2Fannurev.immunol.021908.132612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Immunological and inflammatory functions of the interleukin-1 family</span></div><div class="casAuthors">Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">519-550</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  More than any other cytokine family, the interleukin (IL)-1 family is closely linked to the innate immune response.  This linkage became evident upon the discovery that the cytoplasmic domain of the IL-1 receptor type I is highly homologous to the cytoplasmic domains of all Toll-like receptors (TLRs).  Thus, fundamental inflammatory responses such as the induction of cyclooxygenase type 2, increased expression of adhesion mols., or synthesis of nitric oxide are indistinguishable responses of both IL-1 and TLR ligands.  Both families nonspecifically affect antigen recognition and lymphocyte function.  IL-1β is the most studied member of the IL-1 family because of its role in mediating autoinflammatory diseases.  Although the TLR and IL-1 families evolved to assist in host defense against infection, unlike the TLR family, the IL-1 family also includes members that suppress inflammation, both specifically within the IL-1 family but also nonspecifically for TLR ligands and the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfzkGfyLhwPbVg90H21EOLACvtfcHk0lgbYWVD3iIGXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrc%253D&md5=4db7e2790608526a7ebefd417392e12c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132612%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DImmunological%2520and%2520inflammatory%2520functions%2520of%2520the%2520interleukin-1%2520family%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D519%26epage%3D550%26doi%3D10.1146%2Fannurev.immunol.021908.132612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoetens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceusters, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M.</span><span> </span><span class="NLM_article-title">JNJ-54175446, a CNS penetrant P2X7 antagonist in clinical development for mood disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">S289</span><span class="NLM_x">–</span> <span class="NLM_lpage">S454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=S289-S454&author=A.+Bhattacharyaauthor=B.+Savallauthor=B.+Lordauthor=P.+Bonaventureauthor=L.+Aluisioauthor=T.+Koudriakovaauthor=K.+Sepassiauthor=F.+Schoetensauthor=M.+Ceustersauthor=N.+Carruthersauthor=T.+Lovenbergauthor=M.+Letavic&title=JNJ-54175446%2C+a+CNS+penetrant+P2X7+antagonist+in+clinical+development+for+mood+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DSavall%26aufirst%3DB.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%26aulast%3DLetavic%26aufirst%3DM.%26atitle%3DJNJ-54175446%252C%2520a%2520CNS%2520penetrant%2520P2X7%2520antagonist%2520in%2520clinical%2520development%2520for%2520mood%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3DS289%26epage%3DS454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutheil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glasebrook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koester, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smagin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Psychological stress activates the inflammasome via release of ATP and stimulation of the P2X7 receptor</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2015.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.biopsych.2015.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=26831917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2murw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=12-22&author=M.+Iwataauthor=K.+T.+Otaauthor=X.-Y.+Liauthor=F.+Sakaueauthor=N.+Liauthor=S.+Dutheilauthor=M.+Banasrauthor=V.+Duricauthor=T.+Yamanashiauthor=K.+Kanekoauthor=K.+Rasmussenauthor=A.+Glasebrookauthor=A.+Koesterauthor=D.+Songauthor=K.+A.+Jonesauthor=S.+Zornauthor=G.+Smaginauthor=R.+S.+Duman&title=Psychological+stress+activates+the+inflammasome+via+release+of+ATP+and+stimulation+of+the+P2X7+receptor&doi=10.1016%2Fj.biopsych.2015.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor</span></div><div class="casAuthors">Iwata, Masaaki; Ota, Kristie T.; Li, Xiao-Yuan; Sakaue, Fumika; Li, Nanxin; Dutheil, Sophie; Banasr, Mounira; Duric, Vanja; Yamanashi, Takehiko; Kaneko, Koichi; Rasmussen, Kurt; Glasebrook, Andrew; Koester, Anja; Song, Dekun; Jones, Kenneth A.; Zorn, Stevin; Smagin, Gennady; Duman, Ronald S.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-22</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mechanisms underlying stress-induced inflammation that contribute to major depressive disorder are unknown.  We examine the role of the ATP (ATP)/purinergic type 2X7 receptor (P2X7R) pathway and the NLRP3 (nucleotide-binding, leucine-rich repeat, pyrin domain contg. 3) inflammasome in interleukin (IL)-1β and depressive behavioral responses to stress.  The influence of acute restraint stress on extracellular ATP, glutamate, IL-1β, and tumor necrosis factor alpha in hippocampus was detd. by microdialysis, and the influence of acute restraint stress on the NLRP3 inflammasome was detd. by Western blot anal.  The influence of P2X7R antagonist administration on IL-1β and tumor necrosis factor alpha and on anxiety and depressive behaviors was detd. in the chronic unpredictable stress rodent model.  The role of the NLRP3 inflammasome was detd. by anal. of Nlrp3 null mice.  Acute restraint stress rapidly increased extracellular ATP, an endogenous agonist of P2X7R; the inflammatory cytokine IL-1β; and the active form of the NLRP3 inflammasome in the hippocampus.  Administration of a P2X7R antagonist completely blocked the release of IL-1β and tumor necrosis factor alpha, another stress-induced cytokine, and activated NLRP3.  Moreover, P2X7R antagonist administration reversed the anhedonic and anxiety behaviors caused by chronic unpredictable stress exposure, and deletion of the Nlrp3 gene rendered mice resistant to development of depressive behaviors caused by chronic unpredictable stress.  These findings demonstrate that psychol. "stress" is sensed by the innate immune system in the brain via the ATP/P2X7R-NLRP3 inflammasome cascade, and they identify novel therapeutic targets for the treatment of stress-related mood disorders and comorbid illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPT4PeBplcG7Vg90H21EOLACvtfcHk0lgbYWVD3iIGXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2murw%253D&md5=f17ad7ff32906696e07f3b9e52a7591e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DOta%26aufirst%3DK.%2BT.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DSakaue%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DDutheil%26aufirst%3DS.%26aulast%3DBanasr%26aufirst%3DM.%26aulast%3DDuric%26aufirst%3DV.%26aulast%3DYamanashi%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DGlasebrook%26aufirst%3DA.%26aulast%3DKoester%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DZorn%26aufirst%3DS.%26aulast%3DSmagin%26aufirst%3DG.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DPsychological%2520stress%2520activates%2520the%2520inflammasome%2520via%2520release%2520of%2520ATP%2520and%2520stimulation%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D80%26spage%3D12%26epage%3D22%26doi%3D10.1016%2Fj.biopsych.2015.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lovenberg, T.; Aluisio, L.; Ceusters, M.; Letavic, M.; Bhattacharya, A.</span><span> </span><span class="NLM_article-title">Characterization of P2X7 antagonists in the rodent brain: Promise for a novel mechanism of action for mood disorder?</span> <span class="citation_source-book">Proceedings of the CINP Thematic Meeting on Stress, Inflammation and Depression: Focus on Novel Antidepressant Targets</span>, Dublin, Ireland, June 4–6,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=T.+Lovenberg&author=L.+Aluisio&author=M.+Ceusters&author=M.+Letavic&author=A.+Bhattacharya&title=Proceedings+of+the+CINP+Thematic+Meeting+on+Stress%2C+Inflammation+and+Depression%3A+Focus+on+Novel+Antidepressant+Targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLovenberg%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520P2X7%2520antagonists%2520in%2520the%2520rodent%2520brain%253A%2520Promise%2520for%2520a%2520novel%2520mechanism%2520of%2520action%2520for%2520mood%2520disorder%253F%26btitle%3DProceedings%2520of%2520the%2520CINP%2520Thematic%2520Meeting%2520on%2520Stress%252C%2520Inflammation%2520and%2520Depression%253A%2520Focus%2520on%2520Novel%2520Antidepressant%2520Targets%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Eser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelsang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braddock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinisch, W.</span><span> </span><span class="NLM_article-title">Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn’s disease: a randomized placebo-controlled, double-blind, phase IIa study</span> <span class="citation_source-journal">Inflamm. Bowel Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2253</span><span class="refDoi"> DOI: 10.1097/MIB.0000000000000514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1097%2FMIB.0000000000000514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=26197451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FltVSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2247-2253&author=A.+Eserauthor=J.-F.+Colombelauthor=P.+Rutgeertsauthor=S.+Vermeireauthor=H.+Vogelsangauthor=M.+Braddockauthor=T.+Perssonauthor=W.+Reinisch&title=Safety+and+efficacy+of+an+oral+inhibitor+of+the+purinergic+receptor+P2X7+in+adult+patients+with+moderately+to+severely+active+Crohn%E2%80%99s+disease%3A+a+randomized+placebo-controlled%2C+double-blind%2C+phase+IIa+study&doi=10.1097%2FMIB.0000000000000514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study</span></div><div class="casAuthors">Eser Alexander; Colombel Jean-Frederic; Rutgeerts Paul; Vermeire Severine; Vogelsang Harald; Braddock Martin; Persson Tore; Reinisch Walter</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2247-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  AZD9056 is a selective orally active inhibitor of the purinergic receptor P2X7, which is a key player in the generation and secretion of several proinflammatory cytokines involved in the pathogenesis of Crohn's disease (CD).  The aim of this phase IIa study was to assess the efficacy and safety of AZD9056 for the treatment of moderately to severely active CD.  METHODS:  We conducted a placebo-controlled, multicenter, double-blind phase IIa study in patients with moderately to severely active CD as defined by a CD Activity Index (CDAI) of at least 220.  Patients were randomized in a 2:1 mode either to 200 mg of AZD9056 administered orally as a tablet once daily for 28 days or matching placebo.  Primary endpoint was the change in CDAI from baseline at day 28, and secondary endpoints included clinical remission (CDAI < 150) and CDAI 70 response and improvement in the quality of life measures Short Form 36 and Inflammatory Bowel Disease Questionnaire.  Changes in serum C-reactive protein and fecal calprotectin were assessed.  RESULTS:  In total, 34 patients were enrolled, 24 to AZD9056 and 10 to placebo.  The CDAI dropped in AZD9056-treated subjects from a baseline mean of 311 to 242 and from 262 to 239 in placebo-treated subjects (P = 0.049).  Remission and response rates were numerically higher with AZD9056 versus placebo, (n = 5, 24% versus n = 1, 11%, P = 0.43 and n = 11, 52% versus n = 2, 22%, P = 0.13, respectively).  Marked decrease in disease activity was observed for the CDAI subcomponents, pain and general well-being.  Apart from a statistically significant improvement in the Mental Component Score of Short Form 36 for AZD9056 versus placebo (P = 0.017), no other differences in measurements of quality of life could be observed.  There was no decrease in concentrations of serum C-reactive protein and fecal calprotectin during treatment.  AZD9056 was well-tolerated, and no serious adverse events were reported.  CONCLUSIONS:  Our data suggest that the purinergic receptor P2X7 antagonist AZD9056 has the potential to improve symptoms in patients with moderate-to-severe CD combined with a beneficial risk profile.  Although the lack in change of inflammatory biomarkers questions its anti-inflammatory potential, the results obtained in this study rather suggest P2X7 antagonism for the treatment of chronic abdominal pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHjK0qgS5fO0g6wdEZmT2rfW6udTcc2eaZVy0DxMZSJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FltVSqtA%253D%253D&md5=8ade69d316c57adae49fb595e35ab2f7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2FMIB.0000000000000514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMIB.0000000000000514%26sid%3Dliteratum%253Aachs%26aulast%3DEser%26aufirst%3DA.%26aulast%3DColombel%26aufirst%3DJ.-F.%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DVogelsang%26aufirst%3DH.%26aulast%3DBraddock%26aufirst%3DM.%26aulast%3DPersson%26aufirst%3DT.%26aulast%3DReinisch%26aufirst%3DW.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520an%2520oral%2520inhibitor%2520of%2520the%2520purinergic%2520receptor%2520P2X7%2520in%2520adult%2520patients%2520with%2520moderately%2520to%2520severely%2520active%2520Crohn%25E2%2580%2599s%2520disease%253A%2520a%2520randomized%2520placebo-controlled%252C%2520double-blind%252C%2520phase%2520IIa%2520study%26jtitle%3DInflamm.%2520Bowel%2520Dis.%26date%3D2015%26volume%3D21%26spage%3D2247%26epage%3D2253%26doi%3D10.1097%2FMIB.0000000000000514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Keystone, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2011-143578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1136%2Fannrheumdis-2011-143578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=22966146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=1630-1635&author=E.+C.+Keystoneauthor=M.+M.+Wangauthor=M.+Laytonauthor=S.+Hollisauthor=I.+B.+McInnes&title=Clinical+evaluation+of+the+efficacy+of+the+P2X7+purinergic+receptor+antagonist+AZD9056+on+the+signs+and+symptoms+of+rheumatoid+arthritis+in+patients+with+active+disease+despite+treatment+with+methotrexate+or+sulphasalazine&doi=10.1136%2Fannrheumdis-2011-143578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span></div><div class="casAuthors">Keystone, Edward C.; Wang, Millie M.; Layton, Mark; Hollis, Sally; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1635</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: The P2X7 purinergic receptor antagonist AZD9056 was evaluated in a phase IIa study and subsequently in a phase IIb study to assess the effects of orally administered AZD9056 on the signs/symptoms of rheumatoid arthritis (RA), with American College of Rheumatol. 20% response criteria (ACR20) as the primary outcome.  Methods: Both studies were randomized, double-blind, placebo-controlled, parallel-group studies in patients with RA receiving methotrexate or sulphasalazine.  Phase IIa was an ascending-dose trial in two cohorts (n=75) using AZD9056 administered daily over 4 wk.  Phase IIb included an open-label etanercept treatment group.  Patients were randomized to receive treatment for 6 mo with 50, 100, 200 or 400 mg AZD9056 (oral, once a day) or matching placebo (oral, once a day), or s.c. etanercept (50 mg once a week).  Results: In phase IIa, 65% of AZD9056 recipients at 400 mg/day responded at the ACR20 level compared with 27% of placebo-treated patients.  A significant redn. in swollen and tender joint count was obsd. in the actively treated group compared with placebo, whereas no effect on acute-phase response was obsd.  Of 385 randomized patients in the phase IIb study, 383 received treatment.  AZD9056 (all doses) had no clin. or statistically significant effect on RA relative to placebo as measured by the proportion of patients meeting the ACR20 criteria at 6 mo and further supported by secondary end points.  In both studies AZD9056 was well tolerated up to 400 mg/day.  Conclusions: AZD9056 does not have significant efficacy in the treatment of RA, and the P2X7 receptor does not appear to be a therapeutically useful target in RA.  Trial registration no. ClinicalTrials.gov NCT00520572.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCebkc5d0gLVg90H21EOLACvtfcHk0lid76OvqlJ9mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL&md5=97ca48663327aa8578f11001fa96d8c0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2011-143578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2011-143578%26sid%3Dliteratum%253Aachs%26aulast%3DKeystone%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DClinical%2520evaluation%2520of%2520the%2520efficacy%2520of%2520the%2520P2X7%2520purinergic%2520receptor%2520antagonist%2520AZD9056%2520on%2520the%2520signs%2520and%2520symptoms%2520of%2520rheumatoid%2520arthritis%2520in%2520patients%2520with%2520active%2520disease%2520despite%2520treatment%2520with%2520methotrexate%2520or%2520sulphasalazine%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26volume%3D71%26spage%3D1630%26epage%3D1635%26doi%3D10.1136%2Fannrheumdis-2011-143578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Stock, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishaq, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, C. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.3899/jrheum.110874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.3899%2Fjrheum.110874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=22382341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=720-727&author=T.+C.+Stockauthor=B.+J.+Bloomauthor=N.+Weiauthor=S.+Ishaqauthor=W.+Parkauthor=X.+Wangauthor=P.+Guptaauthor=C.+A.+Mebus&title=Efficacy+and+safety+of+CE-224%2C535%2C+an+antagonist+of+P2X7+receptor%2C+in+treatment+of+patients+with+rheumatoid+arthritis+inadequately+controlled+by+methotrexate&doi=10.3899%2Fjrheum.110874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span></div><div class="casAuthors">Stock, Thomas C.; Bloom, Bradley J.; Wei, Nathan; Ishaq, Saliha; Park, Won; Wang, Xin; Gupta, Pankaj; Mebus, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">720-727</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">To evaluate efficacy and safety of CE-224,535, a selective P2X7 receptor antagonist, vs. placebo, in patients with active rheumatoid arthritis (RA) and inadequate response to methotrexate (MTX).  In our phase IIA study (ClinicalTrials.gov no. NCT00628095; A6341009), patients aged ≥ 18 years with active RA were randomized to receive either CE-224,535 (500 mg bid) or placebo for 12 wk; all patients continued a stable background dose of ≥ 7.5 mg MTX.  The American College of Rheumatol. 20% (ACR20) response rate (primary efficacy endpoint) was not significantly different from placebo for CE-224,535 (34.0% vs 36.2%; p = 0.591) at Week 12, or at any timepoint over the 12-wk treatment period.  There was no significant difference at Week 12 for the ACR20 response rate following subgroup analyses by age, sex, baseline disease activity, baseline duration of disease, geog. region, or concomitant use of steroids.  ACR50/ACR70 response rates and change from baseline in Disease Activity Score 28-joint C-reactive protein (DAS28-3-CRP) and Health Assessment Questionnaire-Disability Index for CE-224,535 were not significant at Week 12 vs. placebo.  Treatment-emergent adverse events (AE) were reported by 62.3% (CE-224,535) and 55.3% (placebo) of patients; the most common AE were nausea (11.3%, CE-224,535; 4.3%, placebo) and diarrhea (7.5%, CE-224,535; 4.3%, placebo).  The proportion of patients discontinuing due to an AE was 9.4% (CE-224,535) and 6.4% (placebo); no deaths were reported.  Serious AE occurred in 3.8% (CE-224,535) and 2.1% (placebo) of patients; none was considered treatment-related.  CE-224,535 was not efficacious, compared with placebo, for the treatment of RA in patients with an inadequate response to MTX.  CE-224,535 demonstrated an acceptable safety and tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorblWg-aNBNLVg90H21EOLACvtfcHk0lid76OvqlJ9mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D&md5=dc919436c3c6e7f3f624c57b77c5dbb2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.110874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.110874%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DT.%2BC.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DIshaq%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DMebus%26aufirst%3DC.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520CE-224%252C535%252C%2520an%2520antagonist%2520of%2520P2X7%2520receptor%252C%2520in%2520treatment%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520inadequately%2520controlled%2520by%2520methotrexate%26jtitle%3DJ.%2520Rheumatol.%26date%3D2012%26volume%3D39%26spage%3D720%26epage%3D727%26doi%3D10.3899%2Fjrheum.110874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceusters, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelin, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otieno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoetens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">4-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-c]pyridine-based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4559</span><span class="NLM_x">–</span> <span class="NLM_lpage">4572</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4559-4572&author=M.+A.+Letavicauthor=B.+M.+Savallauthor=B.+B.+Allisonauthor=L.+Aluisioauthor=J.+I.+Andresauthor=M.+De+Angelisauthor=H.+Aoauthor=D.+Beauchampauthor=P.+Bonaventureauthor=S.+Bryantauthor=N.+I.+Carruthersauthor=M.+Ceustersauthor=K.+Coeauthor=C.+A.+Dvorakauthor=I.+Fraserauthor=C.+F.+Gelinauthor=T.+Koudriakovaauthor=J.+Liangauthor=B.+Lordauthor=T.+Lovenbergauthor=M.+Otienoauthor=F.+Schoetensauthor=D.+Swansonauthor=X.+Wangauthor=A.+Wickendenauthor=A.+Bhattacharya&title=4-Methyl-6%2C7-dihydro-4H-triazolo%5B4%2C5-c%5Dpyridine-based+P2X7+receptor+antagonists%3A+optimization+of+pharmacokinetic+properties+leading+to+the+identification+of+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate</span></div><div class="casAuthors">Letavic, Michael A.; Savall, Brad M.; Allison, Brett D.; Aluisio, Leah; Andres, Jose Ignacio; De Angelis, Meri; Ao, Hong; Beauchamp, Derek A.; Bonaventure, Pascal; Bryant, Stewart; Carruthers, Nicholas I.; Ceusters, Marc; Coe, Kevin J.; Dvorak, Curt A.; Fraser, Ian C.; Gelin, Christine F.; Koudriakova, Tatiana; Liang, Jimmy; Lord, Brian; Lovenberg, Timothy W.; Otieno, Monicah A.; Schoetens, Freddy; Swanson, Devin M.; Wang, Qi; Wickenden, Alan D.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4559-4572</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and preclin. characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described.  Optimization efforts based on previously disclosed unsubstituted 6,7-dihydro-4H-triazolo[4,5-c]pyridines, Me substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazines, and several other series lead to the identification of a series of 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are selective P2X7 antagonists with potency at the rodent and human P2X7 ion channels.  These novel P2X7 antagonists have suitable physicochem. properties, and several analogs have an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing.  Improvements in metabolic stability led to the identification of JNJ-54175446 (I) as a candidate for clin. development.  The drug discovery efforts and strategies that resulted in the identification of the clin. candidate are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx8e5Sq5aYbVg90H21EOLACvtfcHk0ljOWPDz41YWUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D&md5=5b5465d8f64d527da6647997efe34aee</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00408%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DAllison%26aufirst%3DB.%2BB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBeauchamp%26aufirst%3DD.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DBryant%26aufirst%3DS.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DK.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLovenberg%26aufirst%3DT.%26aulast%3DOtieno%26aufirst%3DM.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DSwanson%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWickenden%26aufirst%3DA.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3D4-Methyl-6%252C7-dihydro-4H-triazolo%255B4%252C5-c%255Dpyridine-based%2520P2X7%2520receptor%2520antagonists%253A%2520optimization%2520of%2520pharmacokinetic%2520properties%2520leading%2520to%2520the%2520identification%2520of%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4559%26epage%3D4572%26doi%3D10.1021%2Facs.jmedchem.7b00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrovian, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo-[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3163</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.bmcl.2015.06.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3157-3163&author=D.+A.+Rudolphauthor=J.+Alcazarauthor=M.+K.+Ameriksauthor=A.+B.+Antonauthor=H.+Aoauthor=P.+Bonaventureauthor=N.+I.+Carruthersauthor=C.+C.+Chrovianauthor=M.+De+Angelisauthor=B.+Lordauthor=J.+C.+Rechauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=J.+I.+Andresauthor=M.+A.+Letavic&title=Novel+methyl+substituted+1-%285%2C6-dihydro-%5B1%2C2%2C4%5Dtriazolo-%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%29methanones+are+P2X7+antagonists&doi=10.1016%2Fj.bmcl.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAnton%26aufirst%3DA.%2BB.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520methyl%2520substituted%25201-%25285%252C6-dihydro-%255B1%252C2%252C4%255Dtriazolo-%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%2529methanones%2520are%2520P2X7%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3157%26epage%3D3163%26doi%3D10.1016%2Fj.bmcl.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Swanson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoetens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaptason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Identification of (R)-(2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a small molecule antagonist of the P2X7 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8535</span><span class="NLM_x">–</span> <span class="NLM_lpage">8548</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8535-8548&author=D.+M.+Swansonauthor=B.+M.+Savallauthor=K.+J.+Coeauthor=F.+Schoetensauthor=T.+Koudriakovaauthor=J.+Skaptasonauthor=J.+Wallauthor=J.+Rechauthor=X.+Dengauthor=M.+De+Angelisauthor=A.+Eversonauthor=B.+Lordauthor=Q.+Wangauthor=H.+Aoauthor=B.+Scottauthor=K.+Sepassiauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Identification+of+%28R%29-%282-chloro-3-%28trifluoromethyl%29phenyl%29%281-%285-fluoropyridin-2-yl%29-4-methyl-6%2C7-dihydro-1H-imidazo%5B4%2C5-c%5Dpyridin-5%284H%29-yl%29methanone+%28JNJ+54166060%29%2C+a+small+molecule+antagonist+of+the+P2X7+receptor&doi=10.1021%2Facs.jmedchem.6b00989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor</span></div><div class="casAuthors">Swanson, Devin M.; Savall, Brad M.; Coe, Kevin J.; Schoetens, Freddy; Koudriakova, Tatiana; Skaptason, Judith; Wall, Jessica; Rech, Jason; Deng, Xiahou; De Angelis, Meri; Everson, Anita; Lord, Brian; Wang, Qi; Ao, Hong; Scott, Brian; Sepassi, Kia; Lovenberg, Timothy W.; Carruthers, Nicholas I.; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8535-8548</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and SAR of a series of 4,5,6,7-tetrahydro-imidazo[4,5-c]pyridine P2X7 antagonists are described.  Addressing P2X7 affinity and liver microsomal stability issues encountered with this template afforded Me substituted 4,5,6,7-tetrahydro-imidazo[4,5-c]pyridines ultimately leading to the identification of JNJ 54166060.  JNJ 54166060 is a potent P2X7 antagonist with an ED50=2.3 mg/kg in rat, high oral bioavailability and low-moderate clearance in pre-clin. species, acceptable safety margins in rat, and a predicted human dose of 120 mg QD.  Addnl., JNJ 54166060 possesses a unique CYP profile and was found to be a regioselective inhibitor of midazolam CYP3A metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQfT4dUZEP6bVg90H21EOLACvtfcHk0ljpFkokyaMSvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyqsr%252FO&md5=a48451477fca4bec1fd13df7d5a22ea8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00989%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DRech%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DEverson%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520%2528R%2529-%25282-chloro-3-%2528trifluoromethyl%2529phenyl%2529%25281-%25285-fluoropyridin-2-yl%2529-4-methyl-6%252C7-dihydro-1H-imidazo%255B4%252C5-c%255Dpyridin-5%25284H%2529-yl%2529methanone%2520%2528JNJ%252054166060%2529%252C%2520a%2520small%2520molecule%2520antagonist%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8535%26epage%3D8548%26doi%3D10.1021%2Facs.jmedchem.6b00989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chrovian, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soyode-Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacani, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Novel phenyl-substituted 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists with robust target engagement in rat brain</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=490-497&author=C.+C.+Chrovianauthor=A.+Soyode-Johnsonauthor=H.+Aoauthor=G.+M.+Bacaniauthor=N.+I.+Carruthersauthor=B.+Lordauthor=L.+Nguyenauthor=J.+C.+Rechauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Novel+phenyl-substituted+5%2C6-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+P2X7+antagonists+with+robust+target+engagement+in+rat+brain&doi=10.1021%2Facschemneuro.5b00303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat Brain</span></div><div class="casAuthors">Chrovian, Christa C.; Soyode-Johnson, Akinola; Ao, Hong; Bacani, Genesis M.; Carruthers, Nicholas I.; Lord, Brian; Nguyen, Leslie; Rech, Jason C.; Wang, Qi; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-497</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists were optimized to allow for good blood-brain barrier permeability and high P2X7 target engagement in the brain of rats.  Compd. I (huP2X7 IC50 = 9 nM; rat P2X7 IC50 = 42 nM) achieved 80% receptor occupancy for 6 h when dosed orally at 10 mg/kg in rats as measured by ex vivo radioligand binding autoradiog.  Structure-activity relationships within this series are described, as well as in vitro ADME results.  In vivo pharmacokinetic data for key compds. is also included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFc11o0pApUbVg90H21EOLACvtfcHk0ljpFkokyaMSvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlGmsA%253D%253D&md5=a51ac05ebd3115489ddbabecf0cd1170</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00303%26sid%3Dliteratum%253Aachs%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DSoyode-Johnson%26aufirst%3DA.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBacani%26aufirst%3DG.%2BM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520phenyl-substituted%25205%252C6-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520P2X7%2520antagonists%2520with%2520robust%2520target%2520engagement%2520in%2520rat%2520brain%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D490%26epage%3D497%26doi%3D10.1021%2Facschemneuro.5b00303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Synthesis, SAR, and pharmacological characterization of brain penetrant P2X7 receptor antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00089</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=671-676&author=B.+M.+Savallauthor=D.+Wuauthor=M.+De+Angelisauthor=N.+I.+Carruthersauthor=H.+Aoauthor=Q.+Wangauthor=B.+Lordauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Synthesis%2C+SAR%2C+and+pharmacological+characterization+of+brain+penetrant+P2X7+receptor+antagonists&doi=10.1021%2Facsmedchemlett.5b00089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor Antagonists</span></div><div class="casAuthors">Savall, Brad M.; Wu, Duncan; De Angelis, Meri; Carruthers, Nicholas I.; Ao, Hong; Wang, Qi; Lord, Brian; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">671-676</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and SAR of 1,2,3-triazolopiperidines, e.g., I, as a novel series of potent, brain penetrant P2X7 antagonists was described.  Initial efforts yielded a series of potent human P2X7R antagonists with moderate to weak rodent potency, some CYP inhibition, poor metabolic stability, and low soly.  Further work in this series, which focused on the SAR of the N-linked heterocycle, not only increased the potency at the human P2X7R but also provided compds. with good potency at the rat P2X7R.  These efforts eventually delivered a potent rat and human P2X7R antagonist with good physicochem. properties, an excellent pharmacokinetic profile, good partitioning into the CNS, and demonstrated in vivo target engagement after oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfae7yM_oV1bVg90H21EOLACvtfcHk0lhcXYPfVnqLHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGisbo%253D&md5=11d93747bb8b71d0ca108a3946e3a758</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00089%26sid%3Dliteratum%253Aachs%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%252C%2520SAR%252C%2520and%2520pharmacological%2520characterization%2520of%2520brain%2520penetrant%2520P2X7%2520receptor%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D671%26epage%3D676%26doi%3D10.1021%2Facsmedchemlett.5b00089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.bmcl.2015.12.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=26707399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVKrtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=257-261&author=M.+K.+Ameriksauthor=H.+Aoauthor=N.+I.+Carruthersauthor=B.+Lordauthor=S.+Ravulaauthor=J.+C.+Rechauthor=B.+M.+Savallauthor=J.+L.+Wallauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Preclinical+characterization+of+substituted+6%2C7-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-8%285H%29-one+P2X7+receptor+antagonists&doi=10.1016%2Fj.bmcl.2015.12.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span></div><div class="casAuthors">Ameriks, Michael K.; Ao, Hong; Carruthers, Nicholas I.; Lord, Brian; Ravula, Suchitra; Rech, Jason C.; Savall, Brad M.; Wall, Jessica L.; Wang, Qi; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis, SAR, and preclin. characterization of a series of substituted 6,7-dihydro[1,2,4]triazolo[4,3]pyrazin-8(5H)-one P2X7 receptor antagonists are described.  Optimized leads from this series comprise some of the most potent human P2X7R antagonists reported to date (IC50s < 1 nM).  They also exhibit sufficient potency and oral bioavailability in rat to enable extensive in vivo profiling.  Although many of the disclosed compds. are peripherally restricted, compd. I is brain penetrant and upon oral administration demonstrated dose-dependent target engagement in rat hippocampus as detd. by ex vivo receptor occupancy with radiotracer II (ED50 = 0.8 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre9WCgWhiM_rVg90H21EOLACvtfcHk0lhcXYPfVnqLHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVKrtbjL&md5=d1a36bd7f088f4533308ad49fee7fa5b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWall%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520substituted%25206%252C7-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-8%25285H%2529-one%2520P2X7%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D257%26epage%3D261%26doi%3D10.1016%2Fj.bmcl.2015.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ziff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span> </span><span class="NLM_article-title">Substituted 5,6-(dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 antagonists</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvVemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=498-504&author=J.+Ziffauthor=D.+A.+Rudolphauthor=B.+Stenneauthor=T.+Koudriakovaauthor=B.+Lordauthor=P.+Bonaventureauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavicauthor=B.+T.+Shireman&title=Substituted+5%2C6-%28dihydropyrido%5B3%2C4-d%5Dpyrimidin-7%288H%29-yl%29-methanones+as+P2X7+antagonists&doi=10.1021%2Facschemneuro.5b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 Antagonists</span></div><div class="casAuthors">Ziff, Jeannie; Rudolph, Dale A.; Stenne, Brice; Koudriakova, Tatiana; Lord, Brian; Bonaventure, Pascal; Lovenberg, Timothy W.; Carruthers, Nicholas I.; Bhattacharya, Anindya; Letavic, Michael A.; Shireman, Brock T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">498-504</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the synthesis of a novel class of brain penetrating P2X7 antagonists with high potency at both the rat and human P2X7 receptors.  Disclosed herein are druglike mols. with demonstrated target engagement of the rat P2X7 receptors after an oral dose.  Specifically, compd. 20 occupied the P2X7 receptors >80% over the 6 h time course as measured by an ex vivo radioligand binding expt.  In a dose-response assay, this mol. has a plasma EC50 of 8 ng/mL.  Overall, 20 has suitable druglike properties and pharmacokinetics in rat and dog.  This mol. and others disclosed herein will serve as addnl. tools to elucidate the role of the P2X7 receptor in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4iuRhC8lPbVg90H21EOLACvtfcHk0lgBgTk_87BRPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvVemsA%253D%253D&md5=7f3f1afa4dad4db259189b98d97c8ae9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00304%26sid%3Dliteratum%253Aachs%26aulast%3DZiff%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DStenne%26aufirst%3DB.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26atitle%3DSubstituted%25205%252C6-%2528dihydropyrido%255B3%252C4-d%255Dpyrimidin-7%25288H%2529-yl%2529-methanones%2520as%2520P2X7%2520antagonists%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D498%26epage%3D504%26doi%3D10.1021%2Facschemneuro.5b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Click chemistry: diverse chemical function from a few good reactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2021</span><span class="refDoi"> DOI: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=11433435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVOis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=2004-2021&author=H.+C.+Kolbauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Click+chemistry%3A+diverse+chemical+function+from+a+few+good+reactions&doi=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry: diverse chemical function from a few good reactions</span></div><div class="casAuthors">Kolb, Hartmuth C.; Finn, M. G.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2004-2021</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Review with > 88 refs.  Examn. of nature's favorite mols. reveals a striking preference for making carbon-heteroatom bonds over carbon-carbon bonds - surely no surprise given that carbon dioxide is nature's starting material and that most reactions are performed in water.  Nucleic acids, proteins, and polysaccharides are condensation polymers of small subunits stitched together by carbon-heteroatom bonds.  Even the 35 or so building blocks from which these crucial mols. are made each contain, at most, six contiguous C-C bonds, except for the three arom. amino acids.  Taking a cue from nature's approach, the development of a set of powerful, highly reliable, and selective reactions for the rapid synthesis of useful new compds. and combinatorial libraries through heteroatom links (C-X-C), an approach called "click chem." is addressed.  Click chem. is at once defined, enabled, and constrained by a handful of nearly perfect "spring-loaded" reactions.  The stringent criteria for a process to earn click chem. status are described along with examples of the mol. frameworks that are easily made using this spartan, but powerful, synthetic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptrjo9nxXNRrVg90H21EOLACvtfcHk0lgBgTk_87BRPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVOis78%253D&md5=61c28b416c42c87821bc8a5bc2fdec36</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820010601%252940%253A11%253C2004%253A%253AAID-ANIE2004%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DClick%2520chemistry%253A%2520diverse%2520chemical%2520function%2520from%2520a%2520few%2520good%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D2004%26epage%3D2021%26doi%3D10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N. S.</span><span> </span><span class="NLM_article-title">Allyl-assisted, Cu(I)-catalyzed azide-alkyne cycloaddition/allylation reaction: assembly of the [1,2,3]triazolo-4,5,6,7-tetrahydropyridine core structure</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">11003</span><span class="NLM_x">–</span> <span class="NLM_lpage">11012</span><span class="refDoi"> DOI: 10.1021/acs.joc.5b02174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b02174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=11003-11012&author=X.+Dengauthor=J.+Liangauthor=B.+B.+Allisonauthor=C.+Dvorakauthor=H.+McAllisterauthor=B.+M.+Savallauthor=N.+S.+Mani&title=Allyl-assisted%2C+Cu%28I%29-catalyzed+azide-alkyne+cycloaddition%2Fallylation+reaction%3A+assembly+of+the+%5B1%2C2%2C3%5Dtriazolo-4%2C5%2C6%2C7-tetrahydropyridine+core+structure&doi=10.1021%2Facs.joc.5b02174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b02174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b02174%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DAllison%26aufirst%3DB.%2BB.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DMcAllister%26aufirst%3DH.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DMani%26aufirst%3DN.%2BS.%26atitle%3DAllyl-assisted%252C%2520Cu%2528I%2529-catalyzed%2520azide-alkyne%2520cycloaddition%252Fallylation%2520reaction%253A%2520assembly%2520of%2520the%2520%255B1%252C2%252C3%255Dtriazolo-4%252C5%252C6%252C7-tetrahydropyridine%2520core%2520structure%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26spage%3D11003%26epage%3D11012%26doi%3D10.1021%2Facs.joc.5b02174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span> </span><span class="NLM_article-title">Aryne click chemistry: synthesis of oxadisilole fused benzotriazoles or naphthotriazoles from arynes and azides</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">856</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span><span class="refDoi"> DOI: 10.1016/j.tet.2010.12.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.tet.2010.12.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=856-859&author=Y.+Linauthor=Y.+Chenauthor=X.+Maauthor=D.+Xuauthor=W.+Caoauthor=J.+Chen&title=Aryne+click+chemistry%3A+synthesis+of+oxadisilole+fused+benzotriazoles+or+naphthotriazoles+from+arynes+and+azides&doi=10.1016%2Fj.tet.2010.12.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.12.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.12.039%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DAryne%2520click%2520chemistry%253A%2520synthesis%2520of%2520oxadisilole%2520fused%2520benzotriazoles%2520or%2520naphthotriazoles%2520from%2520arynes%2520and%2520azides%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26spage%3D856%26epage%3D859%26doi%3D10.1016%2Fj.tet.2010.12.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, J. E.</span><span> </span><span class="NLM_article-title">Benzyne click chemistry with in situ generated aromatic azides</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span><span class="refDoi"> DOI: 10.1021/ol9002338</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9002338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BD1MXislKqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1587-1590&author=F.+Zhangauthor=J.+E.+Moses&title=Benzyne+click+chemistry+with+in+situ+generated+aromatic+azides&doi=10.1021%2Fol9002338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Benzyne Click Chemistry with in Situ Generated Aromatic Azides</span></div><div class="casAuthors">Zhang, Fengzhi; Moses, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1587-1590</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient synthesis of substituted benzotriazoles using an azide-alkyne 1,3-dipolar cycloaddn. "click reaction" is described.  Key to the procedure is the in situ generation of the reactive arom. azide and benzyne reaction partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox7AhODpK6OLVg90H21EOLACvtfcHk0lhumKRISLm61g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXislKqsbo%253D&md5=dc8c13a747972c04e718a612096ddc68</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fol9002338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9002338%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26atitle%3DBenzyne%2520click%2520chemistry%2520with%2520in%2520situ%2520generated%2520aromatic%2520azides%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D1587%26epage%3D1590%26doi%3D10.1021%2Fol9002338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Continuous-flow synthesis of 1-substituted benzotriazoles from chloronitrobenzenes and amines in a C-N bond formation /hydrogenation/diazotization/cyclization sequence</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4247</span><span class="NLM_x">–</span> <span class="NLM_lpage">4250</span><span class="refDoi"> DOI: 10.1002/anie.201300615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2Fanie.201300615" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=4247-4250&author=M.+Chenauthor=S.+L.+Buchwald&title=Continuous-flow+synthesis+of+1-substituted+benzotriazoles+from+chloronitrobenzenes+and+amines+in+a+C-N+bond+formation+%2Fhydrogenation%2Fdiazotization%2Fcyclization+sequence&doi=10.1002%2Fanie.201300615"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fanie.201300615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201300615%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DContinuous-flow%2520synthesis%2520of%25201-substituted%2520benzotriazoles%2520from%2520chloronitrobenzenes%2520and%2520amines%2520in%2520a%2520C-N%2520bond%2520formation%2520%252Fhydrogenation%252Fdiazotization%252Fcyclization%2520sequence%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D4247%26epage%3D4250%26doi%3D10.1002%2Fanie.201300615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Huisgen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeimies, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobius, L.</span><span> </span><span class="NLM_article-title">K1.3-Dipolare cycloadditionen, XXXII. Kinetik der additionen organischer azide an CC-mehrfachbindungen</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2494</span><span class="NLM_x">–</span> <span class="NLM_lpage">2507</span><span class="refDoi"> DOI: 10.1002/cber.19671000806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2Fcber.19671000806" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1967&pages=2494-2507&author=R.+Huisgenauthor=G.+Szeimiesauthor=L.+Mobius&title=K1.3-Dipolare+cycloadditionen%2C+XXXII.+Kinetik+der+additionen+organischer+azide+an+CC-mehrfachbindungen&doi=10.1002%2Fcber.19671000806"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fcber.19671000806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.19671000806%26sid%3Dliteratum%253Aachs%26aulast%3DHuisgen%26aufirst%3DR.%26aulast%3DSzeimies%26aufirst%3DG.%26aulast%3DMobius%26aufirst%3DL.%26atitle%3DK1.3-Dipolare%2520cycloadditionen%252C%2520XXXII.%2520Kinetik%2520der%2520additionen%2520organischer%2520azide%2520an%2520CC-mehrfachbindungen%26jtitle%3DChem.%2520Ber.%26date%3D1967%26volume%3D100%26spage%3D2494%26epage%3D2507%26doi%3D10.1002%2Fcber.19671000806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ramachary, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakumar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, V. V.</span><span> </span><span class="NLM_article-title">Amino acid-catalyzed cascade [3+2]-cycloaddition/hydrolysis reactions based on the push-pull dienamine platform: synthesis of highly functionalized NH-1,2,3-triazoles</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">9143</span><span class="NLM_x">–</span> <span class="NLM_lpage">9147</span><span class="refDoi"> DOI: 10.1002/chem.200801325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2Fchem.200801325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=18767077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlKmtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=9143-9147&author=D.+B.+Ramacharyauthor=K.+Ramakumarauthor=V.+V.+Narayana&title=Amino+acid-catalyzed+cascade+%5B3%2B2%5D-cycloaddition%2Fhydrolysis+reactions+based+on+the+push-pull+dienamine+platform%3A+synthesis+of+highly+functionalized+NH-1%2C2%2C3-triazoles&doi=10.1002%2Fchem.200801325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Amino acid-catalyzed cascade [3+2]-cycloaddition/hydrolysis reactions based on the push-pull dienamine platform: synthesis of highly functionalized NH-1,2,3-triazoles</span></div><div class="casAuthors">Ramachary, Dhevalapally B.; Ramakumar, Kinthada; Narayana, Vidadala V.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9143-9147</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A practical and environmentally friendly amino acid catalyzed cascade process for the synthesis of highly substituted NH-1,2,3-triazoles was achieved through cascade [3+2]-cycloaddn./hydrolysis of Hagemann's esters with p-toluenesulfonyl azide (TsN3) in the presence of a catalytic amt. of proline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmoR0fp2ctkbVg90H21EOLACvtfcHk0lhumKRISLm61g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlKmtbbL&md5=2fdf6d7eacd0175f6eacea69007311c1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fchem.200801325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200801325%26sid%3Dliteratum%253Aachs%26aulast%3DRamachary%26aufirst%3DD.%2BB.%26aulast%3DRamakumar%26aufirst%3DK.%26aulast%3DNarayana%26aufirst%3DV.%2BV.%26atitle%3DAmino%2520acid-catalyzed%2520cascade%2520%255B3%252B2%255D-cycloaddition%252Fhydrolysis%2520reactions%2520based%2520on%2520the%2520push-pull%2520dienamine%2520platform%253A%2520synthesis%2520of%2520highly%2520functionalized%2520NH-1%252C2%252C3-triazoles%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D9143%26epage%3D9147%26doi%3D10.1002%2Fchem.200801325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Belkheira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Abed, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bressy, C.</span><span> </span><span class="NLM_article-title">Organocatalytic synthesis of 1,2,3-triazoles from unactivated ketones and arylazides</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">12917</span><span class="NLM_x">–</span> <span class="NLM_lpage">12921</span><span class="refDoi"> DOI: 10.1002/chem.201102046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1002%2Fchem.201102046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=21984230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yjsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=12917-12921&author=M.+Belkheiraauthor=D.+El+Abedauthor=J.-M.+Ponsauthor=C.+Bressy&title=Organocatalytic+synthesis+of+1%2C2%2C3-triazoles+from+unactivated+ketones+and+arylazides&doi=10.1002%2Fchem.201102046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Organocatalytic Synthesis of 1,2,3-Triazoles from Unactivated Ketones and Arylazides</span></div><div class="casAuthors">Belkheira, Mokhtaria; El Abed, Douniazad; Pons, Jean-Marc; Bressy, Cyril</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">12917-12921, S12917/1-S12917/33</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel organocatalytic synthesis of highly substituted 1,2,3-triazoles from unactivated ketones and arylazides is presented.  Proline was established as an excellent organocatalyst for this reaction, with the acid moiety being crucial for the elimination step.  While the reaction needed to be run for a prolonged time under thermal conditions, a dramatic acceleration was obsd. by using microwave activation.  A wide range of arylazides and ketones could be used, with cyclic ketones giving the best results.  Finally, high levels of regio- and chemoselectivity were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdeBj1N6vHsrVg90H21EOLACvtfcHk0lhFvpylUn4AoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yjsrjK&md5=f9d7ab62a6182f5055a21dcbb5c2cb66</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fchem.201102046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201102046%26sid%3Dliteratum%253Aachs%26aulast%3DBelkheira%26aufirst%3DM.%26aulast%3DEl%2BAbed%26aufirst%3DD.%26aulast%3DPons%26aufirst%3DJ.-M.%26aulast%3DBressy%26aufirst%3DC.%26atitle%3DOrganocatalytic%2520synthesis%2520of%25201%252C2%252C3-triazoles%2520from%2520unactivated%2520ketones%2520and%2520arylazides%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D12917%26epage%3D12921%26doi%3D10.1002%2Fchem.201102046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Dean, D. K.; Munoz-Muriedas, J.; Sime, M.; Steadman, J. G. A.; Thewlis, R. E. A.; Trani, G.; Walter, D. S.</span><span> </span><span class="NLM_article-title">5,6,7,8-Tetrahydro[1,2,4]triazolo[4,3-a]pyrazine derivatives as P2X7 modulators</span>. WO 2010125102 A1, November 4,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+K.+Dean&author=J.+Munoz-Muriedas&author=M.+Sime&author=J.+G.+A.+Steadman&author=R.+E.+A.+Thewlis&author=G.+Trani&author=D.+S.+Walter&title=5%2C6%2C7%2C8-Tetrahydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+derivatives+as+P2X7+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DD.%2BK.%26atitle%3D5%252C6%252C7%252C8-Tetrahydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520derivatives%2520as%2520P2X7%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Parsons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, H. D.</span><span> </span><span class="NLM_article-title">Precise absolute-structure determination in light-atom crystals</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">s61</span><span class="refDoi"> DOI: 10.1107/S0108767304098800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1107%2FS0108767304098800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=14684893" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=s61&author=S.+Parsonsauthor=H.+D.+Flack&title=Precise+absolute-structure+determination+in+light-atom+crystals&doi=10.1107%2FS0108767304098800"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0108767304098800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767304098800%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DFlack%26aufirst%3DH.%2BD.%26atitle%3DPrecise%2520absolute-structure%2520determination%2520in%2520light-atom%2520crystals%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3Ds61%26doi%3D10.1107%2FS0108767304098800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Discovery-stage recrystallization techniques employed the following: cooling–evaporation crystallization (25 solvent pairs), cooling crystallization with hot filtration (14 solvent pairs), crash-crystallization by antisolvent addition (15 solvent pairs), evaporative crystallization (15 solvent pairs), long-term slurry conversion (10 solvents), and thermocycling (15 solvents). Vapor diffusion techniques and thermocycling and polymer assisted crystallization were also attempted.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mahmood, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balian, J. D.</span><span> </span><span class="NLM_article-title">Interspecies scaling: predicting clearance of drugs in humans: three different approaches</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span><span class="refDoi"> DOI: 10.3109/00498259609052491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.3109%2F00498259609052491" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=887-895&author=I.+Mahmoodauthor=J.+D.+Balian&title=Interspecies+scaling%3A+predicting+clearance+of+drugs+in+humans%3A+three+different+approaches&doi=10.3109%2F00498259609052491"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3109%2F00498259609052491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498259609052491%26sid%3Dliteratum%253Aachs%26aulast%3DMahmood%26aufirst%3DI.%26aulast%3DBalian%26aufirst%3DJ.%2BD.%26atitle%3DInterspecies%2520scaling%253A%2520predicting%2520clearance%2520of%2520drugs%2520in%2520humans%253A%2520three%2520different%2520approaches%26jtitle%3DXenobiotica%26date%3D1996%26volume%3D26%26spage%3D887%26epage%3D895%26doi%3D10.3109%2F00498259609052491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoblock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepomuceno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1111/bph.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1111%2Fbph.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=23889535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=624-640&author=A.+Bhattacharyaauthor=Q.+Wangauthor=H.+Aoauthor=J.+R.+Shoblockauthor=B.+Lordauthor=L.+Aluisioauthor=I.+Fraserauthor=D.+Nepomucenoauthor=R.+A.+Neffauthor=N.+Weltyauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=A.+D.+Wickendenauthor=M.+A.+Letavic&title=Pharmacological+characterization+of+a+novel+centrally+permeable+P2X7+receptor+antagonist%3A+JNJ-47965567&doi=10.1111%2Fbph.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span></div><div class="casAuthors">Bhattacharya, Anindya; Wang, Qi; Ao, Hong; Shoblock, James R.; Lord, Brian; Aluisio, Leah; Fraser, Ian; Nepomuceno, Diane; Neff, Robert A.; Welty, Natalie; Lovenberg, Timothy W.; Bonaventure, Pascal; Wickenden, Alan D.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">624-640</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : An increasing body of evidence suggests that the purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7) in the CNS may play a key role in neuropsychiatry, neurodegeneration and chronic pain.  In this study, we characterized JNJ-47965567, a centrally permeable, high-affinity, selective P2X7 antagonist.  Exptl. Approach : We have used a combination of in vitro assays (calcium flux, radioligand binding, electrophysiol., IL-1β release) in both recombinant and native systems.  Target engagement of JNJ-47965567 was demonstrated by ex vivo receptor binding autoradiog. and in vivo blockade of Bz-ATP induced IL-1β release in the rat brain.  Finally, the efficacy of JNJ-47965567 was tested in std. models of depression, mania and neuropathic pain.  Key Results : JNJ-47965567 is potent high affinity (pKi 7.9 ± 0.07), selective human P2X7 antagonist, with no significant obsd. speciation.  In native systems, the potency of the compd. to attenuate IL-1β release was 6.7 ± 0.07 (human blood), 7.5 ± 0.07 (human monocytes) and 7.1 ± 0.1 (rat microglia).  JNJ-47965567 exhibited target engagement in rat brain, with a brain EC50 of 78 ± 19 ng·mL-1 (P2X7 receptor autoradiog.) and functional block of Bz-ATP induced IL-1β release.  JNJ-47965567 (30 mg·kg-1) attenuated amphetamine-induced hyperactivity and exhibited modest, yet significant efficacy in the rat model of neuropathic pain.  No efficacy was obsd. in forced swim test.  Conclusion and Implications : JNJ-47965567 is centrally permeable, high affinity P2X7 antagonist that can be used to probe the role of central P2X7 in rodent models of CNS pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS_bU7fI8KzLVg90H21EOLACvtfcHk0lhFvpylUn4AoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI&md5=29d3bc1d3ecedda01f3d33b53d96c289</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fbph.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12314%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DWelty%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520novel%2520centrally%2520permeable%2520P2X7%2520receptor%2520antagonist%253A%2520JNJ-47965567%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26spage%3D624%26epage%3D640%26doi%3D10.1111%2Fbph.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourgeaud, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vliegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verluyten, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haspeslagh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">A novel radioligand for the ATP-gated ionchannel P2X7:[<sup>3</sup>H] JNJ-54232334</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">765</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.1016%2Fj.ejphar.2015.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=26386289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFOrs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=765&publication_year=2015&pages=551-559&author=B.+Lordauthor=M.+K.+Ameriksauthor=Q.+Wangauthor=L.+Fourgeaudauthor=M.+Vliegenauthor=W.+Verluytenauthor=P.+Haspeslaghauthor=N.+I.+Carruthersauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=M.+A.+Letavicauthor=A.+Bhattacharya&title=A+novel+radioligand+for+the+ATP-gated+ionchannel+P2X7%3A%5B3H%5D+JNJ-54232334&doi=10.1016%2Fj.ejphar.2015.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334</span></div><div class="casAuthors">Lord, Brian; Ameriks, Michael K.; Wang, Qi; Fourgeaud, Lawrence; Vliegen, Maarten; Verluyten, Willy; Haspeslagh, Pieter; Carruthers, Nicholas I.; Lovenberg, Timothy W.; Bonaventure, Pascal; Letavic, Michael A.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">765</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">551-559</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ATP-gated ion channel P2X7 has emerged as a potential central nervous system (CNS) drug target based on the hypotheses that pro-inflammatory cytokines such as IL-1β that are released by microglia, may contribute to the etiol. of various disorders of the CNS including depression.  In this study, we identified two closely related P2X7 antagonists, JNJ-54232334 and JNJ-54140515, and then tritium labeled the former to produce a new radioligand for P2X7.  JNJ-54232334 is a high affinity ligand for the rat P2X7 with a pKi of 9.3±0.1.  In rat cortical membranes, [3H] JNJ-54232334 reached saturable binding with equil. dissocn. (Kd) const. of 4.9±1.3 nM.  The compd. displayed monophasic assocn. and dissocn. kinetics with fast on and off rates.  In rat brain sections, specific binding of [3H] JNJ-54232334 was markedly improved compared to the previously described P2X7 radioligand, [3H] A-804598.  In P2X7 knockout mouse brain sections, [3H] A-804598 bound to non-P2X7 binding sites in contrast to [3H] JNJ-54232334.  In rat or wild type mouse brain sections [3H] JNJ-54232334 bound in a more homogenous and region independent manner.  The ubiquitous expression of P2X7 receptors was confirmed with immunohistochem. in rat brain sections.  The partial displacement of [3H] A-804598 binding resulted in the underestimation of the level of ex vivo P2X7 occupancy for JNJ-54140515.  Higher levels of P2X7 ex vivo occupancy were measured using [3H] JNJ-54232334 due to less non-specific binding.  In summary, we describe [3H] JNJ-54232334 as a novel P2X7 radioligand, with improved properties over [3H] A-804598.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqr6Nqq14QSLVg90H21EOLACvtfcHk0li8arwpV1KDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFOrs7zP&md5=b7d9da772882fa3d9e405fa54444d0f3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DFourgeaud%26aufirst%3DL.%26aulast%3DVliegen%26aufirst%3DM.%26aulast%3DVerluyten%26aufirst%3DW.%26aulast%3DHaspeslagh%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DA%2520novel%2520radioligand%2520for%2520the%2520ATP-gated%2520ionchannel%2520P2X7%253A%255B3H%255D%2520JNJ-54232334%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D765%26spage%3D551%26epage%3D559%26doi%3D10.1016%2Fj.ejphar.2015.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Potratz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bäuerle, P.</span><span> </span><span class="NLM_article-title">Thiophene-based donor–acceptor co-oligomers by copper-catalyzed 1,3-dipolar cycloaddition</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.3762/bjoc.8.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=10.3762%2Fbjoc.8.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=23015814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVGisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=683-692&author=S.+Potratzauthor=A.+Mishraauthor=P.+B%C3%A4uerle&title=Thiophene-based+donor%E2%80%93acceptor+co-oligomers+by+copper-catalyzed+1%2C3-dipolar+cycloaddition&doi=10.3762%2Fbjoc.8.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Thiophene-based donor-acceptor co-oligomers by copper-catalyzed 1,3-dipolar cycloaddition</span></div><div class="casAuthors">Potratz, Stefanie; Mishra, Amaresh; Baeuerle, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">683-692, No. 76</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">Herein the authors present a three-component one-pot procedure to synthesize oligomers of a donor-acceptor-donor type (charge transfer complexes) in which thiophene moieties work as donor groups and 1,2,3-triazole derivs. as acceptor units.  In this respect, terminal alkyne (oligo)thiophene derivs. were coupled to halogenated (oligo)thiophenes in the presence of sodium azide and a copper catalyst.  The optoelectronic properties of various thiophene-1,2,3-triazole oligomers were investigated by UV-vis spectroscopy and cyclic voltammetry.  Several co-oligomers were subjected to electrochem. polymn. to form corresponding conjugated polymers.  The synthesis of the target compds. was achieved by a systematic variation of reactants and the title compds. thus formed included a bithiophene-triazole deriv. (I) which was obtained as red-colored monomer, which formed a blue-colored polymer film upon electrochem. polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgMnsrqzi1N7Vg90H21EOLACvtfcHk0ljnytx6r4ty7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVGisb0%253D&md5=1647fbf90f8aeba52bbada779bb6a3e7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.8.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.8.76%26sid%3Dliteratum%253Aachs%26aulast%3DPotratz%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DB%25C3%25A4uerle%26aufirst%3DP.%26atitle%3DThiophene-based%2520donor%25E2%2580%2593acceptor%2520co-oligomers%2520by%2520copper-catalyzed%25201%252C3-dipolar%2520cycloaddition%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2012%26volume%3D8%26spage%3D683%26epage%3D692%26doi%3D10.3762%2Fbjoc.8.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i73"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01279">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08114"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01279">10.1021/acs.jmedchem.7b01279</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis of acid chloride, azide intermediates, <b>30</b>, <b>31</b>, and <b>40</b>, crystallography experiments for <b>29</b>, log <i>D</i> and p<i>K</i><sub>a</sub> measurements for <b>35</b>, CYP data for <b>29</b> and <b>35</b>, experimental protocols and data for HR-XPRD, digital imaging, DSC and TGMS for <b>29</b> and <b>35</b>, and thermal and shock stability screen results for 2-azido-5-fluoropyrimidine (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_001.pdf">jm7b01279_si_001.pdf (3.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01279/suppl_file/jm7b01279_si_002.csv">jm7b01279_si_002.csv (4.89 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01279%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01279" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994cbdbb7d2254","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
